Sentence,class,file
Available from: http://www.deccanherald.com/content/262000/india-give-free-medicine-hundreds.html.,Non-OADS,/arxiv_data1/oa_pdf/da/b3/JFMPC-3-91.PMC4140007.pdf
Available from: http://www.hindustantimes.com/india-news/50-essential-meds-to-be-given-free/article1-1231375.aspx.,Non-OADS,/arxiv_data1/oa_pdf/da/b3/JFMPC-3-91.PMC4140007.pdf
Available from: http://www.who.int/hpr/NPH/docs/declaration_almaata.pdf [Last cited on 2013 Jan 15].,OADS,/arxiv_data1/oa_pdf/ed/cc/JFMPC-3-94.PMC4140008.pdf
Available from: http://www.nrhm-mis.nic.in/UI/RHS/RHS%202010/RHS%202010/Rural%20Health%20Care%20System%20in%20India.pdf [Last accessed on 2013 Jan 21].,Non-OADS,/arxiv_data1/oa_pdf/ed/cc/JFMPC-3-94.PMC4140008.pdf
Available from: http://www.asianhhm.com/healthcare_management/primary-healthcare-india.htm [Last accessed on 2013 Nov 30].,Non-OADS,/arxiv_data1/oa_pdf/ed/cc/JFMPC-3-94.PMC4140008.pdf
Available from: http://www.blogs.hbr.org/cs/2012/04/how_telemedicine_saves_lives_a.html [Last accessed on 2012 Apr 23].,Non-OADS,/arxiv_data1/oa_pdf/ed/cc/JFMPC-3-94.PMC4140008.pdf
Available from: http://www.yourhealth.gov.au/internet/yourhealth/publishing.nsf/Content/nphc-draft-report-toc/$FILE/NPHC-Draft.pdf [Last accessed on 2013 Nov 30].,Non-OADS,/arxiv_data1/oa_pdf/ed/cc/JFMPC-3-94.PMC4140008.pdf
Available from: http://www.ctri.,Non-OADS,/arxiv_data1/oa_pdf/b6/2b/IJMR-139-657.PMC4140027.pdf
"Available 2.  from: http://www.progeriaresearch.org/meet_the_kids.html,  accessed on May 17, 2014.",Non-OADS,/arxiv_data1/oa_pdf/85/69/IJMR-139-667.PMC4140030.pdf
"Data were analyzed with the GraphPad  InStat 3.0 software program (GraphPad Software Inc.,  La Jolla, California, USA) and the VassarStat online  tool (http://vassarstats.net).",OADS,/arxiv_data1/oa_pdf/80/29/IJMR-139-686.PMC4140032.pdf
"Available from: http://europepmc.org/abstract/ MED/2696868 , accessed on January 26, 2013.",Non-OADS,/arxiv_data1/oa_pdf/80/29/IJMR-139-686.PMC4140032.pdf
"Available from: http://www.jultrasoundmed.org/ content/1/2/49.long , accessed on January 26, 2013.",OADS,/arxiv_data1/oa_pdf/80/29/IJMR-139-686.PMC4140032.pdf
Estimates of the overall measurement precision  of fat mass and hydration factor from the 4C model  were calculated using the propagation of error  method ( http://burro.case.edu/Academics/Astr306/ Stats/Appendix_V_Error_Prop.pdf.,OADS,/arxiv_data1/oa_pdf/56/2e/IJMR-139-700.PMC4140034.pdf
"For sensitivity/specificities 95% confidence  intervals were calculated ( http://www.vassarstats.net/ clin1.htm l)12, and for other comparisons kappa statistics  were derived using SPSS version 1713.",OADS,/arxiv_data1/oa_pdf/79/06/IJMR-139-714.PMC4140036.pdf
"Available from: http://www.vassarstats.net/clin1.html ,  accessed on December 20, 2012.",Non-OADS,/arxiv_data1/oa_pdf/79/06/IJMR-139-714.PMC4140036.pdf
"Available from: http://globocan.iarc.f r, accessed on May 22,  2014.",Non-OADS,/arxiv_data1/oa_pdf/d3/a5/IJMR-139-720.PMC4140037.pdf
The primers were designed using  Primer3 Input (version 0.4.0) ( http://primer3.ut.ee ).,OADS,/arxiv_data1/oa_pdf/b2/a0/IJMR-139-737.PMC4140039.pdf
"Sequence analysis : Reference sequences for all  QRDRs ( gyrA, gyrB, parC  and parE ) were obtained  from http://www.ncbi.nlm.nih.gov/gene  and compared  with the sequence of S. Typhi strain CT18 (accession  no.",OADS,/arxiv_data1/oa_pdf/b4/2b/IJMR-139-746.PMC4140040.pdf
"Available from: http://www.psc.edu/biomed/genedoc , accessed  on November 16, 2011.",OADS,/arxiv_data1/oa_pdf/b4/2b/IJMR-139-746.PMC4140040.pdf
"Available 11.  from: http://ibnlive.in.com/news/sharp-rise-in-mumps-cases- in-district/226432-60-122.htm l, accessed on February 3,  2012.",Non-OADS,/arxiv_data1/oa_pdf/59/3d/IJMR-139-773.PMC4140044.pdf
Available from:  http://www.nacoonline.org/NACO/Quick_Links/Publication/ Blood_Safety__Lab_Services/Others/An_Action_Plan_for_Blood_ Safety/ [Last accessed on 2007 Aug 29].,Non-OADS,/arxiv_data1/oa_pdf/a5/ca/AJTS-8-135.PMC4140059.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/51/5b/copd-9-863.PMC4140176.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 863–870International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  863OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S6519 5evaluation of ghrelin level and appetite regulation  in patients with acute exacerbations of chronic  obstructive pulmonary disease Ye Wang1,# Y ongchun shen1,# Qiunan Zuo2 li Zhao3 Chun Wan1 Panwen Tian1 lei Chen1 Fuqiang Wen1 1Department of respiratory  Medicine, West China hospital of  sichuan University and Division  of Pulmonary Diseases, state Key  laboratory of Biotherapy of China,   Chengdu, People’s republic of  China; 2Department of geriatrics,   sichuan Provincial People’s hospital,   Chengdu, People’s republic of China;   3Department of respiratory Medicine,   guizhou People’s hospital, guizhou,   People’s republic of China #These authors contributed equally  to this work and share joint first  authorship Correspondence: Fuqiang Wen   Department of respiratory Medicine,  West China hospital of sichuan  University and Division of Pulmonary  Diseases, state Key laboratory of  Biotherapy of China, Chengdu 610041,  People’s republic of China   Tel +86 28 8542 2350   Fax +86 28 8558 2944   email wenfuqiang.scu@gmail.co mBackground:  Appetite reduction is a major cause of cachexia in acute exacerbations of chronic  obstructive pulmonary disease (AECOPD).",Non-OADS,/arxiv_data1/oa_pdf/51/5b/copd-9-863.PMC4140176.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/51/5b/copd-9-863.PMC4140176.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/51/5b/copd-9-863.PMC4140176.pdf
Available at: http://pewinternet.org/Reports/2013/social-networking-sites.aspx.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/i1936-900X-15-5-567.PMC4140198.pdf
"Available at: http://www.census.gov/newsroom/releases/archives/miscellaneous/cb12-134.html.Accessed December 8, 2013.",OADS,/arxiv_data1/oa_pdf/73/aa/i1936-900X-15-5-567.PMC4140198.pdf
Available at: http://www.ncd.gov/publications/2006/Aug072006.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/i1936-900X-15-5-567.PMC4140198.pdf
Available at: http://www.ncd.gov/publications/2005/04152005.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/i1936-900X-15-5-567.PMC4140198.pdf
Available at: http://www.ada.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/i1936-900X-15-5-567.PMC4140198.pdf
Available at: http://www.ntia.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/i1936-900X-15-5-567.PMC4140198.pdf
Available at: http://www.2010disabilitysurveys.org/pdfs/surveyresults.pdf.,OADS,/arxiv_data1/oa_pdf/73/aa/i1936-900X-15-5-567.PMC4140198.pdf
Available at: http://wirelessrerc.org/sites/ default/files/publications/SUNspot_2013-03_Wireless_Devices_and_Adults_with_Disabilities_2013-07-12%5B1%5D.pdf.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/i1936-900X-15-5-567.PMC4140198.pdf
Available at: http://pewinternet.org/ Reports/2013/Smartphone-Ownership-2013.aspx.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/i1936-900X-15-5-567.PMC4140198.pdf
Available at: http://pewinternet.org/Reports/2013/ Tablet-Ownership-2013.aspx.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/i1936-900X-15-5-567.PMC4140198.pdf
Available at: http://i.dell.com/sites/content/shared-content/campaigns/en/Documents/ Red-Cross-Survey-Social-Media-in-Disasters-Aug-2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/i1936-900X-15-5-567.PMC4140198.pdf
Available at: http://redcrosschat.org/2011/08/24/ how-do-you-use-social-media-in-emergencies.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/i1936-900X-15-5-567.PMC4140198.pdf
Available at: http://a1881.g.akamai.net/7/1881/26640/v0001/redcross.download.akamai.com/26640/PollData/Social.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/i1936-900X-15-5-567.PMC4140198.pdf
Available at: http://wirelessrerc.org/content/publications/2013-sunspot-number-07-adults-disabilities-and-cellphone-internet-use-2.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/i1936-900X-15-5-567.PMC4140198.pdf
Available at: http://www.cnn.com/2012/10/31/tech/social-media/sandy-twitter-hoax/index.html.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/i1936-900X-15-5-567.PMC4140198.pdf
Available at: http://www.fema.gov/hurricane-sandy-rumor-control.,OADS,/arxiv_data1/oa_pdf/73/aa/i1936-900X-15-5-567.PMC4140198.pdf
Available at http://www.e-benchmarksstudy.com.,Non-OADS,/arxiv_data1/oa_pdf/8d/aa/i1936-900X-15-5-582.PMC4140200.pdf
"Available at http://blog.bitly.com/post/9887686919/you-just-shared-a-link-how-long-will-people-pay.Accessed January 2, 2014.",Non-OADS,/arxiv_data1/oa_pdf/8d/aa/i1936-900X-15-5-582.PMC4140200.pdf
"The survey collected information from eligible patients on demographics (including age, gender, education, and income), baseline technology use, preferences for receiving health- related information on 7 pre-deﬁned risky behaviors through aseries of technology-based modalities, and concerns forreceiving health information through various technology mediums (full survey online at http://www.annemergmed.com, Appendix E2, E3).",OADS,/arxiv_data1/oa_pdf/87/55/i1936-900X-15-5-593.PMC4140202.pdf
Accessed online at http://www.ahrq.gov/professionals/ systems/hospital/esi/esi1.html.,Non-OADS,/arxiv_data1/oa_pdf/87/55/i1936-900X-15-5-593.PMC4140202.pdf
"Available at: http://www.cdc.gov/BRFSS/questionnaires/pdf-ques/2008brfss.pdf.Accessed: October 31, 2013 34.",OADS,/arxiv_data1/oa_pdf/87/55/i1936-900X-15-5-593.PMC4140202.pdf
Available at https://www.mhealthevidence.org/whats-new.,Non-OADS,/arxiv_data1/oa_pdf/19/ae/i1936-900X-15-5-600.PMC4140203.pdf
Available at http://www.mhealthinfo.org/what-mhealth.,Non-OADS,/arxiv_data1/oa_pdf/19/ae/i1936-900X-15-5-600.PMC4140203.pdf
Available at http://www.audiencescapes.org/ country-profiles/uganda/country-overview/mobile-communications/ mobile-communications-284.,Non-OADS,/arxiv_data1/oa_pdf/19/ae/i1936-900X-15-5-600.PMC4140203.pdf
Available at http://www.cdc.gov/GSHS/.,OADS,/arxiv_data1/oa_pdf/19/ae/i1936-900X-15-5-600.PMC4140203.pdf
Available at: http://www.cdc.gov/injury/wisqars/index.html.,OADS,/arxiv_data1/oa_pdf/0a/e7/i1936-900X-15-5-609.PMC4140205.pdf
2012; http://www.cdc.gov/violenceprevention/pdf/ yv_factsheet2012-a.pdf.,Non-OADS,/arxiv_data1/oa_pdf/88/82/i1936-900X-15-5-615.PMC4140206.pdf
Role of the Emergency Physician in Injury Prevention and Control for Adult and Pediatric Patients October 2002; http://acep.org/practres.,Non-OADS,/arxiv_data1/oa_pdf/88/82/i1936-900X-15-5-615.PMC4140206.pdf
For full text: http://www.stopyouthviolence.ucr.edu/.,Non-OADS,/arxiv_data1/oa_pdf/88/82/i1936-900X-15-5-615.PMC4140206.pdf
"The online version of this article is published within an Open Access environment subject to the conditions of the Creative CommonsAttribution-NonCommercial-ShareAlike licence ,http://creativecommons.org/licenses/by-nc-sa/3.0/ ..",Non-OADS,/arxiv_data1/oa_pdf/5f/47/S109285291300093Xa.PMC4140225.pdf
Available at:http://www.latuda.com/LatudaPrescribingInformation.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/47/S109285291300093Xa.PMC4140225.pdf
Available at: http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm231512.htm.,Non-OADS,/arxiv_data1/oa_pdf/5f/47/S109285291300093Xa.PMC4140225.pdf
Available at: http://www.sunovion.ca/news/ pressReleases/20120615.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/47/S109285291300093Xa.PMC4140225.pdf
Available at: http://www.sunovion.ca/monographs/latuda.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/47/S109285291300093Xa.PMC4140225.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a9/d0/ott-7-1439.PMC4140227.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a9/d0/ott-7-1439.PMC4140227.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/d0/ott-7-1439.PMC4140227.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/d6/jbm-5-131.PMC4140228.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2014:5 131–141Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  131Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S3876 2Update on argatroban for the prophylaxis   and treatment of heparin-induced   thrombocytopenia type ii elisavet Grouzi Department of Transfusion   Service and Clinical Hemostasis,    “Agios Savvas” Regional Cancer   Hospital, Athens, Greece Correspondence: elisavet Grouzi   Department of Transfusion   Service and Clinical Hemostasis,   “Agios Savvas” Regional Cancer   Hospital, Alexandras Avenue 171,   11522 Ambelikipoi, Athens, Greece   Tel +30 210 6409330   email egrouzi@otenet.g rAbstract:  Heparin-induced thrombocytopenia (HIT) is a rare but potentially severe   complication of heparin therapy that is strongly associated with venous and arterial throm - bosis (HIT and thrombosis syndrome, HITTS), which requires urgent detection and treat - ment with a nonheparin anticoagulant.",Non-OADS,/arxiv_data1/oa_pdf/bc/d6/jbm-5-131.PMC4140228.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/bc/d6/jbm-5-131.PMC4140228.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/d6/jbm-5-131.PMC4140228.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/04/49/opth-8-1515.PMC4140229.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1515–1522Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1515Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S5977 6Intracameral cefuroxime and moxifloxacin used  as endophthalmitis prophylaxis after cataract  surgery: systematic review of effectiveness   and cost-effectiveness Renata Linertová1,2 Rodrigo Abreu-González3 Lidia García-Pérez1,2 Marta Alonso-Plasencia3 Luis Mateo Cordovés- Dorta4 José Augusto Abreu-Reyes4 Pedro Serrano-Aguilar2,5 1Fundación Canaria de investigación  y Salud (FUNC iS), Santa Cruz de  T enerife, Spain; 2Red de investigación  en Servicios Sanitarios en  enfermedades Crónicas (ReDiSSeC),   Madrid, Spain; 3Ophthalmology  Service, University Hospital Ntra  Sra de La Candelaria, Santa Cruz  de T enerife, Spain; 4Ophthalmology  Service, University Hospital of Canary  islands, La Laguna, Spain; 5HTA Unit,   Canary Health Service, Santa Cruz de  T enerife, Spain Correspondence: Renata Linertová   Servicio de evaluación, Servicio Canario  de investigación y Salud (FUNCiS),  Camino Candelaria 44, 1ª Planta, 38109 el  Rosario, Santa Cruz de T enerife, Spain   T el +34 922 684 019   email renata.linertova@sescs.e sAbstract:  Postoperative endophthalmitis is one of the most serious potential complications of  ocular lens surgery.",Non-OADS,/arxiv_data1/oa_pdf/04/49/opth-8-1515.PMC4140229.pdf
Bacteria most commonly identified in endophthalmitis after cataract  surgery in many Western countries may include coagulase-negative staphylococci Journal name: Clinical Ophthalmology Journal Designation: Review Y ear: 2014 Volume: 8 Running head verso: Linertová et al Running head recto: Prophylaxis of postoperative endophthalmitis: cefuroxime and moxifloxacin DOI: http://dx.doi.org/10.2147/OPTH.S59776,Non-OADS,/arxiv_data1/oa_pdf/04/49/opth-8-1515.PMC4140229.pdf
Avail - able from: http://www.chulaophthalmology.org/userfiles/download/ ESCRS_Guidelines_2007.pdf.,Non-OADS,/arxiv_data1/oa_pdf/04/49/opth-8-1515.PMC4140229.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/04/49/opth-8-1515.PMC4140229.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1522Linertová et al 20.,Non-OADS,/arxiv_data1/oa_pdf/04/49/opth-8-1515.PMC4140229.pdf
Available at: http://www.redcaspe.org/ drupal/?q=node/29.,OADS,/arxiv_data1/oa_pdf/04/49/opth-8-1515.PMC4140229.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/91/cd/jpr-7-471.PMC4140230.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2014:7 471–475Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  471ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S6449 7Patient-controlled analgesia in the pediatric  population: morphine versus hydromorphone Matthew Digiusto2 Tarun Bhalla1 David Martin1 Derek Foerschler3 Megan J Jones2 Joseph D T obias1 1Department of anesthesiology  and Pain Medicine, nationwide  children’s hospital and the Ohio  state University,  2The Ohio state  school of Medicine,  3Department  of anesthesiology, The Ohio state  University, columbus, Oh, Usa correspondence: Tarun Bhalla   Department of anesthesiology and  Pain Medicine, nationwide children’s  hospital,  700 children’s Drive,  columbus, Oh  43205, Usa   Tel +1 614 722 4200  Fax +1 614 722 4203  email tarun.bhalla@nationwidechildrens.or gObjective:  Patient controlled analgesia (PCA) is commonly used to provide analgesia following  surgical procedures in the pediatric population.",Non-OADS,/arxiv_data1/oa_pdf/91/cd/jpr-7-471.PMC4140230.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/91/cd/jpr-7-471.PMC4140230.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/91/cd/jpr-7-471.PMC4140230.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/5f/ijwh-6-759.PMC4140231.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 759–769International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  759RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S5348 9Challenges in implementing and maintaining  osteoporosis therapy Ankita Modi1 Shiva Sajjan1 Sampada Gandhi2 1Center for Observational and Real- World evidence, Merck & Co., Inc.,   Whitehouse Station, NJ, USA;    2School of Public Health, Rutgers  University, Piscataway, NJ, USA Correspondence: Ankita Modi   Center for Observational and Real  World evidence, Merck & Co,   Inc, One Merck Drive, PO Box 100,   WS2e-13, Whitehouse Station,   NJ 08889-0100, USA   Tel +1 908 423 6162   email a nkita.modi@mer ck.co mAbstract:  In the United States, an estimated 19% of older men and 30% of older women are  at elevated risk of osteoporotic fracture and considered to be eligible for treatment.",Non-OADS,/arxiv_data1/oa_pdf/a3/5f/ijwh-6-759.PMC4140231.pdf
Available from: http://nof.org/hcp/ resources/91 3.,Non-OADS,/arxiv_data1/oa_pdf/a3/5f/ijwh-6-759.PMC4140231.pdf
Available from: http://guidance.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/a3/5f/ijwh-6-759.PMC4140231.pdf
"Available from: http://www.nice.org.uk/ nicemedia/live/11746/47176/47176.pd f. Accessed May 24, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a3/5f/ijwh-6-759.PMC4140231.pdf
"Available from: http://www.iofbonehealth.org/ national-regional-osteoporosis-guideline s. Accessed October 24, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a3/5f/ijwh-6-759.PMC4140231.pdf
"Avail - able from: http://www.health.ny.gov/diseases/conditions/ osteoporosis/ fda_meds_and_prevention.ht m. Accessed October 24, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a3/5f/ijwh-6-759.PMC4140231.pdf
Available from: http://www.nof.org/articles/2 2.,Non-OADS,/arxiv_data1/oa_pdf/a3/5f/ijwh-6-759.PMC4140231.pdf
Available from: http://www.shef.ac.uk/FRAX /.,Non-OADS,/arxiv_data1/oa_pdf/a3/5f/ijwh-6-759.PMC4140231.pdf
Available from: http://www.fda.gov/Drugs/DrugSafety/ucm270199.,Non-OADS,/arxiv_data1/oa_pdf/a3/5f/ijwh-6-759.PMC4140231.pdf
"Available from: http://www.iofbonehealth.org/bonehealth/   inadequate-responders-working-grou p. Accessed October 24, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a3/5f/ijwh-6-759.PMC4140231.pdf
Available from: http://www.who.int/chp/knowledge/publications/adher - ence_report/en /.,Non-OADS,/arxiv_data1/oa_pdf/a3/5f/ijwh-6-759.PMC4140231.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/a3/5f/ijwh-6-759.PMC4140231.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/5f/ijwh-6-759.PMC4140231.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/44/bf/ijgm-7-401.PMC4140232.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2014:7 401–410International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  401OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S6718 7Public awareness of blood donation   in central saudi arabia Mostafa a abolfotouh1,2 Mohammed h al-assiri1 Manar al-Omani2 alwaleed al Johar3 abdulaziz al hakbani3 ahmed s alaskar1,2 1King abdullah International Medical  research center,  2King saud bin- abdulaziz University for health  sciences,  3college of Medicine,    King saud University , riyadh,    saudi arabia correspondence: Mostafa a abolfotouh   King abdullah International Medical  research center, PO Box 22490,   riyadh 11426, saudi arabia   Tel +966 11 801 1111 ext 14469   Fax +966 11 804 3050   email mabolfotouh@gmail.co mIntroduction:  In Saudi Arabia, voluntary donors are the only source of blood donation.",Non-OADS,/arxiv_data1/oa_pdf/44/bf/ijgm-7-401.PMC4140232.pdf
"Available from: http://apps.who.int/ medicinedocs/documents/s15413e/s15413e.pd f. Accessed July  1, 2014.",OADS,/arxiv_data1/oa_pdf/44/bf/ijgm-7-401.PMC4140232.pdf
Available from: http://archive.ahrq.gov/news/ newsroom/news-and-numbers/092409.html.,Non-OADS,/arxiv_data1/oa_pdf/44/bf/ijgm-7-401.PMC4140232.pdf
Available from:  http://edition.cnn.com/2013/02/20/world/meast/saudi-arabia-hiv-case /.,Non-OADS,/arxiv_data1/oa_pdf/44/bf/ijgm-7-401.PMC4140232.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/44/bf/ijgm-7-401.PMC4140232.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/bf/ijgm-7-401.PMC4140232.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/10/57/opth-8-1507.PMC4140233.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1507–1513Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1507Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S6740 7Capsular block syndrome: a case report   and literature review Mauricio vélez Luis F velásquez Sebastián Rojas Laura Montoya Katherine Zuluaga Kepa Balparda Pontifical Bolivarian University,    School of Medicine, Medellín,   Antioquia, Colombia Correspondence: Mauricio vélez   Carrera 48 #19 A40, office 1517,  Torre Médica, Ciudad del Río, Medellín,  Colombia   email mauroftalmo@hotmail.co m Journal name: Clinical Ophthalmology Journal Designation: Review Y ear: 2014 Volume: 8 Running head verso: Vélez et al Running head recto: Capsular block syndrome DOI: http://dx.doi.org/10.2147/OPTH.S67407 Purpose:  To report the case of a patient who developed late capsular block syndrome and to  review the current literature regarding this complication of phacoemulsification procedures.",Non-OADS,/arxiv_data1/oa_pdf/10/57/opth-8-1507.PMC4140233.pdf
Or use: http://dvpr.es/XbU9L avideo abstract,Non-OADS,/arxiv_data1/oa_pdf/10/57/opth-8-1507.PMC4140233.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/10/57/opth-8-1507.PMC4140233.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1513Capsular block syndrome  6.,Non-OADS,/arxiv_data1/oa_pdf/10/57/opth-8-1507.PMC4140233.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/af/4b/ott-7-1449.PMC4140234.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 1449–1453OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1449CASE REPORTopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S6628 5Glucagonoma syndrome: a case report   with focus on skin disorders Sheng Fang Shuang Li Tao Cai Department of Dermatology, The  First Affiliated Hospital of Chongqing  Medical University, Chongqing,   People’s Republic of China Correspondence: Tao Cai   Department of Dermatology, The First  Affiliated Hospital of Chongqing Medical   University, 1 Youyi Road, Chongqing,  400016, People’s Republic of China   Email caitaocypf@163.co mAbstract:  Glucagonoma syndrome is a rare paraneoplastic phenomenon.",Non-OADS,/arxiv_data1/oa_pdf/af/4b/ott-7-1449.PMC4140234.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/af/4b/ott-7-1449.PMC4140234.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/4b/ott-7-1449.PMC4140234.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/65/ijn-9-3885.PMC4140235.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3885–3902International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3885OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S6435 3size-dependent accumulation of particles   in lysosomes modulates dendritic cell function  through impaired antigen degradation correspondence: Fabian Blank   respiratory Medicine, Department  of clinical research, Murtenstrasse 50,  3008 Bern, switzerland   Tel +41 31 632 7634   Fax +41 31 632 7594   email fabian.blank@dkf.unibe.c hemilie seydoux1,2 Barbara rothen-rutishauser1,3  Izabela M Nita1 sandor Balog3 amiq gazdhar1 Philip a stumbles4,5 alke Petri-Fink3,6 Fabian Blank1,* christophe von garnier1,* 1Department of respiratory Medicine,   Inselspital, Bern University hospital,   Department of clinical research,   University of Bern, 2graduate school  for cellular and Biomedical sciences,   University of Bern, Bern, switzerland;   3adolphe Merkle Institute, University  of Fribourg, Fribourg, switzerland;   4school of Veterinary and life  sciences, Molecular and Biomedical  sciences, Murdoch University,  Perth,   Wa, australia; 5T elethon Kids  Institute, Perth, W a, australia;   6Department of chemistry, University  of Fribourg, Fribourg, switzerland *These authors contributed equally  to the manuscriptJournal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Seydoux et al Running head recto: Particle size modulates dendritic cell function DOI: http://dx.doi.org/10.2147/IJN.S64353 Introduction:  Nanosized particles may enable therapeutic modulation of immune responses by  targeting dendritic cell (DC) networks in accessible organs such as the lung.",Non-OADS,/arxiv_data1/oa_pdf/71/65/ijn-9-3885.PMC4140235.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/71/65/ijn-9-3885.PMC4140235.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3902seydoux et al Figure S2 Assessment of emission fluorescence intensity of PS particles in buffer solutions at pH 5 and pH 7 after 10 minutes, 1 hour, 4 hours, and 16 hours incubation.",Non-OADS,/arxiv_data1/oa_pdf/71/65/ijn-9-3885.PMC4140235.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9f/2f/jpr-7-455.PMC4140236.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2014:7 455–463Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  455ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S6781 7Efficacy and safety profile of combination of   tramadol-diclofenac versus tramadol-paracetamol   in patients with acute musculoskeletal conditions,   postoperative pain, and acute flare of osteoarthritis   and rheumatoid arthritis: a Phase iii,  5-day   open-label study Ajay S Chandanwale1 Subramanian Sundar2 Kaliaperumal  Latchoumibady3 swati Biswas4 Mukesh Gabhane4 Manoj naik5 Kamlesh Patel4 1Department of Orthopedics &  Traumatology, Byramjee Jeejeebhoy  Medical college and sassoon general  hospital, Pune, Maharashtra, india;   2Vasantha Subramanian  hospital,   chennai, Tamil nadu, india;  3Vijay  Hospital, Pondicherry, India;  4Medical  services Department,  5clinical  Research Department, Abbott  Healthcare Pvt Ltd, Mumbai, India correspondence: swati Biswas   Abbott Healthcare Pvt Ltd,  1st floor,   D Mart Bldg, Mulund-goregaon   Link Road, Mumbai  400080, india   Tel +91 982 076 1009  Fax +91 223 9 53 6665   email swatiabiswas@gmail.co mObjective:  We aimed to evaluate the safety and efficacy of a fixed-dose combination (FDC)  of tramadol and diclofenac versus a standard approved FDC of tramadol and paracetamol, in  patients with acute moderate to severe pain.",Non-OADS,/arxiv_data1/oa_pdf/9f/2f/jpr-7-455.PMC4140236.pdf
Available from:  http://www.who.int/cancer/palliative/painladder/en /.,Non-OADS,/arxiv_data1/oa_pdf/9f/2f/jpr-7-455.PMC4140236.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/9f/2f/jpr-7-455.PMC4140236.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/2f/jpr-7-455.PMC4140236.pdf
"Available from: https://www.niehs.nih.gov/research/resources/ assets/docs/haq_instructions.pd f. Accessed July 23, 2014.",OADS,/arxiv_data1/oa_pdf/9f/2f/jpr-7-455.PMC4140236.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/9f/2f/jpr-7-455.PMC4140236.pdf
"Available from: http://www.medicines.org.uk/emc/medicine/24377/ spc#INDICATION S. Accessed June  27, 2014.",Non-OADS,/arxiv_data1/oa_pdf/9f/2f/jpr-7-455.PMC4140236.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0a/24/ott-7-1423.PMC4140237.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 1423–1437OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1423Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5890 0Oncogenic mutations are associated   with histological subtypes but do not have   an independent prognostic value in lung   adenocarcinoma haichuan hu1,3 Yunjian Pan1,3 Yuan li2,3 lei Wang1,3 rui Wang1,3 Yang Zhang1,3 hang li1,3 Ting Ye1,3 Yiliang Zhang1,3 Xiaoyang luo1,3 longlong shao1,3 Zhengliang sun1,3 Deng cai1,3 Jie Xu1,3 Qiong lu1,3 Y oujia Deng1,3 lei shen2,3 hongbin Ji4 Yihua sun1,3,* haiquan chen1,3,* 1Department of Thoracic surgery, 2Department  of Pathology, Fudan University cancer  center, shanghai, People’s republic of china;   3Department of Oncology, shanghai Medical  college, Fudan University, shanghai, People’s  republic of china; 4laboratory of Molecular  cell Biology, institute of Biochemistry and  cell Biology, shanghai institute for Biological  science, chinese academy of science, shanghai,   People’s republic of china *These authors contributed equally to this  work correspondence: haiquan chen;   Yihua sun   Department of Thoracic surgery, Fudan University  shanghai cancer center, Department of Oncology,  shanghai Medical college, Fudan University,   270 Dong an road, shanghai,   People’s republic of china   Tel +86 21 644 30 399   Fax +86 21 644 30 399   email hqchen1@yahoo.co m;   sun_yihua76@hotmail.co mAbstract:  Lung adenocarcinomas have diverse genetic and morphological backgrounds and are  usually classified according to their distinct oncogenic mutations (or so-called driver mutations)  and histological subtypes (the de novo classification proposed by the International Association for  the Study of Lung Cancer/American Thoracic Society/European Respiratory Society [IASLC/ ATS/ERS]).",Non-OADS,/arxiv_data1/oa_pdf/0a/24/ott-7-1423.PMC4140237.pdf
"Available from: http://www.nccn.org/professionals/ physician_gls/pdf/nscl.pd f. Accessed April 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/0a/24/ott-7-1423.PMC4140237.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0a/24/ott-7-1423.PMC4140237.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/24/ott-7-1423.PMC4140237.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3b/f3/opth-8-1495.PMC4140238.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1495–1505Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1495Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6663 7Treatment of allergic conjunctivitis with  bepotastine besilate ophthalmic solution 1.5% Correspondence: Jon i Williams Bausch + lomb, 50 Technology   Drive, irvine, Ca 92618, Usa email jon.williams@bausch.co mMark T Bergmann1 Jon i Williams2 Paul J gomes3 On behalf of the  Bepotastine Besilate  Ophthalmic solutions  Clinical study group 1eye Care associates of greater  Cincinnati, inc., Cincinnati, Oh, Usa;   2Bausch + lomb, irvine, C a, Usa;   3Ora, inc., andover, M a, UsaPurpose:  To examine the pooled per-protocol ocular end points from two conjunctival allergen  challenge (CAC) clinical trials of the dual-action antihistamine bepotastine besilate ophthalmic  solution (BBOS) 1.5%.",Non-OADS,/arxiv_data1/oa_pdf/3b/f3/opth-8-1495.PMC4140238.pdf
"This  is followed by a late or delayed (chronic) phase, hours or days after exposure, that is  manifested by proinflammatory mediators and recruitment of immune cells including  eosinophils and neutrophils.3,4Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Bergmann et al Running head recto: Integrated analysis of bepotastine besilate for allergic conjunctivitis DOI: http://dx.doi.org/10.2147/OPTH.S66637",Non-OADS,/arxiv_data1/oa_pdf/3b/f3/opth-8-1495.PMC4140238.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/3b/f3/opth-8-1495.PMC4140238.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1505integrated analysis of bepotastine besilate for allergic conjunctivitis  20.,Non-OADS,/arxiv_data1/oa_pdf/3b/f3/opth-8-1495.PMC4140238.pdf
Available  from http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/ Guidelines/Efficacy/E6_R1/Step4/E6_R1__Guideline.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3b/f3/opth-8-1495.PMC4140238.pdf
Available from http://www.meddra.org/how-to- use/support-documentation/english.,Non-OADS,/arxiv_data1/oa_pdf/3b/f3/opth-8-1495.PMC4140238.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/7d/ott-7-1441.PMC4140239.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 1441–1447OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1441Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6514 4Isothermal multiple displacement amplification:   a methodical approach enhancing molecular routine  diagnostics of microcarcinomas and small biopsies Fabian D Mairinger1 robert Fh Walter2 claudia Vollbrecht3 Thomas hager1 Karl Worm1 saskia Ting1 Jeremias Wohlschläger1 Paul Zarogoulidis4 Konstantinos Zarogoulidis4 Kurt W schmid1 1institute of Pathology,  2ruhrlandklinik,  West german lung center, University  hospital essen, essen,  3institute  of Pathology, University hospital  cologne, cologne, germany;   4Pulmonary Department, Oncology  Unit, g Papanikolaou general  hospital, aristotle University of  Thessaloniki, Thessaloniki, greece correspondence: Paul Zarogoulidis   Pulmonary Department,   g Papanikolaou general hospital,   aristotle University of Thessaloniki,   Thessaloniki, greece   Tel +30 23 1099 2433  Fax +30 23 1099 2432  email pzarog@hotmail.co mBackground and methods:  Isothermal multiple displacement amplification (IMDA) can be  a powerful tool in molecular routine diagnostics for homogeneous and sequence-independent  whole-genome amplification of notably small tumor samples, eg, microcarcinomas and biopsies  containing a small amount of tumor.",Non-OADS,/arxiv_data1/oa_pdf/52/7d/ott-7-1441.PMC4140239.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/52/7d/ott-7-1441.PMC4140239.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/7d/ott-7-1441.PMC4140239.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/6a/clep-6-287.PMC4140240.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2014:6 287–294Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  287REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S6682 1Disease burden evaluation of fall-related events  in the elderly due to hypoglycemia and other  diabetic complications: a clinical review Usman H Malabu1 venkat N vangaveti1 Richard Lee Kennedy2 1School of Medicine and Dentistry,   James Cook University, QLD,   Australia;  2Department of Medicine,   Deakin University, viC, Australia Correspondence: Usman H Malabu   School of Medicine and Dentistry, James   Cook University,  1 James Cook Drive,   Douglas, QLD  4814, Australia   Tel +61 744 331 111  Fax +61 744 332 239  Email usman.malabu@jcu.edu.a uAbstract:  A hypoglycemia-induced fall is common in older persons with diabetes.",Non-OADS,/arxiv_data1/oa_pdf/e2/6a/clep-6-287.PMC4140240.pdf
Or use: http://dvpr.es/1pfjxd o,Non-OADS,/arxiv_data1/oa_pdf/e2/6a/clep-6-287.PMC4140240.pdf
Available from: http://www.diabetes.org.uk/About_us/What-we-say/ Statistics/Diabetes-prevalence-2013 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/6a/clep-6-287.PMC4140240.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/e2/6a/clep-6-287.PMC4140240.pdf
"The highway system of Hungary, 2010 (Source: http://www.skyscrapercity.com/showthread.php?t=460510&page  =148).",Non-OADS,/arxiv_data1/oa_pdf/4b/b7/jphr-2012-1-e9.PMC4140308.pdf
Available from: http://www.euro.who.int/data/assets/  pdf_file/0010/74746/E90711.pdf  2.,OADS,/arxiv_data1/oa_pdf/7d/88/jphr-2012-1-e11.PMC4140309.pdf
2010 [Cited 15  June 2010]; Available from: http://legal-news.ashbycohen.co.uk/  discrimination/us-hears-first-case-of-genetic-discrimination/  3.,Non-OADS,/arxiv_data1/oa_pdf/b6/c5/jphr-2012-1-e8.PMC4140310.pdf
Available from: http://www.health.gov/phfunctions/public.,Non-OADS,/arxiv_data1/oa_pdf/b6/c5/jphr-2012-1-e8.PMC4140310.pdf
Available from:  http://www.emcdda.europa.eu/publications/annual-report/2011  6.,Non-OADS,/arxiv_data1/oa_pdf/db/7f/jphr-2012-1-e15.PMC4140312.pdf
Available from: http://www.espad.org/documents/Espad/  ESPAD_reports/2007/The_2007_ESPAD_Report-FULL_091006.pdf  7.,Non-OADS,/arxiv_data1/oa_pdf/db/7f/jphr-2012-1-e15.PMC4140312.pdf
Available from:  http://www.home - office.gov.uk/publications/science-research-statistics/research-sta - tistics/crime-research/hosb1310/hosb13101-annex2?view=Binary  10.,Non-OADS,/arxiv_data1/oa_pdf/db/7f/jphr-2012-1-e15.PMC4140312.pdf
Available from:  http://www-nrd.nhtsa.dot.gov/Pubs/810993.pdf  12.,Non-OADS,/arxiv_data1/oa_pdf/db/7f/jphr-2012-1-e15.PMC4140312.pdf
Available from: http://www.drager.ru/ST/  internet/pdf/Master/En/gt/Alcodrug/9044871_ Alcotest6510_e.pdf  25.,Non-OADS,/arxiv_data1/oa_pdf/db/7f/jphr-2012-1-e15.PMC4140312.pdf
Available from URL: http://www.simucar.com/en/simulators/  SimuNomad_3ecrans.html  26.,OADS,/arxiv_data1/oa_pdf/db/7f/jphr-2012-1-e15.PMC4140312.pdf
Available  from: http://www.alcopro.com/mm5/merchant.mvc?Screen=  PROD&Store_Code=A&Product_Code=823B&Categorycode=SALI  VA-DRUG-TEST  27.,Non-OADS,/arxiv_data1/oa_pdf/db/7f/jphr-2012-1-e15.PMC4140312.pdf
Available from: https://www.cia.,Non-OADS,/arxiv_data1/oa_pdf/c5/9c/jphr-2012-1-e2.PMC4140314.pdf
Available from:  http://www.who.int/countries/nga/areas/health_systems/en/index.h  tml.,Non-OADS,/arxiv_data1/oa_pdf/c5/9c/jphr-2012-1-e2.PMC4140314.pdf
OS Office of the Secretary OS is responsible for the management and coordination of programs and No 5 operations of the DHHS that help facilitate achieving the nation’s  public health mission  Total Sources: DHHS Website: http://www.hhs.gov/about/whatwedo.html/ 54,Non-OADS,/arxiv_data1/oa_pdf/2a/c9/jphr-2012-1-e12.PMC4140316.pdf
"Currently, the National Institutes of Health are considering moving  addiction-related activities from across the National Cancer Institute,  National Institute on Drug Abuse, and National Institute on Alcohol  Abuse and Alcoholism into a newly created substance abuse and addic - tions institute by 2014 (http://feedback.nih.gov).",Non-OADS,/arxiv_data1/oa_pdf/2a/c9/jphr-2012-1-e12.PMC4140316.pdf
Available from: http://www.hss.cmu.edu/depart - ments/sds/media/pdfs/loewenstein/loewenstein.pps  15.,Non-OADS,/arxiv_data1/oa_pdf/98/bd/jphr-2012-1-e5.PMC4140317.pdf
Available from:  http://sculpture.gla.,Non-OADS,/arxiv_data1/oa_pdf/59/ea/jphr-2012-1-e10.PMC4140318.pdf
Available from: http://www.casacolumbia.org/  templates/publications_reports.aspx  7.,Non-OADS,/arxiv_data1/oa_pdf/b5/10/jphr-2012-1-e13.PMC4140319.pdf
Accessedon: 20 August 2011 Available from:  http://www.nacoonline.org/upload/HomePage/NACO%20Press%20R  elease%20on%20HIV%20Estimates.pdf  2.,Non-OADS,/arxiv_data1/oa_pdf/55/63/jphr-2012-1-e14.PMC4140320.pdf
Available from: http://www.unaids.,Non-OADS,/arxiv_data1/oa_pdf/55/63/jphr-2012-1-e14.PMC4140320.pdf
Accessed on: 15 July 2011 Available from:  http://www.nacoonline.org/Quick_Links/Publication/ME_and_Rese  arch_Surveillance/Reports_and_Surveys/HIV_Sentinel_Surveillan  ce_2006_India_Country_Report/  7.,Non-OADS,/arxiv_data1/oa_pdf/55/63/jphr-2012-1-e14.PMC4140320.pdf
Available from:  http://nacoonline.org/upload/Policies%20&%20Guidelines/5-  GUILDELINES%20FOR%20HIV%20TESTING.pdf  9.,Non-OADS,/arxiv_data1/oa_pdf/55/63/jphr-2012-1-e14.PMC4140320.pdf
Available from: http://data.undp.org.in/hivre - port/Gender.pdf  12.,OADS,/arxiv_data1/oa_pdf/55/63/jphr-2012-1-e14.PMC4140320.pdf
Available from: https://www.23andme.com/  health/risks/.,Non-OADS,/arxiv_data1/oa_pdf/76/8e/jphr-2012-1-e3.PMC4140321.pdf
Available from: http://genes-r-us.uthscsa.edu/sites/genes-r-us/files/nbsdisorders.,OADS,/arxiv_data1/oa_pdf/7f/49/jphr-2013-1-e3.PMC4140322.pdf
Available from: http://www.phgfoundation.org/file/5502/.,Non-OADS,/arxiv_data1/oa_pdf/7f/49/jphr-2013-1-e3.PMC4140322.pdf
Available from: http://www.uis.unesco.org/literacy/Documents/fs20-literacy-day-2012- en-v3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/16/75/jphr-2013-1-e6.PMC4140323.pdf
Available from: http://siteresources.worldbank.org/EXTANNREP2012/Resources/8784 408-1346247445238/AnnualReport2012_En.pdf.,Non-OADS,/arxiv_data1/oa_pdf/16/75/jphr-2013-1-e6.PMC4140323.pdf
Available from: http://onlinepubs.trb.org/ onlinepubs/circulars/ec008/session_h.pdf.,Non-OADS,/arxiv_data1/oa_pdf/16/75/jphr-2013-1-e6.PMC4140323.pdf
Available from: http://www.redcrossug.,Non-OADS,/arxiv_data1/oa_pdf/16/75/jphr-2013-1-e6.PMC4140323.pdf
Available from: http://www.ubos.org/onlinefiles/uploads/ ubos/pdf%20documents/UDHS2006Preliminaryreport.pdf.,Non-OADS,/arxiv_data1/oa_pdf/16/75/jphr-2013-1-e6.PMC4140323.pdf
Available from: http://anatomyfacts.com/Research/Research MethodsKnowledgeBase.pdf.,Non-OADS,/arxiv_data1/oa_pdf/16/75/jphr-2013-1-e6.PMC4140323.pdf
Available from: http://gkmc.utah.edu/ 7910F/ papers/ISR%20combining%20IS%20research%20methods.pdf.,Non-OADS,/arxiv_data1/oa_pdf/16/75/jphr-2013-1-e6.PMC4140323.pdf
Available from: http://papers.ssrn.com/sol3/ papers.cfm?abstract_id=1513705.,Non-OADS,/arxiv_data1/oa_pdf/be/d5/jphr-2013-1-e4.PMC4140326.pdf
Available from: http://papers.ssrn.com/ sol3/papers.cfm?abstract_id=1577062.,Non-OADS,/arxiv_data1/oa_pdf/be/d5/jphr-2013-1-e4.PMC4140326.pdf
Available from: http://www.ccdmd.qc.ca/en/gis/before.html.,Non-OADS,/arxiv_data1/oa_pdf/be/d5/jphr-2013-1-e4.PMC4140326.pdf
Available from: http://www.who.int/hiv/pub/guidelines/clinicalstaging.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ea/83/jphr-2013-1-e5.PMC4140327.pdf
Available from: http://marsgroupkenya.org/pdfs/2011/01/ Ministry_PDFS/Ministry_of_Public_Health_and_Sanitation/Docu ments/Taking_the_Kenya_Essential_Package_for_Health_to_the _Community.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ea/83/jphr-2013-1-e5.PMC4140327.pdf
Available from: http://www.moh.gov.om/en/ reports/publications/Newsletter17-5.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ea/83/jphr-2013-1-e5.PMC4140327.pdf
Available from: http://www.nascop.,OADS,/arxiv_data1/oa_pdf/ea/83/jphr-2013-1-e5.PMC4140327.pdf
Available from: http://www.unibielefeld.de/ikg/zick/ajzen%20con- struction%20a%20tpb%20questionnaire.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ea/83/jphr-2013-1-e5.PMC4140327.pdf
Available from: http://marsgroupkenya.org/pdfs/2011/01/AID_ EFFECTIVENESS/Documents/Preparation_of_GoK_sector_plans/D raft_MOPHS_Strategic_plan-231108.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ea/83/jphr-2013-1-e5.PMC4140327.pdf
Available from: http://www.who.int/workforcealliance/knowledge/publications/CH W_FullReport_2010.pdf.,OADS,/arxiv_data1/oa_pdf/ea/83/jphr-2013-1-e5.PMC4140327.pdf
[page 28] [Journal of Public Health Research 2013; 2:e5]http://www.knbs.or.ke/docs/PresentationbyMinisterforPlanningrevi sed.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ea/83/jphr-2013-1-e5.PMC4140327.pdf
A manual for training community health workers Available from: http://docs.wat- san.net/Downloaded_Files/PDF/Kenya%20Min%20of%20Health- 2006-Linking.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ea/83/jphr-2013-1-e5.PMC4140327.pdf
Available from: http://africarurallink.org/index.php?option=com_content&view=ar ticle&id=100:nzoia-community-health-unit&catid=1:latest-news.,Non-OADS,/arxiv_data1/oa_pdf/ea/83/jphr-2013-1-e5.PMC4140327.pdf
Availablefrom: http://docs.watsan.net/Downloaded_Files/PDF/Kenya%20Min %20of%20Health-2006-Linking.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ea/83/jphr-2013-1-e5.PMC4140327.pdf
Available from: http://www.nascop.or.ke/home_based_care.php.,Non-OADS,/arxiv_data1/oa_pdf/ea/83/jphr-2013-1-e5.PMC4140327.pdf
Available from: http://www.nascop.or.ke/nutritionpubs.php.,Non-OADS,/arxiv_data1/oa_pdf/ea/83/jphr-2013-1-e5.PMC4140327.pdf
Available from: http://apps.who.int/iris/bitstream/10665/77751/3/978924154 8290_Vol2_eng.pdf.,OADS,/arxiv_data1/oa_pdf/ea/83/jphr-2013-1-e5.PMC4140327.pdf
Available from: http://nces.ed.gov/fastfacts/display.asp?id=372.,OADS,/arxiv_data1/oa_pdf/ba/6b/jphr-2013-1-e7.PMC4140328.pdf
Available from http://www.substanceabusepolicy.com/content/4/1/4.,Non-OADS,/arxiv_data1/oa_pdf/ba/6b/jphr-2013-1-e7.PMC4140328.pdf
Available from: http://www.valoridiriferimento.com/ lista.htm.,Non-OADS,/arxiv_data1/oa_pdf/77/18/jphr-2013-1-e2.PMC4140329.pdf
Available from: http://www.cuore.iss.it/fattori/glicemia.asp.,Non-OADS,/arxiv_data1/oa_pdf/77/18/jphr-2013-1-e2.PMC4140329.pdf
Available at http://go.world- bank.org/D7SN0B8YU0.,Non-OADS,/arxiv_data1/oa_pdf/46/17/jphr-2013-1-e9.PMC4140330.pdf
Available from: http://www.unicef.org/health/index_51412.html.,Non-OADS,/arxiv_data1/oa_pdf/46/17/jphr-2013-1-e9.PMC4140330.pdf
Available from: http://files.dcp2.org/pdf/DCP/DCP19.pdf.,Non-OADS,/arxiv_data1/oa_pdf/46/17/jphr-2013-1-e9.PMC4140330.pdf
Available from: http://edis.ifas.ufl.edu/pdffiles/FS/FS09900.pdf.,Non-OADS,/arxiv_data1/oa_pdf/46/17/jphr-2013-1-e9.PMC4140330.pdf
Available from: http://www.ozfoodnet.gov.au/internet/ozfoodnet/ publishing.nsf/Content/7BDEF9F8EC3835D9CA257165001AB31D/ $File/foodborne_report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/46/17/jphr-2013-1-e9.PMC4140330.pdf
Available from: http://www.who.int/topics/diarrhoea/en/.,Non-OADS,/arxiv_data1/oa_pdf/46/17/jphr-2013-1-e9.PMC4140330.pdf
Available from: http://go.worldbank.org/D7SN0B8YU0.,Non-OADS,/arxiv_data1/oa_pdf/46/17/jphr-2013-1-e9.PMC4140330.pdf
2009: Available from: http://www.imf.org/external/pubs/ft/weo/2009/02/weodata/groups.h tm#ae.,Non-OADS,/arxiv_data1/oa_pdf/46/17/jphr-2013-1-e9.PMC4140330.pdf
Available from: http://www.meta-analysis.com/downloads/Meta-Analysis- Manual.pdf.,Non-OADS,/arxiv_data1/oa_pdf/46/17/jphr-2013-1-e9.PMC4140330.pdf
Available from: https://researchspace.auckland.ac.nz/bitstream/han- dle/2292/8273/PaedsGastro_Apr06.pdf?sequence=2.,OADS,/arxiv_data1/oa_pdf/46/17/jphr-2013-1-e9.PMC4140330.pdf
Available from: http://garnautreview.org.au/CA25734E0016A131/WebObj/03- AThreehealthoutcomes/$File/03-A%20Three%20health%20out- comes.pdf.,Non-OADS,/arxiv_data1/oa_pdf/46/17/jphr-2013-1-e9.PMC4140330.pdf
Available from: http://www.who.int/ vac- cine_safety/topics/hepatitisb/multiple_sclerosis/sep_04/en/ 9.,Non-OADS,/arxiv_data1/oa_pdf/d1/82/jphr-2012-2-e18.PMC4140357.pdf
Available from: http://www.iss.it/seieva/  37.,Non-OADS,/arxiv_data1/oa_pdf/d1/82/jphr-2012-2-e18.PMC4140357.pdf
Available from: http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Scientific_Conclusion/ human/000298/WC500074684.pdf  44.,Non-OADS,/arxiv_data1/oa_pdf/d1/82/jphr-2012-2-e18.PMC4140357.pdf
Available from: http://www.unodc.org/documents/data-and-analysis/ WDR 2011/World_Drug_Report_2011_ebook.pdf 3.,OADS,/arxiv_data1/oa_pdf/fd/ce/jphr-2012-2-e21.PMC4140359.pdf
Available from: http://www.who.int/ substance_abuse/facts/ alcohol/en/index.html  7. WHO.,Non-OADS,/arxiv_data1/oa_pdf/fd/ce/jphr-2012-2-e21.PMC4140359.pdf
Available from:http://www.who.int/mediacentre/factsheets/fs339/en/ 8.,Non-OADS,/arxiv_data1/oa_pdf/fd/ce/jphr-2012-2-e21.PMC4140359.pdf
Available from: http://archives.drugabuse.gov/ about/welcome/aboutdrugabuse/stigma/  10.,Non-OADS,/arxiv_data1/oa_pdf/fd/ce/jphr-2012-2-e21.PMC4140359.pdf
Available from: http://www.ssb.no/pasient/  9.,Non-OADS,/arxiv_data1/oa_pdf/0b/0e/jphr-2012-2-e28.PMC4140360.pdf
Available from: http://www.oecd.org/dataoecd/43/23/4090 5066.pdf   11.,OADS,/arxiv_data1/oa_pdf/0b/0e/jphr-2012-2-e28.PMC4140360.pdf
Available from: http://www.tromso.kom- mune.no/fakta-om-tromsoe-kommune.241052.no.html  15.,Non-OADS,/arxiv_data1/oa_pdf/0b/0e/jphr-2012-2-e28.PMC4140360.pdf
Available from: http://en.uit.no/ansatte/organisasjon/artikkel?,Non-OADS,/arxiv_data1/oa_pdf/0b/0e/jphr-2012-2-e28.PMC4140360.pdf
Available from: http://content.healthaf- fairs.org/cgi/content/full/ hlthaff.w2.96v1/DC1  18.,Non-OADS,/arxiv_data1/oa_pdf/0b/0e/jphr-2012-2-e28.PMC4140360.pdf
Available from: http://www.oecd.org/dataoecd/14/0/31743034.pdf  19.,OADS,/arxiv_data1/oa_pdf/0b/0e/jphr-2012-2-e28.PMC4140360.pdf
Available from: http://statbank.ssb.no/statis- tikkbanken/Default_FR.asp?PXSid=0&nvl=true&PLanguage=0&ti lside=selectvarval/define.asp&Tabellid=04217 23.,OADS,/arxiv_data1/oa_pdf/0b/0e/jphr-2012-2-e28.PMC4140360.pdf
Available from: http://www.ssb.no/ samfunnsspeilet/utg/201102/09/  33.,Non-OADS,/arxiv_data1/oa_pdf/0b/0e/jphr-2012-2-e28.PMC4140360.pdf
Available from: https://www.cms.gov/sharedsavingsprogram/  14.,Non-OADS,/arxiv_data1/oa_pdf/c1/73/jphr-2012-2-e16.PMC4140361.pdf
Available from: http://www.acolearningnetwork.org/  17.,Non-OADS,/arxiv_data1/oa_pdf/c1/73/jphr-2012-2-e16.PMC4140361.pdf
Available from: http://www.fph.,Non-OADS,/arxiv_data1/oa_pdf/c1/73/jphr-2012-2-e16.PMC4140361.pdf
Health and Social Care Bill 2011.Available from: http://www.dh.gov.uk/en/Publicationsandstatistics/ Legislation/Actsandbills/HealthandSocialCareBill2011/index.htm  24.,Non-OADS,/arxiv_data1/oa_pdf/c1/73/jphr-2012-2-e16.PMC4140361.pdf
Available from: http://www.nice.org.uk/aboutnice/whatwedo/aboutpublichealth guidance/about_public_health_guidance.jsp  26.,Non-OADS,/arxiv_data1/oa_pdf/c1/73/jphr-2012-2-e16.PMC4140361.pdf
Available from: http://www.dh.gov.uk/ health/2011/08/baseline-data-collection/ 27.,OADS,/arxiv_data1/oa_pdf/c1/73/jphr-2012-2-e16.PMC4140361.pdf
Available from: http://healthandcare.dh.gov.uk/pathfinder-bulletin-july11/#ph  28.,Non-OADS,/arxiv_data1/oa_pdf/c1/73/jphr-2012-2-e16.PMC4140361.pdf
Available from: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH_132358  29.,Non-OADS,/arxiv_data1/oa_pdf/c1/73/jphr-2012-2-e16.PMC4140361.pdf
Available from: http://www.rcgp.org.uk 30.,Non-OADS,/arxiv_data1/oa_pdf/c1/73/jphr-2012-2-e16.PMC4140361.pdf
Available from: http://www.kingsfund.org.uk/publications/future_commissioning.html 31.,Non-OADS,/arxiv_data1/oa_pdf/c1/73/jphr-2012-2-e16.PMC4140361.pdf
Available from: http://www.dh.gov.uk/ en/Publicationsandstatistics/Publications/PublicationsPolicyAndGui dance/DH_130293 32.,Non-OADS,/arxiv_data1/oa_pdf/c1/73/jphr-2012-2-e16.PMC4140361.pdf
Available from: http://www.who.int/csr/don/2010_04_01/en/index.html 2.,OADS,/arxiv_data1/oa_pdf/ae/2e/jphr-2012-2-e29.PMC4140362.pdf
Available from: http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm 12.,OADS,/arxiv_data1/oa_pdf/ae/2e/jphr-2012-2-e29.PMC4140362.pdf
Available from: http://wwwnc.cdc.gov/ eid/article/17/11/11-0649_article.htm 23.,OADS,/arxiv_data1/oa_pdf/ae/2e/jphr-2012-2-e29.PMC4140362.pdf
Available from: http://www.iss.it/binary/iflu/cont/2010_ 2011.pdf 24.,OADS,/arxiv_data1/oa_pdf/ae/2e/jphr-2012-2-e29.PMC4140362.pdf
Available from: http://www.iss.it/binary/fluv/cont/Rapportostagione1011.pdf 25.,OADS,/arxiv_data1/oa_pdf/ae/2e/jphr-2012-2-e29.PMC4140362.pdf
Available from: http://www.iss.it/binary/iflu/cont/Influnet_2012_04.pdf 26.,OADS,/arxiv_data1/oa_pdf/ae/2e/jphr-2012-2-e29.PMC4140362.pdf
Available from: http://www.iss.it/binary/fluv/cont/settimana15.pdf 27.,OADS,/arxiv_data1/oa_pdf/ae/2e/jphr-2012-2-e29.PMC4140362.pdf
Available from: http://www.iss.it/binary/ publ/cont/ dieci46web.pdf 28.,OADS,/arxiv_data1/oa_pdf/ae/2e/jphr-2012-2-e29.PMC4140362.pdf
Available from: http://www.flutrackers.com/forum/ showthread.php?t=180120 37.,Non-OADS,/arxiv_data1/oa_pdf/ae/2e/jphr-2012-2-e29.PMC4140362.pdf
Available from: http://www.iss.it/binary/publ/cont/ 11_13_web.pdf [Journal of Public Health Research 2012; 1:e29] [page 191] Perspective and Debates,Non-OADS,/arxiv_data1/oa_pdf/ae/2e/jphr-2012-2-e29.PMC4140362.pdf
Available from: http://www.who.int/whr/2008/whr08_en.pdf 6.,OADS,/arxiv_data1/oa_pdf/96/eb/jphr-2012-2-e20.PMC4140363.pdf
Available from: http://www.womenchildrenhiv.org /wchiv?page=gtp-02-01 13.,Non-OADS,/arxiv_data1/oa_pdf/96/eb/jphr-2012-2-e20.PMC4140363.pdf
Available from: http://ec.europa.eu/ public_opinion/archives/ebs/ebs_272d_en.pdf  5.,Non-OADS,/arxiv_data1/oa_pdf/de/8a/jphr-2012-2-e19.PMC4140364.pdf
Available from: http://www.phac-aspc.gc.ca/tbpc- latb/costtb/pdf/cost_tb_e.pdf  4.,Non-OADS,/arxiv_data1/oa_pdf/80/8c/jphr-2012-2-e25.PMC4140365.pdf
Available from: http://www.phac-aspc.gc.ca/tbpc- latb/pubs/tbcan09pre/index-eng.php 9.,Non-OADS,/arxiv_data1/oa_pdf/80/8c/jphr-2012-2-e25.PMC4140365.pdf
Available from:http://www.stat.gouv.qc.ca/ regions/index_2006_an.htm 44.,OADS,/arxiv_data1/oa_pdf/80/8c/jphr-2012-2-e25.PMC4140365.pdf
Available from: http://www.stat.gouv.qc.ca/don- stat/societe/ demographie/index_an.htm 45.,Non-OADS,/arxiv_data1/oa_pdf/80/8c/jphr-2012-2-e25.PMC4140365.pdf
Available from: http://www.arcticstat.org/Statistics.aspx/Region/%5B Canada%5DNunavik/Indicator/Population/  46.,OADS,/arxiv_data1/oa_pdf/80/8c/jphr-2012-2-e25.PMC4140365.pdf
Available from: http://www.nunivaat.org/statistics.aspx 47.,OADS,/arxiv_data1/oa_pdf/80/8c/jphr-2012-2-e25.PMC4140365.pdf
Available from: http://www.inspq.qc.ca/pdf/publications/1085_ Antituberculeux2009.pdf  48.,OADS,/arxiv_data1/oa_pdf/80/8c/jphr-2012-2-e25.PMC4140365.pdf
Available from: http://www.whocc.no/atcddd/ 26.,Non-OADS,/arxiv_data1/oa_pdf/f6/39/jphr-2012-2-e23.PMC4140366.pdf
Avialable from: http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/ human/000546/ WC500046602.pdf30.,Non-OADS,/arxiv_data1/oa_pdf/f6/39/jphr-2012-2-e23.PMC4140366.pdf
Available from: http://www.salute.gov.it/pubblicazioni/ ppRisultati PSN.jsp 4.,Non-OADS,/arxiv_data1/oa_pdf/e5/f0/jphr-2012-2-e30.PMC4140367.pdf
Available from: http://www.aslmonzabrianza.it  18.,Non-OADS,/arxiv_data1/oa_pdf/e5/f0/jphr-2012-2-e30.PMC4140367.pdf
Available from: http://www.phaboard.org   6.,Non-OADS,/arxiv_data1/oa_pdf/1c/20/jphr-2012-2-e27.PMC4140369.pdf
Available from: http://isanet.ccit.,OADS,/arxiv_data1/oa_pdf/1c/20/jphr-2012-2-e27.PMC4140369.pdf
Available from: http://www.mcf.org/resources/evi- dence-based-indicators-of-coalition-success 20.,Non-OADS,/arxiv_data1/oa_pdf/1c/20/jphr-2012-2-e27.PMC4140369.pdf
Available from: http://www.qaproject.org/methods/resmeasure.html  21.,Non-OADS,/arxiv_data1/oa_pdf/1c/20/jphr-2012-2-e27.PMC4140369.pdf
Available from: http://www.guardian.,Non-OADS,/arxiv_data1/oa_pdf/e7/8f/jphr-2012-3-e37.PMC4140370.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/02/e2/jphr-2012-3-e34.PMC4140371.pdf
Available from: http://www.who.int/healthpromotion/conferences/ previous/jakarta/declaration/en/index.html 13.,Non-OADS,/arxiv_data1/oa_pdf/02/e2/jphr-2012-3-e34.PMC4140371.pdf
Available from: http://www.biomedcentral.com/1472- 698X/11/2 24.,Non-OADS,/arxiv_data1/oa_pdf/02/e2/jphr-2012-3-e34.PMC4140371.pdf
Available from: http://www.communityindicators.,Non-OADS,/arxiv_data1/oa_pdf/02/e2/jphr-2012-3-e34.PMC4140371.pdf
Available from: http://apps.who.int/classifications/icd10/browse/2010/en.7.,OADS,/arxiv_data1/oa_pdf/4e/28/jphr-2012-3-e35.PMC4140376.pdf
Available from: http://www.euroqol.org/eq-5d/what-is-eq-5d.html 24.,Non-OADS,/arxiv_data1/oa_pdf/4e/28/jphr-2012-3-e35.PMC4140376.pdf
Available from: http://daccess-dds-ny.un.org/doc/UNDOC/ LTD/N06/645/30/PDF/N0664530.pdf?OpenElement.,Non-OADS,/arxiv_data1/oa_pdf/4e/28/jphr-2012-3-e35.PMC4140376.pdf
Available from: http://data.worldbank.org/indicator.,OADS,/arxiv_data1/oa_pdf/4c/6d/jphr-2012-3-e31.PMC4140377.pdf
Available from: http://www.who.int/whr/2000/en/ 2.,OADS,/arxiv_data1/oa_pdf/4c/6d/jphr-2012-3-e31.PMC4140377.pdf
Available from: http://www.york.ac.uk/ res/herc/documents/wp/08_12.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/4c/6d/jphr-2012-3-e31.PMC4140377.pdf
Available from: http://www.who.int/whr/2006/en/ 10.,OADS,/arxiv_data1/oa_pdf/4c/6d/jphr-2012-3-e31.PMC4140377.pdf
Available from: http://www.ilo.org/public/eng- lish/region/asro/bangkok/events/sis/download/paper33.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/4c/6d/jphr-2012-3-e31.PMC4140377.pdf
Available from: http://www.who.int/health_financing/documents/pb_e_09_03- china_nrcms.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/4c/6d/jphr-2012-3-e31.PMC4140377.pdf
Available from: http://www.stats.gov.cn/was40/gjtjj_en_detail.jsp?chan- nelid=4920&record=32 17.,OADS,/arxiv_data1/oa_pdf/4c/6d/jphr-2012-3-e31.PMC4140377.pdf
Available from: http://www.chinadata- center.tsinghua.edu.cn/data/upload/month_201003/3.NCMS-third- draft_EnikEh.pdf 21.,OADS,/arxiv_data1/oa_pdf/4c/6d/jphr-2012-3-e31.PMC4140377.pdf
Available from: http://www.stiglitz-sen- fitoussi.fr/documents/rapport_anglais.pdf 46.,Non-OADS,/arxiv_data1/oa_pdf/4c/6d/jphr-2012-3-e31.PMC4140377.pdf
Available from: http://www.who.int/healthpromotion/conferences/ previous/ottawa/en/  8.,Non-OADS,/arxiv_data1/oa_pdf/fd/a5/jphr-2014-1-208.PMC4140378.pdf
Available from: http://www.who.int/ sdhconference/Discussion-paper-EN.pdf 28.,Non-OADS,/arxiv_data1/oa_pdf/fd/a5/jphr-2014-1-208.PMC4140378.pdf
Available from: http://www.ncasc.gov.np/uploaded/publication/Reports/IBBS/IDUs/I BBS_IDUs_Pokhara_Final_Report_2011.pdf 9.,Non-OADS,/arxiv_data1/oa_pdf/f7/0c/jphr-2014-1-204.PMC4140379.pdf
Available from: http://www.hnpinfobangladesh.com/ docs/di_220_Consolidated%20Report%20Nov%2030%20final.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/f7/0c/jphr-2014-1-204.PMC4140379.pdf
Available from: http://www.who.int/hiv/pub/idu/searo_strategy/en/ 12.,Non-OADS,/arxiv_data1/oa_pdf/f7/0c/jphr-2014-1-204.PMC4140379.pdf
Available from: http://www.legco.,Non-OADS,/arxiv_data1/oa_pdf/f7/0c/jphr-2014-1-204.PMC4140379.pdf
Available from: http://mmt.niramit.asia/downloads/OST% 20TNA%20Thailand%20Country%20Chapter%20-%20Turning% 20Point%202008.pdf 27.,Non-OADS,/arxiv_data1/oa_pdf/f7/0c/jphr-2014-1-204.PMC4140379.pdf
Available from: http://www.unodc.org/documents/southeastasiaandpacific// poster/Regional_overview_of_IDU_and_HIV_in_Asia_final_3_Ju n_2013.pdf 31.,Non-OADS,/arxiv_data1/oa_pdf/f7/0c/jphr-2014-1-204.PMC4140379.pdf
Available from: http://portfolio.theglobalfund.org/en/ Country/Index/MMR 37. WHO.,OADS,/arxiv_data1/oa_pdf/f7/0c/jphr-2014-1-204.PMC4140379.pdf
Available from: https://apps.searo.who.,Non-OADS,/arxiv_data1/oa_pdf/f7/0c/jphr-2014-1-204.PMC4140379.pdf
Available from: http://www-wds.worldbank.org/external/default/ WDSContentServer/WDSP/IB/2012/07/19/000333037_20120719011 541/Rendered/PDF/712880WP0P113500January020110GM0GS.pdf39.,Non-OADS,/arxiv_data1/oa_pdf/f7/0c/jphr-2014-1-204.PMC4140379.pdf
Available from: http://www.ukdpc.org.uk/publica- tion/getting-serious-about-stigma-problem-stigmatising-drug-users/ 43.,Non-OADS,/arxiv_data1/oa_pdf/f7/0c/jphr-2014-1-204.PMC4140379.pdf
Available from: http://www.indro-online.de/ Newman2011.pdf 48.,Non-OADS,/arxiv_data1/oa_pdf/f7/0c/jphr-2014-1-204.PMC4140379.pdf
Available from: http://australia-unsc.gov.au/2013/06/ implementation-of-the-declaration-of-commitment-on-hivaids- and-the-political-declaration-on-hivaids/ Review and Meta-Analysis,Non-OADS,/arxiv_data1/oa_pdf/f7/0c/jphr-2014-1-204.PMC4140379.pdf
Available from: http://www.who.int/gho/hiv/en/.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs355/en/.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.aidsalliance.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.aidsalliance.org/includes/Document/Prevention%20ca mpaign/Campaign-Policy-Briefing-1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
2012 Available from: http://data.unaids.org/una-docs/three-ones_keyprinciples_en.pdf  11.,OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.accesstomedicineindex.org/ sites/www.,OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.wpro.who.int/health_services/health_ systems_framework/en/.,OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.unaids.org/en/regionscountries/countries/.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.idf.org/diabetesatlas.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.unaids.org/en/regionscountries/countries/.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: ble at: http://www.avert.org/hiv-aids-history.htm.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.ghwatch.org/sites/www.ghwatch.org/files/NCDs_Histor yInternationalPolicyDeclarations.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.moh.gov.my/images/ gallery/Report/NSP_AIDS_2011_2015.pdf 27.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.incd.klinikbistari.com/index.php?view=article&id=158 %3Anational-strategic-plan-for-ncd&format=pdf&option= com_content&Itemid=29.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.health-e.org.za/wp-content/uploads/ 2013/09/NCDs-STRAT-PLAN-CONTENT-8-april-proof.pdf 33.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
"Available from: https://www.pmo.gov.my/dokume- [Journal of Public Health Research 2014; 3:99] [page 35] Reviews and Meta-Analysis Correspondence: Tilahun Nigatu Haregu, Department of Epidemiology and Preventive Medicine, Monash University, The Alfred Centre, 99 Commercial Road, Melbourne Vic 3004, Australia.",Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.healthlink.org.za/publications/874 36.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Availabke from: http://www.health.gov.lk/en/HMP- Guidlines/HMP-07-16/Annual%20Action% 20Plan%202010%20%5B Programmes%20&%20Directorates%5D.pdf 37.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.unaids.org/en/dataanalysis/ knowyourresponse/countryprogressreports/2012countries/ce_ZA_ Narrative_Report.pdf 38.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.unaids.org/ en/dataanalysis/knowyourresponse/countryprogressreports/2012co untries/ce_MY_Narrative_Report.pdf 39.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.aidsdatahub.org/sites/ default/files/documents/UNGASS_2012_SriLanka_Narrative_Repo rt.pdf 40.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.unaids.org /en/dataanalysis/knowyourresponse/countryprogressreports/2012c ountries/GAP%20Report%202012.pdf41.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.ghdonline.org/uploads/ICAP_HIV- NCD_report_Feb2011.pdf 43.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.who.int/chp/chronic_dis- ease_report/full_report.pdf 46.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.cmpi.org/uploads/File/non-communicable-diseases.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/dd/jphr-2014-1-99.PMC4140380.pdf
Available from: http://www.iarc.fr/en/media-centre/pr/2007/pr175.html.,Non-OADS,/arxiv_data1/oa_pdf/83/e4/jphr-2014-1-180.PMC4140383.pdf
Available from: http://www.globalizationadnhealth.com/con- tent/7/1/43.,Non-OADS,/arxiv_data1/oa_pdf/83/e4/jphr-2014-1-180.PMC4140383.pdf
Available from: http://stats.oecd.org/glossary/detail.asp?ID=2626.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jphr-2014-1-218.PMC4140384.pdf
Available from: http://www.un-documents.net/our- common-future.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jphr-2014-1-218.PMC4140384.pdf
Available from: http://africaprogresspanel.org/app/wp-con- tent/uploads/2013/08/2011_APR_The_Transformative_Power_of_P artnerships_ENG.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jphr-2014-1-218.PMC4140384.pdf
"Available from: http://homepages.wmich.edu/~asefa/ Conference%20and%20Seminar/Papers/2003%20papers/Asefa,%20 Sisay_%20Zegeye,%20Tesfaye.pdf 11.",Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jphr-2014-1-218.PMC4140384.pdf
Available from: http://www.sign- schoolfeeding.org/_dynamic/downloads/Constraints%20Constrain ed%20final%2 0A4%20draft.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jphr-2014-1-218.PMC4140384.pdf
Available from: http://www.publicser- vice.co.uk/feature.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jphr-2014-1-218.PMC4140384.pdf
Available from: http://www.cloudave.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jphr-2014-1-218.PMC4140384.pdf
Available from: http://www.future-agri- cultures.org/pdf%20files/SG_paper_3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jphr-2014-1-218.PMC4140384.pdf
Available from: http://siteresources.worldbank.org/ INTETHIOPIA/Resources/PREM/Ethiopia%20-GrowthStartegy2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jphr-2014-1-218.PMC4140384.pdf
Available from: http://www.fao.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jphr-2014-1-218.PMC4140384.pdf
Available from: http://sapiens.revues.org/88.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jphr-2014-1-218.PMC4140384.pdf
Available from: http://www.fao.org/fileadmin/templates/nr/sustainability _pathways/docs/SAFA_Guidelines_12_June_2012_final_v2.pdf 54.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jphr-2014-1-218.PMC4140384.pdf
Available from: http://www.icrisat.org/gt-mpi/ResearchBreifs/ NRM.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jphr-2014-1-218.PMC4140384.pdf
Available from: http://www.ilri.org/InfoServ/Webpub/full- docs/X5513E/X5513E00.HTM 71.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jphr-2014-1-218.PMC4140384.pdf
Available from: http://www.fao.org/ag/againfo/programmes/en/lead/toolbox/Mixed1/ TLU.htm.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jphr-2014-1-218.PMC4140384.pdf
Available from: http://www.rala.is/rade/ralareport/ Hawando.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/e8/jphr-2014-1-218.PMC4140384.pdf
Available form: http://www.euro.who.int/__data/ assets/pdf_file/0005/171770/RC62wd12rev1-Eng.pdf 2. WHO Regional Office for Europe.,OADS,/arxiv_data1/oa_pdf/b7/bc/jphr-2014-1-199.PMC4140385.pdf
Available from: http://www.euro.,Non-OADS,/arxiv_data1/oa_pdf/b7/bc/jphr-2014-1-199.PMC4140385.pdf
Available from: http://ec.europa.eu/eahc/health/ten- ders_capacity.html  5.,Non-OADS,/arxiv_data1/oa_pdf/b7/bc/jphr-2014-1-199.PMC4140385.pdf
Available from: http://europa.eu/legislation_summaries/public_health/euro- pean_health_strategy/sp0017_en.htm 6.,Non-OADS,/arxiv_data1/oa_pdf/b7/bc/jphr-2014-1-199.PMC4140385.pdf
Available from: http://www.health.gov.on.ca/en/common/ministry/publica- tions/reports/capacity_review05/capacity_review05.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/b7/bc/jphr-2014-1-199.PMC4140385.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/8b/amep-5-257.PMC4140394.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2014:5 257–262Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  257OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S6247 3Video- or text-based e-learning when teaching  clinical procedures?,Non-OADS,/arxiv_data1/oa_pdf/eb/8b/amep-5-257.PMC4140394.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/eb/8b/amep-5-257.PMC4140394.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/8b/amep-5-257.PMC4140394.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/36/cia-9-1353.PMC4140395.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1353–1361Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1353OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S6720 0Kattika Thanakwang Wantana Thinganjana roumporn Konggumnerd Institute of nursing, suranaree  University of Technology, nakhon  ratchasima, Thailand Correspondence: Kattika Thanakwang   Institute of nursing, suranaree University  of Technology, 111  University Avenue,  Tambon suranaree Amphur Muang,  nakhon ratchasima, Thailand, 30000   Tel +66 44 223 520   Fax +66 44 223 506   email kattika@sut.ac.t hPsychometric properties of the Thai version of  the Diabetes Distress scale in diabetic seniorsJournal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Thanakwang et al Running head recto: Psychometric properties of the Thai Diabetes Distress Scale DOI: http://dx.doi.org/10.2147/CIA.S67200 Background:  The Diabetes Distress Scale (DDS) is an important measure of diabetes-related  emotional distress that has been widely used in the Western world.",Non-OADS,/arxiv_data1/oa_pdf/6e/36/cia-9-1353.PMC4140395.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/6e/36/cia-9-1353.PMC4140395.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6e/36/cia-9-1353.PMC4140395.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/97/dddt-8-1083.PMC4140443.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 1083–1087Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1083Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6759 2Safety and efficacy of S-1 chemotherapy   in recurrent and metastatic nasopharyngeal   carcinoma patients after failure of platinum-   based chemotherapy: multi-institutional   retrospective analysis Pei-Jian Peng1,* hua cheng2,* Xue-Qing Ou3 Lin-Juan Zeng1 Xuan Wu4 Yu-Meng Liu5 Zhong Lin1 Yan-Na Tang1 Si-Yang Wang3 Hong-Yu Zhang1 Zhi-Bin Chen3 1Department of Medical Oncology,   2Department of surgical Oncology,   3Department of radiation Oncology,   The Fifth affiliated hospital of  Sun-Yat-Sen University, Zhu Hai,   guangdong Province, People’s  republic of china; 4Department  of Medical Oncology, Cancer  Center, Sun-Yat-Sen University,   guangzhou, People’s republic of  china; 5Department of Oncology, the  People’s Hospital of Zhongshan City,   Zhongshan, Guangdong Province,   People’s republic of china *These authors contributed equally to  this work Correspondence: Pei-Jian Peng   Department of Medical Oncology,   The Fifth Affiliated Hospital of Sun-Yat-   Sen University, 52 Mei Hua Road East,   Zhu Hai 519000, Guangdong Province,   People’s republic of china   Tel +86 756 252 8020   Fax +86 756 252 8405   email pengpjian@163.co mPurpose:  This retrospective study evaluates the efficacy and safety of S-1 chemotherapy for  recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based  chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/bb/97/dddt-8-1083.PMC4140443.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/bb/97/dddt-8-1083.PMC4140443.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/97/dddt-8-1083.PMC4140443.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/22/64/dddt-8-1089.PMC4140444.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 1089–1096Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1089O R I G I N A L  R E S E A R C H  open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S6730 0Investigation of aromatase inhibitory activity   of metal complexes of  8-hydroxyquinoline   and uracil derivatives Veda Prachayasittikul1 Ratchanok Pingaew2 Chanin Nantasenamat3 Supaluk Prachayasittikul3 Somsak Ruchirawat4,5 Virapong Prachayasittikul1 1Department of Clinical Microbiology  and Applied Technology, Faculty  of Medical Technology, Mahidol  University, Bangkok, Thailand;   2Department of Chemistry, Faculty of  Science, Srinakharinwirot University,   Bangkok, Thailand;  3Center of Data  Mining and Biomedical Informatics,   Faculty of Medical T echnology,   Mahidol University, Bangkok, Thailand;   4Laboratory of Medicinal Chemistry,   Chulabhorn Research Institute,   5Chulabhorn Graduate Institute,   Bangkok, Thailand Correspondence: Virapong  Prachayasittikul   Department of Clinical Microbiology and  Applied Technology, Faculty of Medical  Technology, Mahidol University,   2 Prannok Road, Bangkok-Noi, Bangkok   10700, Thailand   Tel +66 2 441 4376  Fax +66 2 441 4380  Email virapong.pra@mahidol.ac.t h;  drvirapong@gmail.co mPurpose:  Estrogens play important roles in the pathogenesis and progression of breast cancer  as well as estrogen-related diseases.",Non-OADS,/arxiv_data1/oa_pdf/22/64/dddt-8-1089.PMC4140444.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/22/64/dddt-8-1089.PMC4140444.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/22/64/dddt-8-1089.PMC4140444.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/.0/),whichpermitsnon-commercialre-use,distribution,andreproductioninanymedium,providedtheoriginalworkisproperlycited.",Non-OADS,/arxiv_data1/oa_pdf/aa/59/ddu212.PMC4140471.pdf
Calculated normalized relativequantity (CNRQ) values were calculated and normalized to thetwo or three moststable housekeeping genes using the qBasePlus1.3 analysis software (http://www.biogazelle.com) as previ-ously described ( 75) and graphed using Gene-E (http://www.,OADS,/arxiv_data1/oa_pdf/aa/59/ddu212.PMC4140471.pdf
"Immunoﬂuorescence was visualized by sequen-tial imaging, whereby the channel track was switched each frameto avoid cross-contamination between channels, using a ZeissLSM510 Meta inverted laser scanning confocal microscopedescribed here: http://nisms.stanford.edu/Equipment/LSM510Meta01v01.html.",OADS,/arxiv_data1/oa_pdf/aa/59/ddu212.PMC4140471.pdf
Available at:  http://www.actassociation.org.,OADS,/arxiv_data1/oa_pdf/31/ff/DialoguesClinNeurosci-16-185.PMC4140512.pdf
"An example of a frequently used clinician rating scale is the Liebowitz Social Anxiety Scale  (LSAS; http://healthnet.umassmed.edu/mhealth/LiebowitzSocialAnxietyScale.pdf).130,131 BDI, Beck Depression Inventory; DSM-IV, Diag - nostic Statistical Manual of Mental Disorders IV; HAMRS, Hamilton Depression Rating Scale",Non-OADS,/arxiv_data1/oa_pdf/b8/35/DialoguesClinNeurosci-16-197.PMC4140513.pdf
http://www.uspreventiveservicestaskforce.,Non-OADS,/arxiv_data1/oa_pdf/b8/35/DialoguesClinNeurosci-16-197.PMC4140513.pdf
Available at: http://tmt.sagepub.com/ content/early/2012/04/18/1534765611426793.,Non-OADS,/arxiv_data1/oa_pdf/93/53/DialoguesClinNeurosci-16-213.PMC4140514.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2014 |  84  | e51119 | Page 1 of 8Video Article Multilayer Mounting for Long-term Light Sheet Microscopy of Zebrafish Michael Weber1, Michaela Mickoleit1, Jan Huisken1 1Huisken Lab, Max Planck Institute of Molecular Cell Biology and Genetics Correspondence to: Jan Huisken at huisken@mpi-cbg.de URL: http://www.jove.com/video/51119 DOI: doi:10.3791/51119 Keywords: Developmental Biology, Issue 84, zebrafish, Danio rerio , light sheet microscopy, Selective Plane Illumination Microscopy, sample mounting, time lapse microscopy, long-term imaging Date Published: 2/27/2014 Citation: Weber, M., Mickoleit, M., Huisken, J.",Non-OADS,/arxiv_data1/oa_pdf/58/5a/jove-84-51119.PMC4140555.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51119/ Introduction To understand the complex events and interactions during embryogenesis, research in developmental biology is more and more moving from microscopy of single cells and organs to in vivo  imaging of entire organisms.",Non-OADS,/arxiv_data1/oa_pdf/58/5a/jove-84-51119.PMC4140555.pdf
“What is the Mission of Pharmaceutical  Education?” Available at: http://www.aacp.org/resour ces/historicaldocuments/Do cuments/BackgroundPaper1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/ca/pharmpract-08-001.PMC4140572.pdf
Available at:  http://www.aacp.org/resources/historicaldocuments/Docu ments/JCPPFutureVisionofPharmacyPracticeFINAL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/ca/pharmpract-08-001.PMC4140572.pdf
"Educational Outcomes 2004. http://www.aacp.org/re sources/education/Documents/CAPE2004.pdf (Accessed  December 18, 2009).",Non-OADS,/arxiv_data1/oa_pdf/e9/ca/pharmpract-08-001.PMC4140572.pdf
"Available at:  http://www.aacp.org/resources/education/Documents/Phar macyPracticeDEC006.pdf (Accessed December 18, 2009).",Non-OADS,/arxiv_data1/oa_pdf/e9/ca/pharmpract-08-001.PMC4140572.pdf
"March 2007.  http://www.aacp.org/resources/education/Documents/So cialandAdminDEC06.pdf (Accessed December 18, 2009).",Non-OADS,/arxiv_data1/oa_pdf/e9/ca/pharmpract-08-001.PMC4140572.pdf
"Accessed at http://www.ncspae.org/news/2009/122809.html (Accessed  January 13, 2009).",OADS,/arxiv_data1/oa_pdf/e9/ca/pharmpract-08-001.PMC4140572.pdf
Accessed at http://www.mirixa.,Non-OADS,/arxiv_data1/oa_pdf/e9/ca/pharmpract-08-001.PMC4140572.pdf
"Accessed at http://www.purpl eteal.com/aboutus.htm (Accessed February 7, 2010).",Non-OADS,/arxiv_data1/oa_pdf/e9/ca/pharmpract-08-001.PMC4140572.pdf
"Accessed at http://www.getoutcomes.com (Accessed February 11, 2010).",Non-OADS,/arxiv_data1/oa_pdf/e9/ca/pharmpract-08-001.PMC4140572.pdf
"Available at:  http://edocket.access.gpo.gov/2005/pdf/05-1321.pdf (Accessed February 10, 2010).",OADS,/arxiv_data1/oa_pdf/e9/ca/pharmpract-08-001.PMC4140572.pdf
"Accessed at http://www.cms.hhs.gov/Prescripti onDrugCovContra/Downloads/MTMFactSheet.pdf December  19, 2009.",Non-OADS,/arxiv_data1/oa_pdf/e9/ca/pharmpract-08-001.PMC4140572.pdf
"http://www.cms.gov/MedicaidGenInfo/  (Accessed December 19, 2009).",Non-OADS,/arxiv_data1/oa_pdf/e9/ca/pharmpract-08-001.PMC4140572.pdf
"Available at: http://www.ashp.org/DocLibrary /Advocacy/ProviderStatusPr ograms.aspx (Accessed January  17, 2010).",Non-OADS,/arxiv_data1/oa_pdf/e9/ca/pharmpract-08-001.PMC4140572.pdf
Available at:  http://www.abim.org/pdf/publications/professionalism.pdf.,Non-OADS,/arxiv_data1/oa_pdf/93/3e/pharmpract-08-018.PMC4140573.pdf
"Available at:  http://www.pharmacist.com/AM/Template .cfm?Section=Professionalism_Toolki t_for_Students_and_Faculty (Accessed  July 20, 2009).",Non-OADS,/arxiv_data1/oa_pdf/93/3e/pharmpract-08-018.PMC4140573.pdf
"Available at:  http://static.rbi.com.au/common/contentmanagement/phar macy/pdf/backissues/15_06_2009.pdf (Accessed 20 August,  2009).",Non-OADS,/arxiv_data1/oa_pdf/93/3e/pharmpract-08-018.PMC4140573.pdf
"Available at:  http://www.rpsgb.org.uk/acareerinpharmacy/undergr aduateeducation/index.html (Accessed 20 August, 2009).",OADS,/arxiv_data1/oa_pdf/93/3e/pharmpract-08-018.PMC4140573.pdf
"Available at::  http://www.pharmacyboard.sa.gov.au/registrati ons.htm#studentreg (Accessed August 20, 2009).",Non-OADS,/arxiv_data1/oa_pdf/93/3e/pharmpract-08-018.PMC4140573.pdf
"Available at:  http://www.pharmacybd.vic.gov.au/pharmacists _prereg_student.php (Accessed August 20, 2009).",Non-OADS,/arxiv_data1/oa_pdf/93/3e/pharmpract-08-018.PMC4140573.pdf
Available from:  http://www.keele.ac.uk/schools/pharm/ npcplus/documents/medicationreviewn ewguide_000.pdf (Cited 2009 Nov 16).,Non-OADS,/arxiv_data1/oa_pdf/d9/63/pharmpract-08-035.PMC4140575.pdf
http://www.norpd.no/ (last accessed 2009 May 22).,OADS,/arxiv_data1/oa_pdf/79/dd/pharmpract-08-050.PMC4140577.pdf
http://www.apotek.no/graphics/NAF-bibliotek/Statistikk/ apolegemidl09.pdf (accessed September 1st 2009) [in  Norwegian].,Non-OADS,/arxiv_data1/oa_pdf/f3/0f/pharmpract-08-062.PMC4140579.pdf
Available at  http://www.db.uth.tmc.edu/faculty/vlewis/Vahnspage/2561/RXWritingRefs.htm  6.,Non-OADS,/arxiv_data1/oa_pdf/1b/e1/pharmpract-08-070.PMC4140580.pdf
"First, it utilizes modernfar-reaching technologies [global mobile Internet subscriptions isexpected to reach 4·5 billion by the end of 2018, with the mobilephone remaining the most frequently used access device (http://www.ericsson.com/ericsson-mobility-report accessed date 17March 2014)], allowing huge number of individuals across theglobe to calculate their absolute risk of stroke within the next 5 to10 years and to compare their risk with those of the same age and gender without risk factors.",Non-OADS,/arxiv_data1/oa_pdf/92/1b/ijs0009-0624.PMC4140602.pdf
"download for iPhone, iPad [https://itunes.apple.com/nz/app/ stroke-riskometer/id725335272?mt =8 (access date 17 March 2014)], Android tablets, and other smartphone users [https://play.google.com/store/search?q =stroke%20riskometer&hl =en (access date 17 March 2014)] (Fig.",Non-OADS,/arxiv_data1/oa_pdf/92/1b/ijs0009-0624.PMC4140602.pdf
Available at http://epe.lac-bac.gc.ca/100/ 200/301/hcan-scan/commission_blood_ﬁnal_rep-e/index.html.Accessed 11 June 2014.,Non-OADS,/arxiv_data1/oa_pdf/1c/22/hae0020-e251.PMC4140609.pdf
Availableat http://www1.wfh.org/publications/ﬁles/ pdf-1472.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1c/22/hae0020-e251.PMC4140609.pdf
Available at http://www1.wfh.org/publication/ﬁles/pdf-1451.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1c/22/hae0020-e251.PMC4140609.pdf
"Retrieved February 10, 2014 (http://www.trickortreatforunicef.org/sitedownloads/TOT_3to5_Unit.pdf).",OADS,/arxiv_data1/oa_pdf/e7/5d/tsq0055-0467.PMC4140611.pdf
"Retrieved February23, 2014 (https://www.google.com/search?q =zacharzewski +democracy +pays&ie =utf-8&oe =utf-8&aq =t&rls =org.mozilla:en-US:ofﬁcial&client =ﬁrefox-a&channel =sb).Measuring Grassroots, Empowerment, Accounting Nina Eliasoph 492 The Sociological Quarterly 55(2014) 467–492 © 2014 The Author.",Non-OADS,/arxiv_data1/oa_pdf/e7/5d/tsq0055-0467.PMC4140611.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2014 |  84  | e50703 | Page 1 of 5Video Article Dissection and Lateral Mounting of Zebrafish Embryos: Analysis of Spinal Cord Development Aaron P. Beck1, Roland M. Watt1, Jennifer Bonner1 1Biology Department, Skidmore College Correspondence to: Jennifer Bonner at jbonner@skidmore.edu URL: http://www.jove.com/video/50703 DOI: doi:10.3791/50703 Keywords: Neuroscience, Issue 84, Spinal Cord, Zebrafish, Microscopy, Confocal, Embryonic Development, Nervous System, dissection and mounting, mounting embryos, dissecting embryos Date Published: 2/28/2014 Citation: Beck, A.P., Watt, R.M., Bonner, J. Dissection and Lateral Mounting of Zebrafish Embryos: Analysis of Spinal Cord Development.",Non-OADS,/arxiv_data1/oa_pdf/51/3c/jove-84-50703.PMC4140612.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50703/ Introduction Visualization of the spinal cord in zebrafish is inhibited by a number of factors.,Non-OADS,/arxiv_data1/oa_pdf/51/3c/jove-84-50703.PMC4140612.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/49/e5/ijwh-6-771.PMC4140699.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2014:6 771–779International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  771OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S6550 8Knowledge on uterine prolapse among married  women of reproductive age in nepal Binjwala shrestha1,2 Bhimsen Devkota3,4 Badri Bahadur Khadka5 Bishnu choulagai1,2 Durga Prasad Pahari1 sharad Onta1 Max Petzold6 alexandra Krettek2,7 1Department of community Medicine  and Public Health, Institute of  Medicine, Tribhuvan University,   Kathmandu, nepal; 2Department  of Internal Medicine and clinical  nutrition, Institute of Medicine,   sahlgrenska academy at University of  gothenburg, sweden;  3Development  resource centre, Kathmandu,   nepal; 4Institute of education,   Tribhuvan University, Kathmandu,   nepal; 5national Health education  Information and communication  centre, Ministry of Health and  Population, government of nepal,  Kathmandu, nepal; 6akademistatistik  – centre for applied Biostatistics,   Occupational and environmental  Medicine, University of gothenburg,   sweden;  7nordic school of Public  Health nHV, gothenburg, sweden correspondence: Binjwala shrestha   Department of community Medicine  and Public Health, Institute of Medicine,  Tribhuvan University, Maharajgunj,  Kathmandu 44600, nepal   email binjwalashrestha59@gmail.co mBackground:  Uterine prolapse (UP), which affects about  10% of women of reproductive age  in Nepal, is the most frequently reported cause of poor health in women of reproductive age  and postmenopausal women.",Non-OADS,/arxiv_data1/oa_pdf/49/e5/ijwh-6-771.PMC4140699.pdf
"Available from: http://www.advocacynet.org/modules/fck/ upload/file/upa/Proceedings%20on%20Formation%20of%20Uterine%   20Prolapse%20Alliance%20Workshop%206%20April%202007.pd f.  Accessed August  15, 2013.",Non-OADS,/arxiv_data1/oa_pdf/49/e5/ijwh-6-771.PMC4140699.pdf
Available from: http://www.docstoc.com/docs/75048386/2nd-National- Safe-Motherhood-Conference.,Non-OADS,/arxiv_data1/oa_pdf/49/e5/ijwh-6-771.PMC4140699.pdf
"Available from: http://www.mohp.gov.np/english/files/ new_ publications/NHSP-IP%20II%20.pd f. Accessed August  26,  2013.",Non-OADS,/arxiv_data1/oa_pdf/49/e5/ijwh-6-771.PMC4140699.pdf
"Available from:  http://www.nheicc.gov.np/file/pdf/pdf8/l6tHf9National%20Health%   20Communication%20Policy_2012-Eng.pd f. Accessed August  20, 2013.",Non-OADS,/arxiv_data1/oa_pdf/49/e5/ijwh-6-771.PMC4140699.pdf
"Available from: http://www.nheicc.gov.np/file/pdf/ pdf8/z2QkvyNational%20Communication%20Strategy%20on%20 MNCH%202012-2016.pd f. Accessed August  22, 2013.",Non-OADS,/arxiv_data1/oa_pdf/49/e5/ijwh-6-771.PMC4140699.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/49/e5/ijwh-6-771.PMC4140699.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/49/e5/ijwh-6-771.PMC4140699.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3e/f0/sar-5-095.PMC4140700.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpSubstance Abuse and Rehabilitation 2014:5 95–105Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  95Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S5378 4Drug abuse in athletes Claudia L Reardon Shane Creado Department of Psychiatry, University  of wisconsin School of Medicine and  Public Health, Madison, wi, USA Correspondence: Claudia L Reardon   University of wisconsin School of  Medicine and Public Health, Department  of Psychiatry,  6001 Research Park  Boulevard, Madison, wi  53719, USA   Tel +1 608 263 6100  Fax +1 608 262 9246  email clreardon@wisc.ed uAbstract:  Drug abuse occurs in all sports and at most levels of competition.",Non-OADS,/arxiv_data1/oa_pdf/3e/f0/sar-5-095.PMC4140700.pdf
"Available from:  http://www.monitoringthefuture.org/pubs/monographs/vol2_2003.pd f.  Accessed June  12, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3e/f0/sar-5-095.PMC4140700.pdf
"Available from: http://www.fifa.com/aboutfifa/  footballdevelopment/medical/news/newsid =514062/index.htm l.  Accessed August  29, 2013.",Non-OADS,/arxiv_data1/oa_pdf/3e/f0/sar-5-095.PMC4140700.pdf
Available from: http://www.wada-ama.org/e n/about-wada/history/.,Non-OADS,/arxiv_data1/oa_pdf/3e/f0/sar-5-095.PMC4140700.pdf
Available from: http://www.lagrange.,Non-OADS,/arxiv_data1/oa_pdf/3e/f0/sar-5-095.PMC4140700.pdf
"Available from:  http://www.wada-ama.org/Documents/World_Anti-Doping_Program/ WADP-Prohibited-list/2013/WADA-Prohibited-List-2013-EN.pd f.  Accessed August  23, 2013.",Non-OADS,/arxiv_data1/oa_pdf/3e/f0/sar-5-095.PMC4140700.pdf
Available from: http://www.ncaa.org/wps/wcm/connect/public/NCAA/ Health+and+Safety/Drug +Testing/Drug +Testing+Landing+Page.,Non-OADS,/arxiv_data1/oa_pdf/3e/f0/sar-5-095.PMC4140700.pdf
"Available from: http://www.wada- ama.org/e n. Accessed April  18, 2013.",Non-OADS,/arxiv_data1/oa_pdf/3e/f0/sar-5-095.PMC4140700.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/3e/f0/sar-5-095.PMC4140700.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/f0/sar-5-095.PMC4140700.pdf
"Available from; http://sportsillustrated.cnn.com/vault/article/ magazine/MAG1009868/index.ht m. Accessed June  17, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3e/f0/sar-5-095.PMC4140700.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c9/a1/sar-5-107.PMC4140701.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpSubstance Abuse and Rehabilitation 2014:5 107–120Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  107Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S3791 7Abuse and misuse of antidepressants elizabeth A evans Maria A Sullivan Department of Psychiatry, Columbia  University College of Physicians and  Surgeons, New Y ork, NY, USA Correspondence: Maria A Sullivan   Department of Psychiatry, Columbia   University College of Physicians and  Surgeons, 1051 Riverside DR. Unit 120,  New York, NY, 10032, USA   email mas23@columbia .eduBackground:  Rates of prescription drug abuse have reached epidemic proportions.",Non-OADS,/arxiv_data1/oa_pdf/c9/a1/sar-5-107.PMC4140701.pdf
Available from: http://www.samhsa.,Non-OADS,/arxiv_data1/oa_pdf/c9/a1/sar-5-107.PMC4140701.pdf
Available from: http://www.monitoringthefuture.org/pubs/monographs/ mtf-overview2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c9/a1/sar-5-107.PMC4140701.pdf
Available from: http://www.drugfree.org/wp- content/uploads/2013/04/PATS-2012-FULL-REPORT2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c9/a1/sar-5-107.PMC4140701.pdf
Available from: http://www.samhsa.gov/data/2k13/ DAWN2k11ED/DAWN2k11ED.htm.,OADS,/arxiv_data1/oa_pdf/c9/a1/sar-5-107.PMC4140701.pdf
"Available  from: http://www.wada-ama.org/Documents/World_Anti-Doping_  Program/WADP-Prohibited-list/2014/WADA-Monitoring-Program- 2014-EN.pd f. Accessed June 16, 2014.",Non-OADS,/arxiv_data1/oa_pdf/c9/a1/sar-5-107.PMC4140701.pdf
2011. http://www.samhsa.,Non-OADS,/arxiv_data1/oa_pdf/c9/a1/sar-5-107.PMC4140701.pdf
Available from: http://www.casacolumbia.,Non-OADS,/arxiv_data1/oa_pdf/c9/a1/sar-5-107.PMC4140701.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/c9/a1/sar-5-107.PMC4140701.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/a1/sar-5-107.PMC4140701.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/97/6d/idr-7-203.PMC4140702.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2014:7 203–210Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  203ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IDR.S6726 7Microbiology, resistance patterns, and risk factors  of mortality in ventilator-associated bacterial  pneumonia in a northern Thai tertiary-care   university based general surgical intensive care unit Kaweesak chittawatanarat Wuttipong Jaipakdee narain chotirosniramit Kamtone chandacham Tidarat Jirapongcharoenlap Division of surgical critical care  and Trauma, Department of surgery,   Faculty of Medicine, chiang Mai  University, chiang Mai, Thailand correspondence: Kaweesak  chittawatanarat   Division of surgical critical care and  Trauma, Department of surgery, Faculty  of Medicine, chiang Mai University,  Maharaj nakorn chiang Mai hospital,  Intawarorod Rd, sripume District,   Muang, chiang Mai, 50200, Thailand   Tel +66 5394 5533  Fax +66 5394 6139  email kchittaw@gmail.co mBackground:  Ventilator-associated pneumonia (V AP) occurrence, causative pathogens, and  resistance patterns in surgical intensive care units (SICU) are different between Western and  developing Asian countries.",Non-OADS,/arxiv_data1/oa_pdf/97/6d/idr-7-203.PMC4140702.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/97/6d/idr-7-203.PMC4140702.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/6d/idr-7-203.PMC4140702.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/57/ijwh-6-781.PMC4140703.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 781–788International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  781RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S4933 2Update on new technologies in digital  mammography Stephanie K Patterson Marilyn A Roubidoux Division of Breast Imaging,   Department of Radiology,    University of Michigan Health   System, Ann Arbor, MI, USA Correspondence: Stephanie K Patterson   Division of Breast Imaging, Department   of Radiology, University of Michigan   Health System, C404 Med Inn Building –   SPC 5842, 1500 east Medical Center   Drive, Ann Arbor, MI 48109, USA   Tel +1 734 936 4355   Fax +1 734 232 5877   email spatters@umich.ed uAbstract:  Despite controversy regarding mammography’ s efficacy, it continues to be the most  commonly used breast cancer-screening modality.",Non-OADS,/arxiv_data1/oa_pdf/2c/57/ijwh-6-781.PMC4140703.pdf
Available from: http://globocan.iarc.fr/ Pages/fact_sheets_cancer.aspx.,Non-OADS,/arxiv_data1/oa_pdf/2c/57/ijwh-6-781.PMC4140703.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/2c/57/ijwh-6-781.PMC4140703.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/57/ijwh-6-781.PMC4140703.pdf
"2013. https://www.bcbsal.org/providers/policies/final/252.pd f. Accessed  May 29, 2014.",Non-OADS,/arxiv_data1/oa_pdf/2c/57/ijwh-6-781.PMC4140703.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e0/a3/ijn-9-3903.PMC4140704.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3903–3911International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3903OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6038 7Biomechanical evaluation and surface  characterization of a nano-modified surface   on PeeK implants: a study in the rabbit tibia Pär Johansson1 ryo Jimbo1 Per Kjellin2 Fredrik currie2 Bruno ramos chrcanovic1 ann Wennerberg1 1Department of Prosthodontics,   Faculty of Odontology, Malmö  University, Malmö, sweden; 2Promimic  aB, göteborg, sweden correspondence: Pär Johansson   Department of Prosthodontics,   Faculty of Odontology, Malmö University,  205 06 Malmö, sweden   T el +46 40 665 8514   email par.johansson@mah.s eAbstract:  Polyether ether ketone (PEEK) is today frequently used as a biomaterial in differ - ent medical operations due to its excellent mechanical and chemical properties.",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/ijn-9-3903.PMC4140704.pdf
"It has been reported that by applying  hydroxyapatite (HA) to PEEK, either mixed with the polymer or applied onto its  surface, PEEK becomes more hydrophilic and possesses bioactivity.15,16 HA has  been found to be an excellent coating material for enhanced osseointegration and  previous studies have shown a significantly increased rate of bone formation com - pared to untreated surfaces.17–20 The modification converts the PEEK from bioinert Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Johansson et al Running head recto: Biomechanical evaluation of PEEK DOI: http://dx.doi.org/10.2147/IJN.S60387",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/ijn-9-3903.PMC4140704.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/ijn-9-3903.PMC4140704.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 3911Biomechanical evaluation of PeeK  27.,Non-OADS,/arxiv_data1/oa_pdf/e0/a3/ijn-9-3903.PMC4140704.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/28/ijn-9-3923.PMC4140705.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3923–3935International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3923OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S6226 3enhanced brain delivery of lamotrigine   with Pluronic® P123-based nanocarrier Jian-sheng liu1,* Jian-hong Wang1,* Jie Zhou2 Xing-hua Tang1 lan Xu1 T eng shen2 Xun-Yi Wu1 Zhen hong1 1Department of Neurology,   huashan hospital, Fudan University,   shanghai, People’s republic of china;   2Department of Pharmaceutics,   school of Pharmacy, Fudan University,   shanghai, People’s republic of china *These authors contributed equally to  this work correspondence: Xun-Yi Wu   Department of Neurology, huashan  hospital, Fudan University, 12 Wulumuqi  Zhong road, shanghai 200040, People’s  republic of china   T el +86 21 6564 3671   Fax +86 21 6564 3671   email dr.xunyiwu@163.co m T eng shen   Department of Pharmaceutics, school  of Pharmacy, Fudan University, 826  Zhangheng road, shanghai 201203,  People’s republic of china   T el +86 21 5198 0081   Fax +86 21 5198 0081   email shenteng@fudan.edu.c nBackground:  P-glycoprotein (P-gp) mediated drug efflux across the blood –brain barrier (BBB)  is an important mechanism underlying poor brain penetration of certain antiepileptic drugs  (AEDs).",Non-OADS,/arxiv_data1/oa_pdf/31/28/ijn-9-3923.PMC4140705.pdf
Previous studies have Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Liu et al Running head recto: Pluronics enhance brain delivery of lamotrigine DOI: http://dx.doi.org/10.2147/IJN.S62263,Non-OADS,/arxiv_data1/oa_pdf/31/28/ijn-9-3923.PMC4140705.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/31/28/ijn-9-3923.PMC4140705.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3935Pluronics enhance brain delivery of lamotrigine  51.,Non-OADS,/arxiv_data1/oa_pdf/31/28/ijn-9-3923.PMC4140705.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/9a/ijn-9-3913.PMC4140706.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3913–3922International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3913OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S6563 3Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Sawosz et al Running head recto: Toxicity of pG in experiments in a chicken embryo model DOI: http://dx.doi.org/10.2147/IJN.S65633 T oxicity of pristine graphene in experiments   in a chicken embryo model ewa sawosz1 slawomir Jaworski1 Marta Kutwin1 anna hotowy1 Mateusz Wierzbicki1 Marta grodzik1 Natalia Kurantowicz1 Barbara strojny1 Ludwika Lipińska2 andré chwalibog3 1Division of Nanobiotechnology,   Warsaw University of life sciences,   Warsaw, Poland; 2Institute of  electronic Materials T echnology,   Warsaw, Poland; 3Department of  Veterinary clinical and animal  sciences, University of copenhagen,   Frederiksberg, Denmark correspondence: andré chwalibog   University of copenhagen, Department  of Veterinary clinical and animal  sciences, groennegaardsvej 3, 1870  Frederiksberg, Denmark   Tel +45 3533 3044   Fax +45 3533 3020   email ach@sund.ku.d k Abstract:  Evaluation of the potential cytotoxicity of graphene is a key factor for medical  applications, where flakes or a surface of graphene may be used as bioactive molecules, drug  carriers, or biosensors.",Non-OADS,/arxiv_data1/oa_pdf/8a/9a/ijn-9-3913.PMC4140706.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/8a/9a/ijn-9-3913.PMC4140706.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3922sawosz et al  20.,Non-OADS,/arxiv_data1/oa_pdf/8a/9a/ijn-9-3913.PMC4140706.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/66/b2/dddt-8-1097.PMC4140707.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 1097–1106Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1097Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6698 1Predictive performance of gentamicin   dosing nomograms Jieon lee1 seonghae Y oon1 Donghoon shin1 hyeKyung han1 hyungmi an1,2 Jongtae lee1 Kyoung soo lim3 Kyung-sang Yu1 howard lee1 1Department of clinical Pharmacology  and Therapeutics, seoul national  University college of Medicine and  hospital, seoul, Korea; 2Department  of statistics, college of natural  sciences, seoul national University,   seoul, Korea; 3Department of clinical  Pharmacology and Therapeutics,   cha University school of Medicine  and cha Bundang Medical center,   seongnam, Korea correspondence: howard lee   Department of clinical Pharmacology   and Therapeutics, seoul national   University college of Medicine and   hospital, 101 Daehak-ro, Jongno-gu,   seoul 110-799, Korea   Tel +82 2 3668 7602   Fax +82 2 742 9252   email howardlee@snu.ac.k rBackground:  Several nomograms have been proposed to facilitate the determination of  initial gentamicin dosing regimens in clinical settings.",Non-OADS,/arxiv_data1/oa_pdf/66/b2/dddt-8-1097.PMC4140707.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/66/b2/dddt-8-1097.PMC4140707.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/b2/dddt-8-1097.PMC4140707.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/41/a2/ijwh-6-789.PMC4140708.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2014:6 789–797International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  789OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S6326 1attributes and perspectives of public providers  related to provision of medical abortion at public  health facilities in Vietnam: a cross-sectional study  in three provinces Thoai D ngo1,2 caroline Free1 Hoan T le3 Phil edwards1 Kiet HT Pham4 Yen BT nguyen4 Thang H nguyen5 1Faculty of epidemiology and  Population Health, london  school of Hygiene and Tropical  Medicine, london, UK;  2research,   Monitoring and evaluation T eam,   Health system Department, Marie  stopes International, london, UK;   3Department of environmental Health,   4Department of Health economics,   Hanoi Medical University,  5research  and Metrics Team, Marie stopes  International Vietnam, Hanoi, Vietnam correspondence: Thoai D ngo   research, Monitoring and evaluation  Team, Health system Department,   Marie stopes International,  1 conway  street, london, W1T  6lP, UK   Tel +44 20 7034 2352  Fax +44 20 7034 2372  email t hoai.ngo@mariestopes.or gBackground:  The purpose of this study was to investigate attributes of public service providers  associated with the provision of medical abortion in Vietnam.",Non-OADS,/arxiv_data1/oa_pdf/41/a2/ijwh-6-789.PMC4140708.pdf
Available from: http://apps.who.int/rhl/fertility/abortion/dgcom/en /.,Non-OADS,/arxiv_data1/oa_pdf/41/a2/ijwh-6-789.PMC4140708.pdf
Available  from: http://dhsprogram.com/pubs/pdf/fr139/00frontmatter00.pdf.,Non-OADS,/arxiv_data1/oa_pdf/41/a2/ijwh-6-789.PMC4140708.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/41/a2/ijwh-6-789.PMC4140708.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/a2/ijwh-6-789.PMC4140708.pdf
"Available from: http://www.medicalabortionconsortium.org/pres/ lee%20cullingworth.pd f. Accessed November  8, 2013.",Non-OADS,/arxiv_data1/oa_pdf/41/a2/ijwh-6-789.PMC4140708.pdf
Available  from: http://www.path.org/publications/files/CP_vietnam_med_abt_ cost_study_rpt.pdf.,Non-OADS,/arxiv_data1/oa_pdf/41/a2/ijwh-6-789.PMC4140708.pdf
"Available from: http://apps.who.int/iris/bitstream/   10665/70914/1/9789241548434_eng.pd f. Accessed November  8,  2013.",OADS,/arxiv_data1/oa_pdf/41/a2/ijwh-6-789.PMC4140708.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e6/93/mder-7-273.PMC4140709.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2014:7 273–281Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  273ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S6778 4comparing the auscultatory accuracy of   health care professionals using three different   brands of stethoscopes on a simulator Mansoor Mehmood1 hazem l abu grara1 Joshua s stewart2 Faisal a Khasawneh3 1Department of internal   Medicine, Texas Tech University   health sciences center, 2surgical   intensive care Unit, northwest   T exas hospital, 3section of infectious   Diseases, Department of internal   Medicine, Texas Tech University   health sciences center, amarillo,    TX, Usa correspondence: Faisal a Khasawneh   section of infectious Diseases,   Department of internal Medicine,   Texas Tech University health sciences   center, 1400 s coulter street,   amarillo, TX 79106, Usa   Tel +1 806 354 5480   Fax +1 806 354 5765   Email faisal.khasawneh@ttuhsc.ed uBackground:  It is considered standard practice to use disposable or patient-dedicated stetho - scopes to prevent cross-contamination between patients in contact precautions and others in  their vicinity.",Non-OADS,/arxiv_data1/oa_pdf/e6/93/mder-7-273.PMC4140709.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2014:7submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 281Disposable stethoscopes: are they worth it?,Non-OADS,/arxiv_data1/oa_pdf/e6/93/mder-7-273.PMC4140709.pdf
GM Crops Food  2014 ;  5:4-7; PMID:24561916 ; http://dx.doi.org/10.4161/ gmcr.27777Review of four recent European court of justice law cases on GM crops,Non-OADS,/arxiv_data1/oa_pdf/0a/c8/bbug-5-209.PMC4140863.pdf
"GM Crops Food  2014 ;  5:11-5; PMID:24637519 ; http://dx.doi.org/10.4161/ gmcr.26560Conference report: “Surrogate species selection for assessing potential adverse  environmental impacts of genetically engineered plants on non-target organisms”The precautionary principle applied to the risk assessments of GM crops In this commentary, two industry based  scientists discuss the current regulatory  hurdles for genetically modified crops.",Non-OADS,/arxiv_data1/oa_pdf/0a/c8/bbug-5-209.PMC4140863.pdf
GM Crops Food  2014 ; 5:8- 10; PMID:24637724 ; http://dx.doi.org/10.4161/ gmcr.28331,Non-OADS,/arxiv_data1/oa_pdf/0a/c8/bbug-5-209.PMC4140863.pdf
GM Crops Food  2014 ; 5:65- 75; PMID:24637520 ; http://dx.doi.org/10.4161/ gmcr.28098Economic impact of GM crops: An update,Non-OADS,/arxiv_data1/oa_pdf/0a/c8/bbug-5-209.PMC4140863.pdf
Available from: http://www.nature.com/ news/seven-days-9-15-may-2014-1.15217?W t. ec_id=NA tURe-20140515GM-food to be labeled in Vermont?,Non-OADS,/arxiv_data1/oa_pdf/e1/56/bbug-5-212.PMC4140864.pdf
"Available from:  http://www.nytimes.com/2014/05/27/science/ craft-beer-at-the-genetic-level.html?_r=0 Synthetic biology enters the market According to a recent article in “ the  New York t imes,” several companies have  started using ingredients produced by  synthetic biology methods.",Non-OADS,/arxiv_data1/oa_pdf/e1/56/bbug-5-212.PMC4140864.pdf
"Available from:  http://www.nytimes.com/2014/05/31/business/ biofuel-tools-applied-to-household-soaps.html Direct ethanol production from switchgrass in a publication authored by Janet  Westpheling, the direct conversion of  plant biomass to ethanol by engineered  Caldicellulosiruptor bescii  is reported.",Non-OADS,/arxiv_data1/oa_pdf/e1/56/bbug-5-212.PMC4140864.pdf
Available from: https://www.qut.,Non-OADS,/arxiv_data1/oa_pdf/e1/56/bbug-5-212.PMC4140864.pdf
"Megan S Lord and John M Whitelock* Graduate School of Biomedical Engineering; The University of New South Wales; Sydney, Australia Keywords:  heparin, recombinant  expression, heparan sulfate Abbreviations:  ATIII, anti-thrombin  III; CHO, Chinese hamster ovary; CS,  chondroitin sulphate; DS, dermatan  sulphate; GlcA, glucuronic acid;  GlcNAC, N-acetyl glucosamine;  HA, hyaluronic acid; HS, heparan  sulphate; HITT, heparin-induced  thrombocytopenia and thrombosis;  IdoA, iduronic acid; KS, keratan sulfate;  LMWH, low molecular weight heparin;  NDST, N-deacetylase/N-sulfotransferase  OSCS, oversulfated chondroitin sulphate *Correspondence to: John M Whitelock;   Email: j.whitelock@unsw.edu.au Submitted: 05/18/2014; Revised: 05/27/2014;   Accepted: 05/28/2014;   Published Online: 06/05/2014 http://dx.doi.org/10.4161/bioe.29388",Non-OADS,/arxiv_data1/oa_pdf/24/82/bbug-5-222.PMC4140866.pdf
N Engl J Med 2008; 358:2457-67;  PMID:18434646 ;  http://dx.doi.org/10.1056/NEJMoa0803200 3.,OADS,/arxiv_data1/oa_pdf/24/82/bbug-5-222.PMC4140866.pdf
Proc Natl Acad Sci U S A  1986; 83:6485-8;  PMID:3462707 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/82/bbug-5-222.PMC4140866.pdf
Matrix Biol 2014; 35:60-72;   PMID :24361527 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/24/82/bbug-5-222.PMC4140866.pdf
Glycoconj J  2002; 19:355-61;  PMID:12975616 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/82/bbug-5-222.PMC4140866.pdf
Development 2012; 139:191-202;   PMID:22115756 ; http://dx.doi.org/10.1242/ dev.070151 12.,Non-OADS,/arxiv_data1/oa_pdf/24/82/bbug-5-222.PMC4140866.pdf
J Biol Chem 2004; 279:42732-41;  PMID:15292174 ;  http://dx.doi.org/10.1074/jbc.M405382200 14.,OADS,/arxiv_data1/oa_pdf/24/82/bbug-5-222.PMC4140866.pdf
Cell Mol Life Sci 2008; 65:1073-85;   PMID:18066495 ; http://dx.doi.org/10.1007/ s00018-007-7455-6 15.,OADS,/arxiv_data1/oa_pdf/24/82/bbug-5-222.PMC4140866.pdf
Carbohydr Res 2013; 371:32-9;  PMID:23474455 ;  http://dx.doi.org/10.1016/j.carres.2013.01.003 16.,OADS,/arxiv_data1/oa_pdf/24/82/bbug-5-222.PMC4140866.pdf
Bioengineered 2012; 3:227- 31; PMID:22714556 ; http://dx.doi.org/10.4161/ bioe.20902 17.,OADS,/arxiv_data1/oa_pdf/24/82/bbug-5-222.PMC4140866.pdf
J Biol Chem 2005; 280:42817-25;   PMID:16260789 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/24/82/bbug-5-222.PMC4140866.pdf
J Med Chem  2005; 48:349-52;  PMID :15658847 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/24/82/bbug-5-222.PMC4140866.pdf
Glycobiology 2014; 24:272- 80; PMID:24326668 ; http://dx.doi.org/10.1093/ glycob/cwt10821.,Non-OADS,/arxiv_data1/oa_pdf/24/82/bbug-5-222.PMC4140866.pdf
J Biol Chem 2011; 286:19892- 904; PMID:21454685 ; http://dx.doi.org/10.1074/ jbc.M111.228114,OADS,/arxiv_data1/oa_pdf/24/82/bbug-5-222.PMC4140866.pdf
"This has in turn led  to recent attempts for developing orally-administered small  molecule inhibitors of the mTOR signaling network.4 The  classical mTOR inhibitor, the macrolide rapamycin, has been  minimally successful as a candidate drug for cancers such as  renal cell carcinoma or endometrial cancer, lacking a broad  range of activity.5 The more recently developed small molecule  inhibitors of mTOR kinase target both mTOR and mTOR/ PI3K pathways that can be orally administered and where phase  I/II clinical trials are on-going against cancers such as breast,  lymphoma, malignant glioma, and others, either singly or in  combination with known anticancer drugs such as vincristine  and doxorubicin.6 The outcome of the clinical trials of these  mTOR-specific kinase inhibitors is ongoing and their success  will depend on the ability of the cancer cells to develop resistance *Correspondence to: Ananda M Chakrabarty; Email: pseudomo@uic.edu Submitted: 04/14/2014; Revised: 05/16/2014; Accepted: 05/16/2014;  Published Online: 05/29/2014 http://dx.doi.org/10.4161/bioe.29266Bacterial proteins and peptides in cancer therapy Today and tomorrow Ananda M Chakrabarty1,*, Nuno Bernardes2, and Arsenio M Fialho2 1Department of Microbiology & Immunology; University of Illinois College of Medicine; Chicago, IL USA; 2Institute for Biotechnology & Bioengineering;   Department of Bioengineering; Instituto Superior Técnico; Universidade de Lisboa; Lisbon, Portugal Keywords:  cancer, monoclonal antibodies, tyrosine kinase inhibitors, therapeutic peptide/proteins, bacterial proteins, azurin Cancer is one of the most deadly diseases worldwide.",Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
"Indeed, the role of bacterial proteins has been fictionalized in  a book Bugging Cancer  (http://logos-press.com/books/bugging- cancer/) to draw attention to the role microorganisms can play  in our efforts to combat cancer and other diseases, as will also  be discussed in a colloquium entitled Bugs as Drugs, organized",Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Nat  Rev Clin Oncol 2010; 7:163-72;  PMID:20101258 ;  http://dx.doi.org/10.1038/nrclinonc.2009.236 2.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Drug Discov Today  2013; 18:992-1000;  PMID:23769978 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
J  Clin Oncol 2009; 27:2278-87;  PMID:19332717 ;  http://dx.doi.org/10.1200/JCO.2008.20.0766 5.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Rev Recent Clin Trials  2011; 6:24-35;  PMID:20868343 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Drug Discov Today 2011; 16:325- 31; PMID:21333749 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Nat Rev Clin Oncol 2012; 9:16-32; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Bioengineered 2012; 3:262-70;  PMID:22750915 ;  http://dx.doi.org/10.4161/bioe.21130 10.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Mol Cell Proteomics 2009; 8:1278-94;   PMID:19329653 ; http://dx.doi.org/10.1074/mcp.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Nat Biotechnol  2008; 26:127-32;  PMID:18183025 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Nat Rev Drug Discov 2007; 6:734- 45; PMID:17690708 ; http://dx.doi.org/10.1038/ nrd2380 13.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Lancet  2007; 370:2011-9;  PMID:18083403 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Nat Rev Cancer 2007; 7:332-44;  PMID:17457301 ;  http://dx.doi.org/10.1038/nrc2106 15.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Drug Discov Today  2012; 17:850-60;  PMID:22465171 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Drug Discov Today  2013; 18:807-17;  PMID:23726889 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Mol Ther 2014; 22:547- 53; PMID:24394185 ; http://dx.doi.org/10.1038/ mt.2013.267 19.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
"Cancer Res 2009; 69:537-46;  PMID:19147567 ;  http://dx.doi.org/10.1158/0008-5472.CAN-08-2932by the American Academy of Microbiology in San Diego during  April 9–11, 2014.",Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Int J Nanomedicine  2011; 6:3011-9;  PMID:22162658 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Mol Cancer Ther  2009; 8:2947-58;  PMID:19808975 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Angiogenesis 2011; 14:355- 69; PMID:21667138 ; http://dx.doi.org/10.1007/ s10456-011-9220-6 23.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Cancer Prev Res (Phila) 2010; 3:1351-60;   PMID:20841487 ; http://dx.doi.org/10.1158/1940- 6207.CAPR-10-0024 24.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Cancer Biol Ther 2012; 13:1229-34;   PMID:22954683 ; http://dx.doi.org/10.4161/ cbt.21958 26.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Br J Cancer  2013; 108:1061-70;  PMID:23449360 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
ISRN  Neurol 2012; 2012:642345; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Cell Microbiol  2005; 7:1418-31;  PMID :16153242 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Curr  Opin Biotechnol 2007; 18:279-86;  PMID:17451932 ;  http://dx.doi.org/10.1016/j.copbio.2007.04.001 33.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Appl Environ Microbiol  2012; 78:7603-10;  PMID:22923405 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Int J Pept Res Ther 2011; 17:247-57; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Yonsei Med J 2011; 52:773-8;  PMID:21786442 ;  http://dx.doi.org/10.3349/ymj.2011.52.5.773 36.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Biochemistry 2007;  46:1799-810;  PMID:17249693 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
PLoS One 2013; 8:e69023;   PMID:23894398 ; http://dx.doi.org/10.1371/jour - nal.pone.0069023 39.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Clin Cancer Res 2005; 11:5869-77;   PMID :16115928 ; http://dx.doi.org/10.1158/1078- 0432.CCR-05-0059 40.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Int J Dev Biol  2011; 55:811-22;  PMID:22161837 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Cell Mol Life Sci 2011; 68:3853- 68; PMID:21744247 ; http://dx.doi.org/10.1007/ s00018-011-0763-x 42.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Cancer Sci 2008;  99:2160-9;  PMID:18811693 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Cancer Lett 2010; 289:127-39;   PMID:19643531 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Curr Opin Cell Biol 2005; 17:542- 7; PMID:16099634 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
J Cell Sci  2012; 125:497-506;  PMID:22302985 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Int  J Biochem Cell Biol 2014; 50:1-9;  PMID:24509127 ;  http://dx.doi.org/10.1016/j.biocel.2014.01.023 49.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Drug Discov Today  2008; 13:433-9;  PMID:18468561 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Indian J Pharm Sci 2008;  70:269-77;  PMID:20046732 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
PLoS One 2013; 8:e59524;   PMID:23593142 ; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Mol Ther  2014; 22:535-46;  PMID:24281246 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Blood 2011; 118:5767- 73; PMID:21900191 ; http://dx.doi.org/10.1182/ blood-2011-07-366955 54.,Non-OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
Environ Microbiol  2014; 16:9-18;  PMID:24387039 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/08/d6/bbug-5-234.PMC4140868.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/05/main.PMC4140983.pdf
Deposited data can be found here: http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE52086 .,OADS,/arxiv_data1/oa_pdf/8b/05/main.PMC4140983.pdf
Consent N/A Sample source locationN/A http://dx.doi.org/10.1016/j.gdata.2014.07.001 2213-5960/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/05/main.PMC4140983.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/05/main.PMC4140983.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/8b/05/main.PMC4140983.pdf
"Epigenetics 9 (2014) 513 –522, http://dx.doi.org/ 10.4161/epi.2764 (PMID: 24442241).",Non-OADS,/arxiv_data1/oa_pdf/8b/05/main.PMC4140983.pdf
"19 (2012) 361 –363, http://dx.doi.org/10.1038/nsmb.2252 (PMID: 22343720).",Non-OADS,/arxiv_data1/oa_pdf/8b/05/main.PMC4140983.pdf
"28 (2010) 511 –515, http://dx.doi.org/10.1038/nbt.162 (PMID: 20436464).218 G. Mas Martín et al.",OADS,/arxiv_data1/oa_pdf/8b/05/main.PMC4140983.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/48/main.PMC4141080.pdf
"The a-amylase family (glycoside hydrolase family 13, GHF13) is one of ﬁve structural families (GHF4, GHF13, GHF31, GHF97 and GHF122) of starch- http://dx.doi.org/10.1016/j.fob.2014.06.002 2211-5463/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9a/48/main.PMC4141080.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: ApAmy59, Aplysia 59-kDa a-amylase; ApAmy80, Aplysia 80-kDa a-amylase; ApAGL74, Aplysia 74-kDa a-glucosidase; ApAGL86, Aplysia 86-kDa a-glucosidase; CMC, carboxymethylcellulose; 4MU- a-Glu, 4-methylumbelliferyl a-glucoside; GHF, glycoside hydrolase family; PVDF, polyvinylidene ﬂuoride; TLC, thin layer chromatography ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/9a/48/main.PMC4141080.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.06.002 .",OADS,/arxiv_data1/oa_pdf/9a/48/main.PMC4141080.pdf
"13, 16,http://dx.doi.org/10.1186/1472-6750-13-16 .",Non-OADS,/arxiv_data1/oa_pdf/9a/48/main.PMC4141080.pdf
"2014 July;20(3):161-162.  http://dx.doi.org/10.4258/hir.2014.20.3.161 pISSN 2093-3681  •  eISSN 2093-369X  Editorial This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Com - mons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by- nc/3.0/)	which	permits	unrestricted	non-commercial	use,	distribution,	and	reproduc - tion	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/90/0d/hir-20-161.PMC4141129.pdf
162 www.e-hir.orgYoung Moon Chae http://dx.doi.org/10.4258/hir.2014.20.3.161of CPOE on a real-time basis.,OADS,/arxiv_data1/oa_pdf/90/0d/hir-20-161.PMC4141129.pdf
Available from: http://www.econotalking.kr/ news/articleView.html?idxno=124848.,Non-OADS,/arxiv_data1/oa_pdf/90/0d/hir-20-161.PMC4141129.pdf
"2014 July;20(3):163-172.  http://dx.doi.org/10.4258/hir.2014.20.3.163 pISSN 2093-3681  •  eISSN 2093-369X  Review Article Submitted: 	May	24,	2014 Revised: 	July	17,	2014 Accepted: 	July	17,	2014 Corresponding Author  William	T.	F.	Goossen,	PhD Results4Care	 B.V.,	 De	Stinse	 15,	3823	 VM	Amersfoort,	 The	Nether - lands.",Non-OADS,/arxiv_data1/oa_pdf/f9/85/hir-20-163.PMC4141130.pdf
"Tel:	+31-654614458, 	Fax:	+31-332570169, 	E-mail: 	wgoos - sen@results4care.nl This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Com - mons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by- nc/3.0/)	which	permits	unrestricted	non-commercial	use,	distribution,	and	reproduc - tion	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/85/hir-20-163.PMC4141130.pdf
"164 www.e-hir.orgWilliam T. F. Goossen http://dx.doi.org/10.4258/hir.2014.20.3.163healthcare in general, and Electronic Health Records (EHR)  in particular.",Non-OADS,/arxiv_data1/oa_pdf/f9/85/hir-20-163.PMC4141130.pdf
"For  example, FileFormat.Info (http://www.fileformat.info) in - cludes file format conversion tools for images only based on  Java Advanced Imaging libraries (javax.imageio.",OADS,/arxiv_data1/oa_pdf/f9/85/hir-20-163.PMC4141130.pdf
"com about 20 multi-media formats; http://www.zamzar.com  selected conversions of document, image, music, video, and  couple of CAD formats).",Non-OADS,/arxiv_data1/oa_pdf/f9/85/hir-20-163.PMC4141130.pdf
166 www.e-hir.orgWilliam T. F. Goossen http://dx.doi.org/10.4258/hir.2014.20.3.163  In order to design an extensible file format conversion sys - tem based on utilizing third party software several problems  have to be addressed [12].,Non-OADS,/arxiv_data1/oa_pdf/f9/85/hir-20-163.PMC4141130.pdf
AutoHotkey  (http://www.autohotkey.com) scripting is a viable option  for the Windows operating system and the current Poly - glot implementation is based on it.,Non-OADS,/arxiv_data1/oa_pdf/f9/85/hir-20-163.PMC4141130.pdf
"globus.org/toolkit/), for building computational grids, and  the design of workflow middleware that would manage the  execution, such as DAGMan, CCA (http://www.cca-forum.",OADS,/arxiv_data1/oa_pdf/f9/85/hir-20-163.PMC4141130.pdf
"org) or Taverna (http://www.taverna.org.uk/), among others.",Non-OADS,/arxiv_data1/oa_pdf/f9/85/hir-20-163.PMC4141130.pdf
168 www.e-hir.orgWilliam T. F. Goossen http://dx.doi.org/10.4258/hir.2014.20.3.163Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/f9/85/hir-20-163.PMC4141130.pdf
"170 www.e-hir.orgWilliam T. F. Goossen http://dx.doi.org/10.4258/hir.2014.20.3.163eye opening, best motor response and best verbal response  that are summed up into a total score.",Non-OADS,/arxiv_data1/oa_pdf/f9/85/hir-20-163.PMC4141130.pdf
Available from: http://www.clini - calcontentsmodel.org.,Non-OADS,/arxiv_data1/oa_pdf/f9/85/hir-20-163.PMC4141130.pdf
172 www.e-hir.orgWilliam T. F. Goossen http://dx.doi.org/10.4258/hir.2014.20.3.16311.,Non-OADS,/arxiv_data1/oa_pdf/f9/85/hir-20-163.PMC4141130.pdf
Available from: http://wiki.hl7.org/index.,Non-OADS,/arxiv_data1/oa_pdf/f9/85/hir-20-163.PMC4141130.pdf
Available from: http://www.ihtsdo.org/snomed-ct/.,OADS,/arxiv_data1/oa_pdf/f9/85/hir-20-163.PMC4141130.pdf
Available from: http://loinc.org/.,Non-OADS,/arxiv_data1/oa_pdf/f9/85/hir-20-163.PMC4141130.pdf
"2014 July;20(3):173-182.  http://dx.doi.org/10.4258/hir.2014.20.3.173 pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: 	January	17,	2014 Revised: 	July	10,	2014 Accepted: 	July	18,	2014 Corresponding Author  Un-Gu	Kang,	PhD U-Healthcare 	Institute, 	Gachon 	University, 	191	Hambakmoero,	 Yeonsu-gu, 	Incheon 	406-799, 	Korea.",Non-OADS,/arxiv_data1/oa_pdf/a7/ae/hir-20-173.PMC4141131.pdf
"Tel:	+82-32-820-4392, 	Fax:	 +82-32-820-4504,	E-mail:	ugkang@gachon.ac.kr	 This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Com - mons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by- nc/3.0/)	which	permits	unrestricted	non-commercial	use,	distribution,	and	reproduc - tion	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/ae/hir-20-173.PMC4141131.pdf
"174 www.e-hir.orgJi-In Woo et al http://dx.doi.org/10.4258/hir.2014.20.3.173gery; however, continuous management is required by pa - tients.",Non-OADS,/arxiv_data1/oa_pdf/a7/ae/hir-20-173.PMC4141131.pdf
"176 www.e-hir.orgJi-In Woo et al http://dx.doi.org/10.4258/hir.2014.20.3.173each layer of the HDSS, for providing the HDSS.",OADS,/arxiv_data1/oa_pdf/a7/ae/hir-20-173.PMC4141131.pdf
178 www.e-hir.orgJi-In Woo et al http://dx.doi.org/10.4258/hir.2014.20.3.173ic.,OADS,/arxiv_data1/oa_pdf/a7/ae/hir-20-173.PMC4141131.pdf
180 www.e-hir.orgJi-In Woo et al http://dx.doi.org/10.4258/hir.2014.20.3.173Figure 8.,OADS,/arxiv_data1/oa_pdf/a7/ae/hir-20-173.PMC4141131.pdf
Available from: http://kostat.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/a7/ae/hir-20-173.PMC4141131.pdf
182 www.e-hir.orgJi-In Woo et al http://dx.doi.org/10.4258/hir.2014.20.3.173tronic medical record system at a tertiary care hospital.,Non-OADS,/arxiv_data1/oa_pdf/a7/ae/hir-20-173.PMC4141131.pdf
Avail - able from: http://www.hl7.org.,Non-OADS,/arxiv_data1/oa_pdf/a7/ae/hir-20-173.PMC4141131.pdf
Available  from: http://www.ncbi.nlm.nih.gov/pubmed/.,OADS,/arxiv_data1/oa_pdf/a7/ae/hir-20-173.PMC4141131.pdf
"2014 July;20(3):183-190.  http://dx.doi.org/10.4258/hir.2014.20.3.183 pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted:  April 18, 2014 Revised:  July 18, 2014 Accepted:  July 27, 2014 Corresponding Author  Jinhyung Lee, PhD Department of Economics, Sungkyunkwan University, 25-2, Sung - kyunkwan-ro, Jongno-gu, Seoul 110-745, Korea.",Non-OADS,/arxiv_data1/oa_pdf/1d/ec/hir-20-183.PMC4141132.pdf
"Tel: +82-2-760- 0263, Fax: +82-2-760-0946, E-mail: leejinh@skku.edu This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/ec/hir-20-183.PMC4141132.pdf
184 www.e-hir.orgYoung-Taek Park and Jinhyung Lee http://dx.doi.org/10.4258/hir.2014.20.3.183healthcare practice [6-11].,Non-OADS,/arxiv_data1/oa_pdf/1d/ec/hir-20-183.PMC4141132.pdf
186 www.e-hir.orgYoung-Taek Park and Jinhyung Lee http://dx.doi.org/10.4258/hir.2014.20.3.183independent variables were the covariates mentioned above.,OADS,/arxiv_data1/oa_pdf/1d/ec/hir-20-183.PMC4141132.pdf
188 www.e-hir.orgYoung-Taek Park and Jinhyung Lee http://dx.doi.org/10.4258/hir.2014.20.3.183determine how to motivate small hospitals to invest financial  and human resources in EMR system adoption in order to  address the ‘adoption gap’ in small clinical practice settings  with regard to health information technologies [19].,Non-OADS,/arxiv_data1/oa_pdf/1d/ec/hir-20-183.PMC4141132.pdf
190 www.e-hir.orgYoung-Taek Park and Jinhyung Lee http://dx.doi.org/10.4258/hir.2014.20.3.183[cited at 2014 Jul 1].,Non-OADS,/arxiv_data1/oa_pdf/1d/ec/hir-20-183.PMC4141132.pdf
Available from: http://en.wikipedia.,Non-OADS,/arxiv_data1/oa_pdf/1d/ec/hir-20-183.PMC4141132.pdf
Available from: http://support.sas.,OADS,/arxiv_data1/oa_pdf/1d/ec/hir-20-183.PMC4141132.pdf
"2014 July;20(3):191-198.  http://dx.doi.org/10.4258/hir.2014.20.3.191 pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted:  June 25, 2014 Revised:  July 22, 2014 Accepted:  July 25, 2014 Corresponding Author  Kwang Gi Kim, PhD Biomedical Engineering Branch, Division of Convergence Tech - nology, Research Institute, National Cancer Center, 323 Ilsan-ro,  Ilsandong-gu, Goyang 410-769, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b0/ba/hir-20-191.PMC4141133.pdf
"Tel: +82-31-920-2241, Fax:  +82-31-920-2242, E-mail: kimkg@ncc.re.kr This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/ba/hir-20-191.PMC4141133.pdf
192 www.e-hir.orgYoung Jae Kim et al http://dx.doi.org/10.4258/hir.2014.20.3.191ally reveal.,Non-OADS,/arxiv_data1/oa_pdf/b0/ba/hir-20-191.PMC4141133.pdf
"194 www.e-hir.orgYoung Jae Kim et al http://dx.doi.org/10.4258/hir.2014.20.3.191trast agents affects the decreasing part of the time-intensity  curve, CAIF(t) and CROI(t) need to be fitted to the gamma- variate function.",OADS,/arxiv_data1/oa_pdf/b0/ba/hir-20-191.PMC4141133.pdf
"196 www.e-hir.orgYoung Jae Kim et al http://dx.doi.org/10.4258/hir.2014.20.3.191respectively, before and after registration.",OADS,/arxiv_data1/oa_pdf/b0/ba/hir-20-191.PMC4141133.pdf
198 www.e-hir.orgYoung Jae Kim et al http://dx.doi.org/10.4258/hir.2014.20.3.191References 1.,OADS,/arxiv_data1/oa_pdf/b0/ba/hir-20-191.PMC4141133.pdf
"2014 July;20(3):199-208.  http://dx.doi.org/10.4258/hir.2014.20.3.199 pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted:  March 4, 2014 Revised:  1st, April 22, 2014; 2nd, June 9, 2014 Accepted:  June 19, 2014 Corresponding Author  Eunjoo Lee, PhD Department of Nursing, Research Institute of Nursing Science, Col - lege of Nursing, Kyungpook National University, 680, Gukchaebo - sang-ro, Jung-gu, Daegu 700-842, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4f/86/hir-20-199.PMC4141134.pdf
"Tel: +82-53-420-4934,  Fax: +82-53-425-1258, E-mail: jewelee@knu.ac.kr  This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/86/hir-20-199.PMC4141134.pdf
"200 www.e-hir.orgBu Kyung Park and Eunjoo Lee http://dx.doi.org/10.4258/hir.2014.20.3.199settings and educating healthcare professionals were not effec - tive and had limitations in reducing medical errors [4,5].",Non-OADS,/arxiv_data1/oa_pdf/4f/86/hir-20-199.PMC4141134.pdf
202 www.e-hir.orgBu Kyung Park and Eunjoo Lee http://dx.doi.org/10.4258/hir.2014.20.3.199many factors are necessary to explain the inter-relationships  among a set of indicators of patient safety in the developed  questionnaire [15].,Non-OADS,/arxiv_data1/oa_pdf/4f/86/hir-20-199.PMC4141134.pdf
204 www.e-hir.orgBu Kyung Park and Eunjoo Lee http://dx.doi.org/10.4258/hir.2014.20.3.199tion and disease from the hospital (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/4f/86/hir-20-199.PMC4141134.pdf
"206 www.e-hir.orgBu Kyung Park and Eunjoo Lee http://dx.doi.org/10.4258/hir.2014.20.3.199tiatives started from the diverse organization level, and there  have been many studies or campaigns promoted by hospital  or by individual researchers [5].",Non-OADS,/arxiv_data1/oa_pdf/4f/86/hir-20-199.PMC4141134.pdf
Available from: http://isis.kisa.or.kr/eng/ board/index.jsp?pageId=040100&bbsId=10&itemId=32 1&pageIndex=1.,OADS,/arxiv_data1/oa_pdf/4f/86/hir-20-199.PMC4141134.pdf
208 www.e-hir.orgBu Kyung Park and Eunjoo Lee http://dx.doi.org/10.4258/hir.2014.20.3.199promote collaboration and patient safety.,Non-OADS,/arxiv_data1/oa_pdf/4f/86/hir-20-199.PMC4141134.pdf
Available from: http://www.jointcom - mission.org/speakup.aspx.,Non-OADS,/arxiv_data1/oa_pdf/4f/86/hir-20-199.PMC4141134.pdf
Available from: http://www.ahrq.gov/patients- consumers/index.html.,Non-OADS,/arxiv_data1/oa_pdf/4f/86/hir-20-199.PMC4141134.pdf
"2014 July;20(3):209-215.  http://dx.doi.org/10.4258/hir.2014.20.3.209 pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted:  June 18, 2014 Revised:  July 24, 2014 Accepted:  July 25, 2014 Corresponding Author  Noriko Nakamura, MPharm, JD Department of Gastroenterological Surgery, Faculty of Medicine,  Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814- 0180, Japan.",Non-OADS,/arxiv_data1/oa_pdf/50/79/hir-20-209.PMC4141135.pdf
"Tel: +81-92-801-1011, Fax: +81-92-863-9759, E-mail:  nn0904@fukuoka-u.ac.jp This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/79/hir-20-209.PMC4141135.pdf
210 www.e-hir.orgNoriko Nakamura et al http://dx.doi.org/10.4258/hir.2014.20.3.209  It is necessary to establish effective and continuous incident  reporting systems in hospitals to promote patient safety.,Non-OADS,/arxiv_data1/oa_pdf/50/79/hir-20-209.PMC4141135.pdf
212 www.e-hir.orgNoriko Nakamura et al http://dx.doi.org/10.4258/hir.2014.20.3.209and the study periods ( p = 0.548).,OADS,/arxiv_data1/oa_pdf/50/79/hir-20-209.PMC4141135.pdf
"214 www.e-hir.orgNoriko Nakamura et al http://dx.doi.org/10.4258/hir.2014.20.3.209drug reactions, the duration of the change in actions was  reported to be 1 year in one study [15] and 16 months in  another [27].",OADS,/arxiv_data1/oa_pdf/50/79/hir-20-209.PMC4141135.pdf
"2014 July;20(3):216-225.  http://dx.doi.org/10.4258/hir.2014.20.3.216 pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: 	June	27,	2014 Revised: 	July	27,	2014 Accepted: 	July	28,	2014 Corresponding Author  Ji-Young	An,	PhD u-Healthcare 	Design 	&	Healthcare 	Service 	Design 	Development	 Program, 	Design 	Institute, 	Inje	University, 	31	Supyo-ro, 	Jung-gu,	 Seoul 	100-032, 	Korea.",Non-OADS,/arxiv_data1/oa_pdf/de/62/hir-20-216.PMC4141136.pdf
"Tel:	+82-2-2270-0904, 	Fax:	+82-2-2270- 0517,	E-mail:	ajy0130@inje.ac.kr This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Com - mons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by- nc/3.0/)	which	permits	unrestricted	non-commercial	use,	distribution,	and	reproduc - tion	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/de/62/hir-20-216.PMC4141136.pdf
218 www.e-hir.orgHaeran Jang and Ji-Young An http://dx.doi.org/10.4258/hir.2014.20.3.216MeSH terms with the corresponding number of selected ar - ticles: health communication AND aged (9 out of 23); health  literacy AND aged (61 out of 191); computer literacy AND  aged (39 out of 104); computer literacy AND health educa - tion AND aged (18 out of 48).,Non-OADS,/arxiv_data1/oa_pdf/de/62/hir-20-216.PMC4141136.pdf
220 www.e-hir.orgHaeran Jang and Ji-Young An http://dx.doi.org/10.4258/hir.2014.20.3.216‘Health literacy’ was ranked first in 2010.,Non-OADS,/arxiv_data1/oa_pdf/de/62/hir-20-216.PMC4141136.pdf
222 www.e-hir.orgHaeran Jang and Ji-Young An http://dx.doi.org/10.4258/hir.2014.20.3.216in the study of the use of online health information on the  Internet.,Non-OADS,/arxiv_data1/oa_pdf/de/62/hir-20-216.PMC4141136.pdf
224 www.e-hir.orgHaeran Jang and Ji-Young An http://dx.doi.org/10.4258/hir.2014.20.3.216connections between nodes [35].,OADS,/arxiv_data1/oa_pdf/de/62/hir-20-216.PMC4141136.pdf
"In particular, an educational program and detailed  guidelines to increase health literacy in elderly Koreans, simi - lar to ‘Helping older adults search for health information on - line’ (http://nihseniorhealth.gov/toolkit/toolkit.html), estab - lished by the National Institute on Aging in the United States,  is needed.",Non-OADS,/arxiv_data1/oa_pdf/de/62/hir-20-216.PMC4141136.pdf
"2014 July;20(3):226-230.  http://dx.doi.org/10.4258/hir.2014.20.3.226 pISSN 2093-3681  •  eISSN 2093-369X  Case Report Submitted: 	June	26,	2014 Revised: 	July	28,	2014 Accepted: 	July	29,	2014 Corresponding Author  Hwa	Jeong	Seo,	PhD Medical	Informatics	and	health	Technology	(MIT),	Department	 of	Health	Care	Management,	College	of	Social	Science,	Gachon	 University,	1342,	Seongnam-daero,	Sujeong-gu,	Seongnam	461- 701,	Korea.",Non-OADS,/arxiv_data1/oa_pdf/2d/06/hir-20-226.PMC4141137.pdf
"Tel:	+82-31-750-5372,	Fax:	+82-31-750-5372,	E-mail:	 hjseo@gachon.ac.kr This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Com - mons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by- nc/3.0/)	which	permits	unrestricted	non-commercial	use,	distribution,	and	reproduc - tion	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/06/hir-20-226.PMC4141137.pdf
228 www.e-hir.orgHye Hyeon Kim and Hwa Jeong Seo http://dx.doi.org/10.4258/hir.2014.20.3.226based on our developed TTM model-based intervention  algorithm.,OADS,/arxiv_data1/oa_pdf/2d/06/hir-20-226.PMC4141137.pdf
Available from: http://kostat.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/2d/06/hir-20-226.PMC4141137.pdf
230 www.e-hir.orgHye Hyeon Kim and Hwa Jeong Seo http://dx.doi.org/10.4258/hir.2014.20.3.226tance factors in the healthcare industry: a structural  equation model.,OADS,/arxiv_data1/oa_pdf/2d/06/hir-20-226.PMC4141137.pdf
Available from: https://play.google.com/store/apps/ details?id=com.smartcare.,Non-OADS,/arxiv_data1/oa_pdf/2d/06/hir-20-226.PMC4141137.pdf
Available from:  http://www.diabetes.,Non-OADS,/arxiv_data1/oa_pdf/2d/06/hir-20-226.PMC4141137.pdf
"2014 July;20(3):231-235.  http://dx.doi.org/10.4258/hir.2014.20.3.231 pISSN 2093-3681  •  eISSN 2093-369X  Case Report Submitted: 	June	29,	2014 Revised: 	July	18,	2014 Accepted: 	July	19,	2014 Corresponding Author  Sung	Soo	Kim,	MD,	PhD Department	 of	Ophthalmology,	 Yonsei	 University	 College	 of	Medi - cine, 	50-1, 	Yonsei-ro, 	Seodaemun-gu, 	Seoul 	120-752, 	Korea.",Non-OADS,/arxiv_data1/oa_pdf/b0/56/hir-20-231.PMC4141138.pdf
"ac	 This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Com - mons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by- nc/3.0/)	which	permits	unrestricted	non-commercial	use,	distribution,	and	reproduc - tion	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/56/hir-20-231.PMC4141138.pdf
"232 www.e-hir.orgYoungAh Kim et al http://dx.doi.org/10.4258/hir.2014.20.3.231solutions, the target customers, purposes of services, service  concepts, service maintenance, and reaction to customer  needs are the top priorities for consideration [1,2].",OADS,/arxiv_data1/oa_pdf/b0/56/hir-20-231.PMC4141138.pdf
234 www.e-hir.orgYoungAh Kim et al http://dx.doi.org/10.4258/hir.2014.20.3.231note that was rendered by the process described above.,Non-OADS,/arxiv_data1/oa_pdf/b0/56/hir-20-231.PMC4141138.pdf
Available from: http://www.hl7.org/implement/standards/product_brief.,Non-OADS,/arxiv_data1/oa_pdf/b0/56/hir-20-231.PMC4141138.pdf
"2014 July;20(3):236-242.  http://dx.doi.org/10.4258/hir.2014.20.3.236 pISSN 2093-3681  •  eISSN 2093-369X  Case Report Submitted:  April 14, 2014 Revised:  July 8, 2014 Accepted:  July 16, 2014 Corresponding Authors  Danhong Liu, PhD Institute for Health Informatics, Fourth Military Medical Univer - sity, 169 Changle West Road, Xi’an 710032, China.",Non-OADS,/arxiv_data1/oa_pdf/2b/d1/hir-20-236.PMC4141139.pdf
"Tel: +86-29-84774431, E-mail: su - jkuan@fmmu.edu.cn This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/d1/hir-20-236.PMC4141139.pdf
238 www.e-hir.orgDanhong Liu et al http://dx.doi.org/10.4258/hir.2014.20.3.2362.,OADS,/arxiv_data1/oa_pdf/2b/d1/hir-20-236.PMC4141139.pdf
"240 www.e-hir.orgDanhong Liu et al http://dx.doi.org/10.4258/hir.2014.20.3.236heart disease, diabetes or impaired glucose tolerance, reti - nopathy, kidney disease, and peripheral vascular disease,  while the patients’ records categorize them as cerebrovascu - lar, heart, neural, eye, kidney, and vascular diseases, as well  as diseases of other systems.",OADS,/arxiv_data1/oa_pdf/2b/d1/hir-20-236.PMC4141139.pdf
Avail -able from: http://www.gov.cn/zwgk/2011-05/24/con - tent_1870181.htm.,Non-OADS,/arxiv_data1/oa_pdf/2b/d1/hir-20-236.PMC4141139.pdf
Avail - able from: http://protegewiki.stanford.edu/wiki/Main_ Page.,Non-OADS,/arxiv_data1/oa_pdf/2b/d1/hir-20-236.PMC4141139.pdf
Available  from: http://wiki.hl7.org/images/7/71/HL7vMR_vMR_ Domain_Analysis_Model_Release_1.pdf.,OADS,/arxiv_data1/oa_pdf/2b/d1/hir-20-236.PMC4141139.pdf
Avail - able from: http://ihtsdo.org/fileadmin/user_upload/ doc/download/doc_UserGuide_Current-en-US_ INT_20130731.pdf.,OADS,/arxiv_data1/oa_pdf/2b/d1/hir-20-236.PMC4141139.pdf
242 www.e-hir.orgDanhong Liu et al http://dx.doi.org/10.4258/hir.2014.20.3.23624.,OADS,/arxiv_data1/oa_pdf/2b/d1/hir-20-236.PMC4141139.pdf
Available from: http://loinc.org/downloads/files/LOINCManual.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2b/d1/hir-20-236.PMC4141139.pdf
"2014 July;20(3):243-244.  http://dx.doi.org/10.4258/hir.2014.20.3.243 pISSN 2093-3681  •  eISSN 2093-369X  Book Review This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Com - mons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by- nc/3.0/)	which	permits	unrestricted	non-commercial	use,	distribution,	and	reproduc - tion	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/78/c9/hir-20-243.PMC4141140.pdf
244 www.e-hir.orgMona Choi http://dx.doi.org/10.4258/hir.2014.20.3.243for marketing campaigns.,Non-OADS,/arxiv_data1/oa_pdf/78/c9/hir-20-243.PMC4141140.pdf
Available  from: http://www.eudat.eu/.,Non-OADS,/arxiv_data1/oa_pdf/78/c9/hir-20-243.PMC4141140.pdf
http://dx.doi.org/10.1136/amiajnl-2014-002974.,Non-OADS,/arxiv_data1/oa_pdf/78/c9/hir-20-243.PMC4141140.pdf
Available  from: http://data2discovery.org/dev/wp-content/up - loads/2012/09/NCDS-Consortium-Roadmap_July.pdf.,OADS,/arxiv_data1/oa_pdf/78/c9/hir-20-243.PMC4141140.pdf
"Correction: Massive Open Online Course for  Health Informatics Education Chris Paton, BMBS, BMedSci, FACHI http://dx.doi.org/10.4258/hir.2014.20.2.81 Healthc	Inform	Res	2014;20(2):81-7 To the Editor: I have noticed an inadvertent error in my article.",Non-OADS,/arxiv_data1/oa_pdf/73/a9/hir-20-245.PMC4141141.pdf
"2014 July;20(3):245.  http://dx.doi.org/10.4258/hir.2014.20.3.245 pISSN 2093-3681  •  eISSN 2093-369X  Erratum This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Commons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by-nc/3.0/)	which	 permits	unrestricted	non-commercial	use,	distribution,	and	reproduction	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/73/a9/hir-20-245.PMC4141141.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/licenses/   by-nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproducti on in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/3f/TOCMJ-8-68.PMC4141169.pdf
"All participants enrolled (n=6729) were interviewed  to record their health and lifestyle antecedents including  physic al activity, smoking, alcohol consumption and other  aspects (available at http://www.cdcdecanarias.org).",Non-OADS,/arxiv_data1/oa_pdf/9a/b4/TOCMJ-8-61.PMC4141177.pdf
"REFERENCES   [1] European Hospital Morbidity Database http://data.euro.who.int/  hmdb/ index.php   [2] Roger VL, Go AS, Lloyd -Jones DM, et al.",Non-OADS,/arxiv_data1/oa_pdf/9a/b4/TOCMJ-8-61.PMC4141177.pdf
"[22] Encuesta domiciliaria sobre alcohol y drogas en España  (EDADES) , 1995 -2009. http://www.pnsd.msc.es/Categoria2/   observ a/pdf /EDADES_2009.pdf   [23] Kocabay G, Yildiz M, Duran NE, Ozkan M. Acute inferior  myocardial infarction due to cannabis smoking in a young man .",Non-OADS,/arxiv_data1/oa_pdf/9a/b4/TOCMJ-8-61.PMC4141177.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/licenses/   by-nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/b4/TOCMJ-8-61.PMC4141177.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/71/main.PMC4141191.pdf
"In contrast, tumor necrosis factor- adecreases AQP3 expression in DJM-1 keratinocytes, and nicotinamide atten- uates augmented AQP3 expression in HaCat cells treated with RA http://dx.doi.org/10.1016/j.fob.2014.06.004 2211-5463/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/37/71/main.PMC4141191.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: AQPs, aquaporins; DUOX1, dual oxidase I; GAPDH, glyceralde- hyde 3-phosphate dehydrogenase; LXR, liver X receptor; NHEK, normal humanepidermal keratinocytes; PPAR c, peroxisome proliferators-activated receptor gamma; RA, retinoic acid; SG, stratum granulosum; TJs, tight junctions; VD 3, 1,25-dihydroxyvitamin D 3 ⇑Corresponding author at: Innovative Beauty Science Laboratory, Kanebo Cos- metics Inc., 5-3-28, Kotobuki-cho, Odawara, Kanagawa 250-0002, Japan.",Non-OADS,/arxiv_data1/oa_pdf/37/71/main.PMC4141191.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/71/main.PMC4141192.pdf
"The fact that these four strains belong to a unique genospecies, displaying a low level of intra-speciﬁc diversity compared with that observed http://dx.doi.org/10.1016/j.fob.2014.07.009 2211-5463/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c4/71/main.PMC4141192.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/71/main.PMC4141192.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.07.009 .",OADS,/arxiv_data1/oa_pdf/c4/71/main.PMC4141192.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/8f/main.PMC4141193.pdf
Apoptosis execution is http://dx.doi.org/10.1016/j.fob.2014.07.001 2211-5463/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/69/8f/main.PMC4141193.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: (FP-) assay, ﬂuorescence polarization assay; ARPF-FAM, ARPF- K(5-Fam)-NH2-peptide; BIR-3, baculovirus-IAP-repeat-3; CC, column chromatog- raphy; Kd, dissociation constant; Ki, binding afﬁnity; MAC, methanol crude extract of mulberry root bark; PCA, protein fragment complementation analysis; RLU,relative luminescence units; SG1, sanggenon G; XIAP, X-linked inhibitor ofapoptosis protein ⇑Corresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/69/8f/main.PMC4141193.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.07.001 .",OADS,/arxiv_data1/oa_pdf/69/8f/main.PMC4141193.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f5/f9/main.PMC4141194.pdf
As these are the sequences of three http://dx.doi.org/10.1016/j.fob.2014.06.006 2211-5463/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/f5/f9/main.PMC4141194.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: Cr(III), trivalent chromium; Cr(IV), tetravalent chromium; Cr(V), pentavalent chromium; Cr(VI), hexavalent chromium; DCF, 20,70-dichloroﬂuores- cein; 2-DG, 2-deoxyglucose; 2,4-DNP, 2,4-dinitrophenol; EDTA, ethylenediamin-etetracetic acid; ETC, mitochondrial electron transport chain; b-F 1-ATPase, catalytic subunit (subunit b) of the mitochondrial H+-ATP synthase; GAPDH, glyceraldehyde- 3-phosphate dehydrogenase; IARC, International Agency for Research on Cancer;OCR, oxygen consumption rate; OXPHOS, oxidative phosphorylation; PBS, phos-phate-buffered saline; PI, propidium iodide; ROS, reactive oxygen species; TCA, tricarboxylic acid ⇑Corresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/f5/f9/main.PMC4141194.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/26/main.PMC4141196.pdf
"As a result, the P1L variant http://dx.doi.org/10.1016/j.fob.2014.07.003 2211-5463/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d4/26/main.PMC4141196.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/d4/26/main.PMC4141196.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/a9/main.PMC4141197.pdf
Our preliminary experiments indicate that http://dx.doi.org/10.1016/j.fob.2014.07.008 2211-5463/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/79/a9/main.PMC4141197.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: AdoCbl, 50-deoxyadenosylcobalamin; Cbl, cobalamin; C. elegans , Caenorhabditis elegans ;C H 3-Cbl, methylcobalamin; CN-Cbl, cyanocobalamin; Hcy, homocysteine; IF, intrinsic factor; MCM, methylmalonyl-CoA mutase; MMA, methylmalonic acid; MMAA, methylmalonic acidemia cobalamin A complementa-tion group; MMAB, cob(I)alamin adenosyltransferase; MMACHC, methylmalonicaciduria cblC type; MS, methionine synthase; MSR, methionine synthase reductase;NGM, nematode growth medium; qPCR, quantitative PCR analysis ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/79/a9/main.PMC4141197.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/ba/main.PMC4141199.pdf
http://dx.doi.org/10.1016/j.fob.2014.07.002 2211-5463/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/4d/ba/main.PMC4141199.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: SpAdK, Streptococcus pneumoniae adenylate kinase; Ap5A, aden- osine pentaphosphate ⇑Corresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/4d/ba/main.PMC4141199.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.07.002 .",OADS,/arxiv_data1/oa_pdf/4d/ba/main.PMC4141199.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/a6/main.PMC4141200.pdf
"More recently, DNA nuclease technology using Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/CRISPR associated protein (Cas) has been shown to have http://dx.doi.org/10.1016/j.fob.2014.06.007 2211-5463/ /C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/48/a6/main.PMC4141200.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: Cas, CRISPR-associated protein; Cas9n, Cas9 nickase; CRISPR, Clustered Regularly Interspaced Short Palindromic Repeat; DSBs, double standbreaks; ES, embryonic stem cells; HDR, homology directed repair; indel, insertion and deletion mutations; lspd, isoprenoid synthase containing domain; sgRNA, single guide RNA; TALENs, transcription activator-like effector nucleases; ZFNs, zincﬁnger nucleases ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/48/a6/main.PMC4141200.pdf
"We chose to conduct this pilot study using the Ispd gene because a conditional allele for this gene has not yet beendescribed in the literature, nor has it been targeted by the large International Mouse Phenotyping Consortium (IMPC) production and phenotyping projects currently underway ( http://www.mous- ephenotype.org/ ).",Non-OADS,/arxiv_data1/oa_pdf/48/a6/main.PMC4141200.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.06.007 .",OADS,/arxiv_data1/oa_pdf/48/a6/main.PMC4141200.pdf
"Published by Oxford University Press, on behalf of the Society of Systematic Biologists.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/c9/syu031.PMC4141202.pdf
"2013 , see Supplemental Material for the full list, availableon Dryad http://dx.doi.org/10.5061/dryad.d7639).",Non-OADS,/arxiv_data1/oa_pdf/4c/c9/syu031.PMC4141202.pdf
"1, available at http://dx.doi.org/10.5061/dryad.d7639); and (3) one gains the ability toview a list of their jobs and manage them.",OADS,/arxiv_data1/oa_pdf/4c/c9/syu031.PMC4141202.pdf
"2, available at http://dx.doi.org/10.5061/dryad.d7639) consists of thefollowing general steps: (1) speciﬁcation of a job name,analysis type (best tree or bootstrap search), and numberof replicates (up to 2000); (2) upload or speciﬁcationof necessary input ﬁles (sequence data, starting tree,and/or constraint ﬁle); and (3) speciﬁcation of modelparameters and other program settings.",OADS,/arxiv_data1/oa_pdf/4c/c9/syu031.PMC4141202.pdf
"3, available athttp://dx.doi.org/10.5061/dryad.d7639) allows aregistered user to view and manage a list of theirjobs.",OADS,/arxiv_data1/oa_pdf/4c/c9/syu031.PMC4141202.pdf
"4, availableat http://dx.doi.org/10.5061/dryad.d7639).",Non-OADS,/arxiv_data1/oa_pdf/4c/c9/syu031.PMC4141202.pdf
"5,available at http://dx.doi.org/10.5061/dryad.d7639),rather than by manually composing a NEXUS sets block and GARLI model blocks.",Non-OADS,/arxiv_data1/oa_pdf/4c/c9/syu031.PMC4141202.pdf
"6, availableat http://dx.doi.org/10.5061/dryad.d7639).",Non-OADS,/arxiv_data1/oa_pdf/4c/c9/syu031.PMC4141202.pdf
"6, availableat http://dx.doi.org/10.5061/dryad.d7639).",Non-OADS,/arxiv_data1/oa_pdf/4c/c9/syu031.PMC4141202.pdf
"In supplemental material(http://dx.doi.org/10.5061/dryad.d7639) we describe two system performance improvements in some detail:use of optimal-length jobs for grid computing, andautomatic measurement of resource throughput.",Non-OADS,/arxiv_data1/oa_pdf/4c/c9/syu031.PMC4141202.pdf
SUPPLEMENTARY MATERIAL Data available from the Dryad Digital Repository: http://dx.doi.org/10.5061/dryad.d7639.,OADS,/arxiv_data1/oa_pdf/4c/c9/syu031.PMC4141202.pdf
GARLI 2.0 https://www.nescent.org/wg_garli/ main_page.,Non-OADS,/arxiv_data1/oa_pdf/4c/c9/syu031.PMC4141202.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/35/main.PMC4141204.pdf
"It was recently reported that reactive oxygen species (ROS) reg- ulate mitotic clonal expansion through activation of the CCAAT/ enhancer binding protein (C/EBP) bduring adipogenesis [11].I n addition, the C/EBP b-mediated activation of the signaling pathway, including the endoplasmic reticulum to nucleus signaling 1 ( Ern1 ), which is a homolog of the yeast Ire1, and X-box binding protein 1 http://dx.doi.org/10.1016/j.fob.2014.06.008 2211-5463/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f2/35/main.PMC4141204.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: ER, endoplasmic reticulum; Ern1 , endoplasmic reticulum to nucleus signaling 1; FABP, fatty acid binding protein; GSH, reduced glutathione;GSTA4, glutathione S-transferase A4; H 2O2, hydrogen peroxide; Ormdl3 , ORM1-like 3; ROS, reactive oxygen species; siRNA, small interfering RNA; SOD, superoxidedismutase; Ssr1, signal sequence receptor a; UPR, unfolded protein response; VEGF, vascular endothelial growth factor; Xbp1 , X-box binding protein 1.",Non-OADS,/arxiv_data1/oa_pdf/f2/35/main.PMC4141204.pdf
Mean ﬂuorescent inten- sity (average intensity of pixels per cell) for 30 cells per condition was determined using the ImageJ software ( http://rsb.info.nih.gov/ ij/).,OADS,/arxiv_data1/oa_pdf/f2/35/main.PMC4141204.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.06.008 .",OADS,/arxiv_data1/oa_pdf/f2/35/main.PMC4141204.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/23/main.PMC4141205.pdf
"Since the structural stability of nucleic acids is strongly dependent on the salt concentration, empirical expres- sions have been developed for evaluating the salt concentration http://dx.doi.org/10.1016/j.fob.2014.06.009 2211-5463/ /C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/1b/23/main.PMC4141205.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/1b/23/main.PMC4141205.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.06.009 .",OADS,/arxiv_data1/oa_pdf/1b/23/main.PMC4141205.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/6a/main.PMC4141206.pdf
"The APC/C coactivators (Cdc20 and Cdh1) contain the C-box, KILR, and IR motifs, which http://dx.doi.org/10.1016/j.fob.2014.06.010 2211-5463/ /C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/4b/6a/main.PMC4141206.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: APC/C, anaphase-promoting complex/cyclosome; Emi2, endoge- nous meiotic inhibitor 2; ZBR, zinc-binding region; Cdc20, cell-division cycle protein 20; E2C, ubiquitin-conjugating enzyme E2 C or UBE2C ⇑Corresponding authors at: RIKEN Systems and Structural Biology Center, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.",Non-OADS,/arxiv_data1/oa_pdf/4b/6a/main.PMC4141206.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.06.010 .",OADS,/arxiv_data1/oa_pdf/4b/6a/main.PMC4141206.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/dc/main.PMC4141208.pdf
"The luminal NADPH concentration is http://dx.doi.org/10.1016/j.fob.2014.07.006 2211-5463/Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: ER, endoplasmic reticulum; mTOR, mammalian target of rapa- mycin; UPR, unfolded protein response ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/19/dc/main.PMC4141208.pdf
"Dynamical simulations, phase plane and bifurcation analysis were carried out using the program XPPAUT, which is freely available from http://www.math.pitt.edu/ ~bard/xpp/xpp.html [47,48] .",OADS,/arxiv_data1/oa_pdf/19/dc/main.PMC4141208.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.07.006 .",OADS,/arxiv_data1/oa_pdf/19/dc/main.PMC4141208.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/e6/main.PMC4141209.pdf
The ﬁnal http://dx.doi.org/10.1016/j.fob.2014.07.005 2211-5463/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/e6/main.PMC4141209.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: OCD, ornithine cyclodeaminase; CRYM, l-crystallin; AlaDH, L-alanine dehydrogenase; Pyr2C, D1-pyrroline-2-carboxylate; T3LHyp, trans -3- hydroxy- L-proline; NMAlaDH, N-methyl- L-alanine dehydrogenase ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/7d/e6/main.PMC4141209.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.07.005 .",OADS,/arxiv_data1/oa_pdf/7d/e6/main.PMC4141209.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/a7/main.PMC4141210.pdf
NS2 has a http://dx.doi.org/10.1016/j.fob.2014.07.004 2211-5463/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/10/a7/main.PMC4141210.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: K d, dissociation constant; HA, hemagglutinin; Hsc70, heat shock cognate 70; NA, neuraminidase; NES, nuclear export signal; NLS, nuclear localiza- tion signal; vRNP, viral ribonucleoprotein complex ⇑Corresponding author at: Laboratory of Molecular Biology of Infectious Agents, Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi,Nagasaki 852-8521, Japan.",Non-OADS,/arxiv_data1/oa_pdf/10/a7/main.PMC4141210.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/bc/main.PMC4141211.pdf
A previous study reported that the level of h1- calponin was decreased in smooth muscle-derived cancerous tis- sues with a correlation to metastasis phenotypes and prognosis http://dx.doi.org/10.1016/j.fob.2014.06.003 2211-5463/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/bc/main.PMC4141211.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: FBS, fetal bovine serum; mAb, monoclonal antibody; MES, 2-[ N morpholino]ethanesulfonic acid; SDS–PAGE, SDS–polyacrylamide gel electropho- resis; PBS, phosphate buffered saline ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/c0/bc/main.PMC4141211.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f8/d1/srep06167.PMC4141246.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cf/34/srep06171.PMC4141248.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6171 | DOI: 10.1038/srep06171 9",Non-OADS,/arxiv_data1/oa_pdf/cf/34/srep06171.PMC4141248.pdf
"Sendbusch, P. V. http://www.biologie.uni-hamburg.de/b-online/e26/26d.htm, Botany Online: Cell Walls of Algae., (2003) Date of access: 29/10/2007.",OADS,/arxiv_data1/oa_pdf/fd/5f/srep06162.PMC4141250.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5977 | DOI: 10.1038/srep05977 7",Non-OADS,/arxiv_data1/oa_pdf/e6/54/srep05977.PMC4141251.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/76/75/srep06109.PMC4141253.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6109 | DOI: 10.1038/srep06109 5",Non-OADS,/arxiv_data1/oa_pdf/76/75/srep06109.PMC4141253.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ea/b6/srep06160.PMC4141254.pdf
http://www.budde.com.au/Research/Cote-d-Ivoire-Ivory- Coast-Telecoms-Mobile-and-Broadband-Market-Insights-Statistics-and- Forecasts.html (2014) Date of access: 2014-07-10.,Non-OADS,/arxiv_data1/oa_pdf/f9/5a/srep06174.PMC4141257.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6174 | DOI: 10.1038/srep06174 6",Non-OADS,/arxiv_data1/oa_pdf/f9/5a/srep06174.PMC4141257.pdf
"Statistical analyses were conductedin Review Manager (RevMan version 5.2, the Cochrane Collaboration, Oxford, England; available at: http://ims.cochrane.org/revman).",OADS,/arxiv_data1/oa_pdf/d1/53/srep06113.PMC4141258.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d1/53/srep06113.PMC4141258.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/01/d7/srep06172.PMC4141259.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6172 | DOI: 10.1038/srep06172 10",Non-OADS,/arxiv_data1/oa_pdf/01/d7/srep06172.PMC4141259.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bc/5d/srep06173.PMC4141260.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6173 | DOI: 10.1038/srep06173 6",Non-OADS,/arxiv_data1/oa_pdf/bc/5d/srep06173.PMC4141260.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/59/d9/srep06163.PMC4141261.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6163 | DOI: 10.1038/srep06163 5",Non-OADS,/arxiv_data1/oa_pdf/59/d9/srep06163.PMC4141261.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a5/96/srep06126.PMC4141262.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6126 | DOI: 10.1038/srep06126 5",Non-OADS,/arxiv_data1/oa_pdf/a5/96/srep06126.PMC4141262.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6096 | DOI: 10.1038/srep06096 8",Non-OADS,/arxiv_data1/oa_pdf/a4/36/srep06096.PMC4141263.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Komai, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/30/2a/srep06175.PMC4141270.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6175 | DOI: 10.1038/srep06175 12",Non-OADS,/arxiv_data1/oa_pdf/30/2a/srep06175.PMC4141270.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests A patent application with priority date 23 April 2013 has been filed for the space-saving image-readout optical system.,Non-OADS,/arxiv_data1/oa_pdf/7d/e9/srep06177.PMC4141271.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Urinary iodine concentrations during pregnancy Rydbeck et al 509 &2014 Nature America, Inc. Journal of Exposure Science and Environmental Epidemiology (2014), 504 – 509",Non-OADS,/arxiv_data1/oa_pdf/52/28/jes201379a.PMC4141302.pdf
"Gene silencing was performed as reported above using siGLO red (Cy3-labeled siGLO RISC-free siRNA, Dharmacon, number D-001600-01) as a transfection efﬁciency read-out following the manufacturer’s instructions.Three days after transfection, IF was performed with a rabbit a-CSF-1R antibody; ﬂuorescence in the cytosol (cyto) or the nucleus (nuc) was quantiﬁed using ImageJ (graph) (http://rsb.info.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/f3/10/onc2013542a.PMC4141303.pdf
"Nuclear localization signals (NLS) have been identiﬁed in RTK.32To determine whether CSF-1R contains putative NLS, we used the online databaseNucPred (http://www.sbc.su.se/ Bmaccallr/nucpred).33NucPred assigns a score equal to 1 to an amino-acid sequence that is recognized as a bona ﬁde NLS.",OADS,/arxiv_data1/oa_pdf/f3/10/onc2013542a.PMC4141303.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)CSF-1R binds to the promoters of proliferation genes V Barbetti et al 4364 Oncogene (2014) 4359 – 4364 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/f3/10/onc2013542a.PMC4141303.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)RNF31 stabilizes ER ain breast cancer cells J Zhu et al 4351 &2014 Macmillan Publishers Limited Oncogene (2014) 4340 – 4351",Non-OADS,/arxiv_data1/oa_pdf/c9/be/onc2013573a.PMC4141304.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2014/5/1/21/137642,Non-OADS,/arxiv_data1/oa_pdf/5b/d1/JPI-5-21.PMC4141358.pdf
"J Pathol Inform 2014, 1:20  http://www.jpathinformatics.org/content/5/1/20production.",Non-OADS,/arxiv_data1/oa_pdf/5b/d1/JPI-5-21.PMC4141358.pdf
"J Pathol Inform 2014, 1:20  http://www.jpathinformatics.org/content/5/1/20neuropathology expertise from the central hospital for  immediate interpretations.",Non-OADS,/arxiv_data1/oa_pdf/5b/d1/JPI-5-21.PMC4141358.pdf
"J Pathol Inform 2014, 1:20  http://www.jpathinformatics.org/content/5/1/20without the use of any additional technology, so it cannot  be assumed that all of these variances represent an error  attributable to RT .",Non-OADS,/arxiv_data1/oa_pdf/5b/d1/JPI-5-21.PMC4141358.pdf
"J Pathol Inform 2014, 1:20  http://www.jpathinformatics.org/content/5/1/20CONCLUSIONS This validation study has demonstrated the feasibility  of RT using the iScan Coreo Au LiveMode platform.",OADS,/arxiv_data1/oa_pdf/5b/d1/JPI-5-21.PMC4141358.pdf
"J Pathol Inform 2014, 1:20  http://www.jpathinformatics.org/content/5/1/20move the slide and change the microscope lenses and  focus.",Non-OADS,/arxiv_data1/oa_pdf/5b/d1/JPI-5-21.PMC4141358.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/b9/63/SJA-8-345.PMC4141382.pdf
Available from: http://www.measuringusability.com/ papers/sauro-lewisHFES.pdf [Last accessed on 2014 Apr 6].,OADS,/arxiv_data1/oa_pdf/4d/73/SJA-8-355.PMC4141384.pdf
Available from: http://www.medicinescomplete.com/.,Non-OADS,/arxiv_data1/oa_pdf/8a/92/SJA-8-359.PMC4141385.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/48/ec/SJA-8-396.PMC4141394.pdf
Available from: http://www.iasp-pain.org/AM/Template.,Non-OADS,/arxiv_data1/oa_pdf/54/1c/SJA-8-428.PMC4141404.pdf
Available from: http://www.doctorsonfetalpain.com/ fetal-pain-the-evidence/.,Non-OADS,/arxiv_data1/oa_pdf/54/1c/SJA-8-428.PMC4141404.pdf
Available from: http://www.draeger.com/AE/en_US/products/ anesthesia_workplaces/.,Non-OADS,/arxiv_data1/oa_pdf/94/8e/SJA-8-434.PMC4141406.pdf
Available from http://www.aagbi.org/publications/guidelines/ docs/standardsofmonitoring07.pdf.,Non-OADS,/arxiv_data1/oa_pdf/94/8e/SJA-8-434.PMC4141406.pdf
J Clin Imaging Sci 2014;4:S2.Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2014/4/2/2/133258Received  : 10‑02‑2014 Accepted  : 04‑03‑2014 Published  : 27‑05‑2014 DENTAL ARTICLE,Non-OADS,/arxiv_data1/oa_pdf/12/e2/JCIS-4-2.PMC4141417.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2014/4/1/1/129262DENTAL ARTICLE Received  : 08‑11‑2013 Accepted  : 07‑01‑2014 Published  : 21‑03‑2014,Non-OADS,/arxiv_data1/oa_pdf/e3/f3/JCIS-4-1.PMC4141418.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2014/5/1/25/137729 Abstract Background:  Learning pathology is fundamental for a successful medical practice.,Non-OADS,/arxiv_data1/oa_pdf/8d/3f/JPI-5-25.PMC4141419.pdf
"J Pathol Inform 2014, 1:25  http://www.jpathinformatics.org/content/5/1/25the development of a core curriculum that integrates  clinical medicine with basic science.",Non-OADS,/arxiv_data1/oa_pdf/8d/3f/JPI-5-25.PMC4141419.pdf
"All educational material was intended to  meet medical curriculum requirements recommended  by the Colombian National Accreditation Council of  Higher Education  (CNA)  (http://www.cna.gov .co/),  under the Latin - America Andres Bello standards  (http:// www.convenioandresbello.org/) to grant academic titles  recognized in Latin - America countries.",Non-OADS,/arxiv_data1/oa_pdf/8d/3f/JPI-5-25.PMC4141419.pdf
"J Pathol Inform 2014, 1:25  http://www.jpathinformatics.org/content/5/1/25for a total of 48  weeks of training in pathology.",Non-OADS,/arxiv_data1/oa_pdf/8d/3f/JPI-5-25.PMC4141419.pdf
"J Pathol Inform 2014, 1:25  http://www.jpathinformatics.org/content/5/1/25Each	Student’s 	 score 	 was 	 calculated 	 from 	 0.0 	 to 	 5.0, 	 with each correct answer yielding 0.05 points.",Non-OADS,/arxiv_data1/oa_pdf/8d/3f/JPI-5-25.PMC4141419.pdf
"This  test has been administered after every pathology  course over the last 10  years, and is modeled after the  Colombian National Examination for Higher Education  in	Medicine 	 (Saber‑pro), 	 a 	 professional 	 exam 	 sponsored 	 by the Colombian Institute for the Promotion of Higher  Education  (http://www.icfes.gov .co/examenes/saber - pro).",Non-OADS,/arxiv_data1/oa_pdf/8d/3f/JPI-5-25.PMC4141419.pdf
The exam is mandatory for aspiring physicians to obtain  a	Colombian 	 Medical 	 License 	 and 	 access 	 to 	 Graduate 	 Medical	 Education 	 (http://tramites.minsalud.gov.co/ tramitesservicios/tarjetaMedico/Default.aspx).,Non-OADS,/arxiv_data1/oa_pdf/8d/3f/JPI-5-25.PMC4141419.pdf
"J Pathol Inform 2014, 1:25  http://www.jpathinformatics.org/content/5/1/25group, or both groups attained similar proficiency in these  subjects.",Non-OADS,/arxiv_data1/oa_pdf/8d/3f/JPI-5-25.PMC4141419.pdf
"J Pathol Inform 2014, 1:25  http://www.jpathinformatics.org/content/5/1/25high- resolution imaging, classroom - based computers with  audiovisual systems have provided a new teaching tool  within this environment.",Non-OADS,/arxiv_data1/oa_pdf/8d/3f/JPI-5-25.PMC4141419.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2014/5/1/27/137731 Access this article online Quick Response Code: Website:    www.jpathinformatics.org DOI:  10.4103/2153-3539.137731,Non-OADS,/arxiv_data1/oa_pdf/49/03/JPI-5-27.PMC4141420.pdf
"J Pathol Inform 2014, 1:27  http://www.jpathinformatics.org/content/5/1/27through some of the questions where the answers seem  most intriguing based on the presentations offered at  the sessions we attended.",Non-OADS,/arxiv_data1/oa_pdf/49/03/JPI-5-27.PMC4141420.pdf
"J Pathol Inform 2014, 1:27  http://www.jpathinformatics.org/content/5/1/27fall under the heading of in‑vivo  microscopy has  begun to cross the interface from investigational  research to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/49/03/JPI-5-27.PMC4141420.pdf
"J Pathol Inform 2014, 1:27  http://www.jpathinformatics.org/content/5/1/27our current foundation paradigm of “artifacts”?",Non-OADS,/arxiv_data1/oa_pdf/49/03/JPI-5-27.PMC4141420.pdf
"The CyTOF™ http://www.dvssciences.com/ cytof ‑ instrument.php accessed 31May 2014  instrumentation is just one example of ultra‑high  assay sensitivity of detection that  might impact  anatomic pathology samples, but discussion of  newly developed clinical laboratory instrumentation  also needs to be mentioned as these begin to push  downward the detection thresholds for standard  and newer analytes such as tumor markers, drugs or  infectious agents.",Non-OADS,/arxiv_data1/oa_pdf/49/03/JPI-5-27.PMC4141420.pdf
"J Pathol Inform 2014, 1:27  http://www.jpathinformatics.org/content/5/1/27developing around the questions.",Non-OADS,/arxiv_data1/oa_pdf/49/03/JPI-5-27.PMC4141420.pdf
Available from: http://www.americantelemed.org/docs/default‑source/ standards/clinical‑guidelines‑for‑telepathology.pdf?sfvrsn=4.,Non-OADS,/arxiv_data1/oa_pdf/49/03/JPI-5-27.PMC4141420.pdf
Available from: http://www.cap‑acp.org/cmsUploads/CAP/File/ T elepathology_Guidelines_Final_v_13.pdf.,Non-OADS,/arxiv_data1/oa_pdf/49/03/JPI-5-27.PMC4141420.pdf
Arch Pathol Lab Med 2013; doi: http://dx.doi.org/10.5858/arpa.,OADS,/arxiv_data1/oa_pdf/49/03/JPI-5-27.PMC4141420.pdf
Available  FREE   in   open   access   from:   http://www.jpathinformatics.org/text.asp?2014/5/1/24/137728,Non-OADS,/arxiv_data1/oa_pdf/fd/43/JPI-5-24.PMC4141421.pdf
"J Pathol Inform 2014, 1:24  http://www.jpathinformatics.org/content/5/1/24well as required additional optics are housed within the  mounted camera, which stores the images in a smart card  for later transfer or communicates to a computer to relay a  static digital image or streaming of an image.",Non-OADS,/arxiv_data1/oa_pdf/fd/43/JPI-5-24.PMC4141421.pdf
"J Pathol Inform 2014, 1:24  http://www.jpathinformatics.org/content/5/1/24adapter, which slides into the stage.",Non-OADS,/arxiv_data1/oa_pdf/fd/43/JPI-5-24.PMC4141421.pdf
"J Pathol Inform 2014, 1:24  http://www.jpathinformatics.org/content/5/1/24digital zoom that is standard within most smartphone  cameras.",Non-OADS,/arxiv_data1/oa_pdf/fd/43/JPI-5-24.PMC4141421.pdf
"J Pathol Inform 2014, 1:24  http://www.jpathinformatics.org/content/5/1/24to preview cases.",Non-OADS,/arxiv_data1/oa_pdf/fd/43/JPI-5-24.PMC4141421.pdf
Available   from: http://www.arcturuslabs.com.,Non-OADS,/arxiv_data1/oa_pdf/fd/43/JPI-5-24.PMC4141421.pdf
Available  from:   http://www.skylightscope.com.,Non-OADS,/arxiv_data1/oa_pdf/fd/43/JPI-5-24.PMC4141421.pdf
Available  from:   http://snapzooms.com.,Non-OADS,/arxiv_data1/oa_pdf/fd/43/JPI-5-24.PMC4141421.pdf
Available   from:   http://www.phoneskope.com.,Non-OADS,/arxiv_data1/oa_pdf/fd/43/JPI-5-24.PMC4141421.pdf
Available   from:   http://www.meoptasportsoptics.com/shop/ us/4‑4s‑iscoping‑adapter/pxdpgdce72jh/ctgMPus.html.,Non-OADS,/arxiv_data1/oa_pdf/fd/43/JPI-5-24.PMC4141421.pdf
Available   from:   http://www.instructables.com/id/ microscope‑adapter‑for‑cell‑phone.,Non-OADS,/arxiv_data1/oa_pdf/fd/43/JPI-5-24.PMC4141421.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2014/5/1/23/137726 Abstract Introduction:  Recent technology developments have demonstrated the benefit of  using whole slide imaging  (WSI) in computer‑aided diagnosis.,Non-OADS,/arxiv_data1/oa_pdf/2b/e8/JPI-5-23.PMC4141422.pdf
"J Pathol Inform 2014, 1:23  http://www.jpathinformatics.org/content/5/1/23Clear cell RCC has been manually  (i.e.",OADS,/arxiv_data1/oa_pdf/2b/e8/JPI-5-23.PMC4141422.pdf
"J Pathol Inform 2014, 1:23  http://www.jpathinformatics.org/content/5/1/23where yi is a scalar feature of the ith stain.",OADS,/arxiv_data1/oa_pdf/2b/e8/JPI-5-23.PMC4141422.pdf
"J Pathol Inform 2014, 1:23  http://www.jpathinformatics.org/content/5/1/23at a nuclear size of 6  µm.",OADS,/arxiv_data1/oa_pdf/2b/e8/JPI-5-23.PMC4141422.pdf
"J Pathol Inform 2014, 1:23  http://www.jpathinformatics.org/content/5/1/23this encountered between Grades III and IV tumors.",Non-OADS,/arxiv_data1/oa_pdf/2b/e8/JPI-5-23.PMC4141422.pdf
"J Pathol Inform 2014, 1:23  http://www.jpathinformatics.org/content/5/1/23WSI analysis.",Non-OADS,/arxiv_data1/oa_pdf/2b/e8/JPI-5-23.PMC4141422.pdf
"J Pathol Inform 2014, 1:23  http://www.jpathinformatics.org/content/5/1/23Histopathological image analysis: A review.",Non-OADS,/arxiv_data1/oa_pdf/2b/e8/JPI-5-23.PMC4141422.pdf
"Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2014/5/1/22/137717 Abstract The Partners HealthCare system’s Clinical Fellowship in Pathology Informatics  (Boston, MA, USA) faces ongoing challenges to the delivery of its core curriculum  in the forms of:  (1) New classes of fellows annually with new and varying  educational needs and increasingly fractured, enterprise‑wide commitments;  (2)  taxing electronic health record  (EHR) and laboratory information system  (LIS)  implementations; and  (3) increasing interest in the subspecialty at the academic  medical centers  (AMCs) in what is a large health care network.",Non-OADS,/arxiv_data1/oa_pdf/ff/e8/JPI-5-22.PMC4141423.pdf
"J Pathol Inform 2014, 1:22  http://www.jpathinformatics.org/content/5/1/22BACKGROUND The Pathology Informatics Fellowship The Partners HealthCare system’s Clinical Fellowship  in Pathology Informatics  (Boston, MA, USA) has been  described previously.",Non-OADS,/arxiv_data1/oa_pdf/ff/e8/JPI-5-22.PMC4141423.pdf
"J Pathol Inform 2014, 1:22  http://www.jpathinformatics.org/content/5/1/22best position to determine those educational techniques  that work best for them.",Non-OADS,/arxiv_data1/oa_pdf/ff/e8/JPI-5-22.PMC4141423.pdf
"J Pathol Inform 2014, 1:22  http://www.jpathinformatics.org/content/5/1/22with representation from virtually all pathology  domains and subspecialties.",Non-OADS,/arxiv_data1/oa_pdf/ff/e8/JPI-5-22.PMC4141423.pdf
"J Pathol Inform 2014, 1:22  http://www.jpathinformatics.org/content/5/1/22Weekly group meetings between the fellows, interested  residents, rotating medical students and the program  director continue, but formal discussions of the core  curriculum’s divisions, associated topics and readings  have been de‑emphasized.",Non-OADS,/arxiv_data1/oa_pdf/ff/e8/JPI-5-22.PMC4141423.pdf
"J Pathol Inform 2014, 1:22  http://www.jpathinformatics.org/content/5/1/22The learning laboratories’ content consists of a  kaleidoscope of subjects in pathology informatics  [ Table  3].",Non-OADS,/arxiv_data1/oa_pdf/ff/e8/JPI-5-22.PMC4141423.pdf
"J Pathol Inform 2014, 1:22  http://www.jpathinformatics.org/content/5/1/22institution of lectures and learning laboratories.",Non-OADS,/arxiv_data1/oa_pdf/ff/e8/JPI-5-22.PMC4141423.pdf
"J Pathol Inform 2014, 1:22  http://www.jpathinformatics.org/content/5/1/22narrative addresses salient tenets for engagement by all  levels of professional in pathology informatics.",Non-OADS,/arxiv_data1/oa_pdf/ff/e8/JPI-5-22.PMC4141423.pdf
"J Pathol Inform 2014, 1:22  http://www.jpathinformatics.org/content/5/1/22to changes in both its content and the methods needed  to communicate its content.",Non-OADS,/arxiv_data1/oa_pdf/ff/e8/JPI-5-22.PMC4141423.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2014/5/1/26/137730 Access this article online Website:    www.jpathinformatics.org DOI:  10.4103/2153-3539.137730 Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/d5/a5/JPI-5-26.PMC4141424.pdf
"J Pathol Inform 2014, 1:26  http://www.jpathinformatics.org/content/5/1/26INTRODUCTION The majority of women in the United States will never  develop breast cancer, however, all women are eligible for  periodic mammography screening at age 40 or 50 and  continuing every year or two for 25  years or more.",Non-OADS,/arxiv_data1/oa_pdf/d5/a5/JPI-5-26.PMC4141424.pdf
"J Pathol Inform 2014, 1:26  http://www.jpathinformatics.org/content/5/1/26analysis of the data mart data has been approved by the  health system’s Institutional Review Board and Privacy  Board.",Non-OADS,/arxiv_data1/oa_pdf/d5/a5/JPI-5-26.PMC4141424.pdf
"J Pathol Inform 2014, 1:26  http://www.jpathinformatics.org/content/5/1/26 Figure 2: Screen shot of the search application Figure 3: Screen shot of an individual patient’s diagnosis from the pathology report",Non-OADS,/arxiv_data1/oa_pdf/d5/a5/JPI-5-26.PMC4141424.pdf
"J Pathol Inform 2014, 1:26  http://www.jpathinformatics.org/content/5/1/26 Figure 4: Breast Pathology Assessment T ool and Hierarchy for  Diagnosis data collection form for the Breast Pathology Study  (B-Path).",Non-OADS,/arxiv_data1/oa_pdf/d5/a5/JPI-5-26.PMC4141424.pdf
"J Pathol Inform 2014, 1:26  http://www.jpathinformatics.org/content/5/1/26with nonproliferative lesions  [Table  3].",Non-OADS,/arxiv_data1/oa_pdf/d5/a5/JPI-5-26.PMC4141424.pdf
"J Pathol Inform 2014, 1:26  http://www.jpathinformatics.org/content/5/1/26of NLP compared to a human coded gold standard,  sensitivity was 90.6% and specificity 91.6%.",OADS,/arxiv_data1/oa_pdf/d5/a5/JPI-5-26.PMC4141424.pdf
"J Pathol Inform 2014, 1:26  http://www.jpathinformatics.org/content/5/1/262009;151:716‑26, W‑236.",Non-OADS,/arxiv_data1/oa_pdf/d5/a5/JPI-5-26.PMC4141424.pdf
Available from: http://www.cancer.gov/cancertopics/factsheet/Detection/ screening‑mammograms  .,Non-OADS,/arxiv_data1/oa_pdf/d5/a5/JPI-5-26.PMC4141424.pdf
Available from: http://www.cap.org/apps/cap.portal?_nfpb=true and  _ pageLabel=reference.,Non-OADS,/arxiv_data1/oa_pdf/d5/a5/JPI-5-26.PMC4141424.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2014/5/1/19/135606 Abstract We propose a methodology for the design of features mimicking the visual cues  used by pathologists when identifying tissues in hematoxylin and eosin (H&E)-stained  samples.,Non-OADS,/arxiv_data1/oa_pdf/e8/3e/JPI-5-19.PMC4141425.pdf
"J Pathol Inform 2014, 1:19  http://www.jpathinformatics.org/content/5/1/19Challenges and Guiding Principle Histopathological data from teratomas present numerous  challenges: The samples consist of different tissues at  various developmental stages, tissue boundaries may not  be well‑defined, and staining techniques can vary from  sample to sample and from lab to lab.",Non-OADS,/arxiv_data1/oa_pdf/e8/3e/JPI-5-19.PMC4141425.pdf
"J Pathol Inform 2014, 1:19  http://www.jpathinformatics.org/content/5/1/19V ocabulary Creation Methodology To find a set of features emulating the visual cues used  by pathologists, we propose the following methodology.",Non-OADS,/arxiv_data1/oa_pdf/e8/3e/JPI-5-19.PMC4141425.pdf
"J Pathol Inform 2014, 1:19  http://www.jpathinformatics.org/content/5/1/19Lumen Density Lumen density characterizes those regions where the  H&E stain was not absorbed, such as lumen (inside  space of a cellular component) or lack of tissue (e.g.",Non-OADS,/arxiv_data1/oa_pdf/e8/3e/JPI-5-19.PMC4141425.pdf
"J Pathol Inform 2014, 1:19  http://www.jpathinformatics.org/content/5/1/19organization); on the other hand, if the nuclei  around a given pixel are oriented randomly, then it is  one (unstructured organization).",Non-OADS,/arxiv_data1/oa_pdf/e8/3e/JPI-5-19.PMC4141425.pdf
"J Pathol Inform 2014, 1:19  http://www.jpathinformatics.org/content/5/1/19Experimental Setup We use bone (B), cartilage (C), immature neuroglial (I),  neuroepithelial (N), and fat (F) tissues to make our  feature comparison.",Non-OADS,/arxiv_data1/oa_pdf/e8/3e/JPI-5-19.PMC4141425.pdf
"J Pathol Inform 2014, 1:19  http://www.jpathinformatics.org/content/5/1/19 Figure 5: Comparison of results with the combined set consisting of Gabor, local binary patterns and texton features.",OADS,/arxiv_data1/oa_pdf/e8/3e/JPI-5-19.PMC4141425.pdf
"J Pathol Inform 2014, 1:19  http://www.jpathinformatics.org/content/5/1/19classifier should not mark any pixels as bone), but it  does need training images for each new tissue type it  aims to identify.",Non-OADS,/arxiv_data1/oa_pdf/e8/3e/JPI-5-19.PMC4141425.pdf
"J Pathol Inform 2014, 1:19  http://www.jpathinformatics.org/content/5/1/19APPENDIX In this appendix, we present the mathematical expressions  for each term in the HV .",Non-OADS,/arxiv_data1/oa_pdf/e8/3e/JPI-5-19.PMC4141425.pdf
"J Pathol Inform 2014, 1:19  http://www.jpathinformatics.org/content/5/1/19The local average of this distance at a pixel (, )mn  gives  an indication of the uniformity of the arrangement of  nuclei in that region, forming one feature fw d a mn nr/nobreakspace/nobreakspace=´(), We compute a second feature at pixel (, )mn  by  computing the orientations of the vectors to the local  centers of mass and calculating their local entropy with  the same approach as above, fPl ogP logKbiK mn im ni nr/nobreakspace/nobreakspace=-=-å01 ,,() () qq where Pwmn ii mn ,,() ()q/nobreakspace/nobreakspace=´ QLabel Refinement For the NN classifier, label masks  01 1 ,, ....,/nobreakspaceL- are  accompanied by corresponding confidences cmn,(,]Î01.",OADS,/arxiv_data1/oa_pdf/e8/3e/JPI-5-19.PMC4141425.pdf
Available from:  http://www.nigeriastat.gov.ng.,Non-OADS,/arxiv_data1/oa_pdf/4e/8d/NJS-20-79.PMC4141450.pdf
Available from: http://www.bloomberg.com/news/2011‑01‑18/ nigeria‑s‑poverty‑ratio‑rises‑to‑70‑of‑population‑trust‑says.html.,Non-OADS,/arxiv_data1/oa_pdf/4e/8d/NJS-20-79.PMC4141450.pdf
"Received April 5, 2013; Accepted October 29, 2013 Decision Editor: Bob Knight, PhDThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/15/gbt123.PMC4141499.pdf
"Retrieved from http://www.frontier - sin.org/personality_science_and_individual_differences/10.3389/ fpsyg.2013.00405/abstract   Glück, J., Strasser, I., & Bluck, S. (2009).",OADS,/arxiv_data1/oa_pdf/a1/15/gbt123.PMC4141499.pdf
"Published by Oxford University Press on behalf of the UK Environmental Mutagen Society.doi:10.1093/mutage/geu025 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/57/geu025.PMC4141685.pdf
"The Effective Practice and Organization of Care (EPOC) group within Cochrane (http://epoc.cochrane.org/) and others have conducted several systematic reviews of such KT strategies, as well as organi- zational and institutional strategies, aimed at reducing barri- ers and facilitating the use of research evidence in decision making among healthcare professionals (Bero et al., 1998; Boaz, Baeza, Fraser, & European Implementation Score Col- laborative Group [EIS], 2011; Flodgren et al., 2011; Forsetlund et al., 2012; Grimshaw et al., 2001, 2004; Heselmans, Van d, Donceel, Aertgeerts, & Ramaekers, 2009; Jamtvedt, Young, Kristoffersen, O’Brien, & Oxman, 2006; O’Brien et al., 2007; Shojania et al., 2010; Thomas et al., 1998, 2000).",Non-OADS,/arxiv_data1/oa_pdf/04/6c/wvn0011-0156.PMC4141701.pdf
"To identify grey litera- ture the following searches were completed on June 14, 2013: Open Grey (http://www.opengrey.eu/); a key registry, KT Plus (http://plus.mcmaster.ca/kt/); online sites for relevant confer- ence proceedings, abstracts, and reports (the Research Transfer Network of Alberta (http://www.aihealthsolutions.ca/rtna/), KT Canada (http://ktclearinghouse.ca/ktcanada), Knowl- edge Utilization Colloquia (http://www.kusp.ualberta.ca/en /KnowledgeUtilizationColloquia.aspx), National Institutes of Health Science of Dissemination and Implementation con- ferences (http://obssr.od.nih.gov/scientiﬁc_areas/translation /dissemination_and_implementation), and Joanna Briggs In- stitute (http://joannabriggs.org/).",Non-OADS,/arxiv_data1/oa_pdf/04/6c/wvn0011-0156.PMC4141701.pdf
Position statement: Evidence-informed decision-making and nursing practice .R e - trieved from http://www2.cna-aiic.ca/CNA/documents/pdf/ publications/PS113_Evidence_informed_2010_e.pdf Cochrane Consumer Network.,OADS,/arxiv_data1/oa_pdf/04/6c/wvn0011-0156.PMC4141701.pdf
Retrieved from http://consumers.cochrane.org/levels-evidence Cochrane Effective Practice Organization of Care Group.,OADS,/arxiv_data1/oa_pdf/04/6c/wvn0011-0156.PMC4141701.pdf
Retrieved from http://epoc.cochrane.org/sites/epoc.cochrane.org/ﬁles/uploads /EPOC%20Study%20Designs%20About.pdf Norwegian Satellite of the Effective Practice and Organiza- tion of Care Group.,OADS,/arxiv_data1/oa_pdf/04/6c/wvn0011-0156.PMC4141701.pdf
Retrieved from http://epoc.cochrane.org/epoc-resources Nursing & Midwifery Council.,OADS,/arxiv_data1/oa_pdf/04/6c/wvn0011-0156.PMC4141701.pdf
"The code: Standards of conduct, performance and ethics for nurses and midwives .R e - trieved from http://www.nmc-uk.org/Documents/Standards/ The-code-A4--20100406.pdf O’Brien, M. A., Rogers, S., Jamtvedt, G., Oxman, A. D., Odgaard- Jensen, J., Kristoffersen, D. T., .",Non-OADS,/arxiv_data1/oa_pdf/04/6c/wvn0011-0156.PMC4141701.pdf
"Retrieved from http://www.nursingsociety.org/aboutus/PositionPapers /Pages/EBN_positionpaper.aspx Squires, J. E., Hutchinson, A. M., Bostrom, A. M., O’Rourke, H. M .",Non-OADS,/arxiv_data1/oa_pdf/04/6c/wvn0011-0156.PMC4141701.pdf
"Image taken from http://clearedleavesdb.org ( Das et al., 2014 ).",OADS,/arxiv_data1/oa_pdf/ae/d3/apps.1400005.PMC4141711.pdf
The source code for all examples is available on  https://github.com/abucksch.,Non-OADS,/arxiv_data1/oa_pdf/ae/d3/apps.1400005.PMC4141711.pdf
Website  http://www.mathworks.com/ matlabcentral/ﬁ  leexchange/4917-skeleton-in-3d  [accessed 10 July 2014].,Non-OADS,/arxiv_data1/oa_pdf/ae/d3/apps.1400005.PMC4141711.pdf
Website  http://dsp.stackexchange.com/questions/7622/ﬁ  nd- branches-in-skeleton-image-using-matlab  [accessed 15 April 2014].,Non-OADS,/arxiv_data1/oa_pdf/ae/d3/apps.1400005.PMC4141711.pdf
"A second pollen image database, PalDat (http://www.paldat.org), has a similar query structure and Web-based interface and includes both transmitted light images and scanning electron microscopy (SEM) images from ~2200 modern species and 32 fossil ones.",OADS,/arxiv_data1/oa_pdf/05/28/apps.1400030.PMC4141714.pdf
The demo website can be accessed at http://www.bioshapes.org/mioceneDB.,Non-OADS,/arxiv_data1/oa_pdf/05/28/apps.1400030.PMC4141714.pdf
Website  http://biogeodb.stri.si.edu/jaramillo/palynomorph/  [accessed 15 July 2014].,OADS,/arxiv_data1/oa_pdf/05/28/apps.1400030.PMC4141714.pdf
39p.Available from:  http://www.usp.org/pdf/EN/consumers/guide.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8f/09/pharmpract-06-178.PMC4141727.pdf
Available from:  http://www.kidshealth.org/teen/your_body/medical_care/meds.html.,Non-OADS,/arxiv_data1/oa_pdf/8f/09/pharmpract-06-178.PMC4141727.pdf
Available from:  http://www.hsrpp.org.uk/abstracts/2004_22.shtml.,Non-OADS,/arxiv_data1/oa_pdf/8f/09/pharmpract-06-178.PMC4141727.pdf
Available at:  http://www.census.gov/prod/2003pubs/c2kbr- 29.pdf.,OADS,/arxiv_data1/oa_pdf/17/b6/pharmpract-06-197.PMC4141730.pdf
Available at:  http://www.commonwealthfund.org/usr_doc/collins_comm onconcerns_surveycharts.p df?section=4056.,Non-OADS,/arxiv_data1/oa_pdf/17/b6/pharmpract-06-197.PMC4141730.pdf
Available at: http://www.census.gov/prod/ 2004pubs/censr-17.pdf.,OADS,/arxiv_data1/oa_pdf/17/b6/pharmpract-06-197.PMC4141730.pdf
"Available at: http://www.census.gov/prod/ 2004pubs/censr-18.pdf Accessed December 19, 2007.",OADS,/arxiv_data1/oa_pdf/17/b6/pharmpract-06-197.PMC4141730.pdf
Available at: http://www.census.gov/Press- Release/www/releases/archives/amer ican_community_survey_acs/007748.html.,Non-OADS,/arxiv_data1/oa_pdf/17/b6/pharmpract-06-197.PMC4141730.pdf
Available from: http://www.regeringen.se/sb/d/108/a/25107 (Accessed 21  October 2008).,Non-OADS,/arxiv_data1/oa_pdf/13/5b/pharmpract-06-211.PMC4141732.pdf
Available from: http://www.regeringen.se/content/1/c6/02/25/75/5be1e7e6.pdf (Accessed 21 October 2008).,Non-OADS,/arxiv_data1/oa_pdf/13/5b/pharmpract-06-211.PMC4141732.pdf
"Årsredovisning 2006 - Yearly report 2006 (in Swedish), available at http://www.apoteket.se Accessed Aug  2007.",Non-OADS,/arxiv_data1/oa_pdf/13/5b/pharmpract-06-211.PMC4141732.pdf
Vårdbarometern) (In Swedish) Available at  http://www.vardbarometern.nu/downloads/Vardbarometern_2006.pdf Accessed 23 October 2007.,Non-OADS,/arxiv_data1/oa_pdf/13/5b/pharmpract-06-211.PMC4141732.pdf
"Available at  http://www.acpe-accredit.org/ (Accessed November 28, 2007).",OADS,/arxiv_data1/oa_pdf/3a/98/pharmpract-06-219.PMC4141733.pdf
"Available at:  http://books.google.com/books?id=x1H7Tn2qig4C&pg=PA21& lpg=PA21&dq=30+american+phar maceutical+association +principles+of+practice+for+pharmac eutical+care&source=web&ots=EQ9IeQX iA_&sig=Cq6jNFRTuek62zsaG7z6z8LJN 3I#PPA22,M1 (accessed Oct 13, 2007).",Non-OADS,/arxiv_data1/oa_pdf/cc/55/pharmpract-06-057.PMC4141866.pdf
"Available at:  http://www.ccapp-accredit.ca/standards/ (accessed Oct 13, 2007).",OADS,/arxiv_data1/oa_pdf/cc/55/pharmpract-06-057.PMC4141866.pdf
Available at: http://ijahsp.nova.,Non-OADS,/arxiv_data1/oa_pdf/cc/55/pharmpract-06-057.PMC4141866.pdf
Council  meeting in the Hague 1998  [cited; 06-07-02] URL:  http://www.fip.org/www2/uploads/database_file.php?id=269&table_id=.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/pharmpract-06-074.PMC4141868.pdf
1997  [cited; 060615] Available  from: http://www.fip.org/www2/uploads /database_file.php?id=261&table_id=.,OADS,/arxiv_data1/oa_pdf/6f/e2/pharmpract-06-074.PMC4141868.pdf
"2006  [cited 060714]; Available from:  (http://www2.apoteket.se/Apoteket/om/VilkaViAr/default.htm060714), .",OADS,/arxiv_data1/oa_pdf/6f/e2/pharmpract-06-074.PMC4141868.pdf
2007; Available from: http://www.bpfk.gov.my/  [Accessed 3/10/2007];  6.,OADS,/arxiv_data1/oa_pdf/ee/c3/pharmpract-06-093.PMC4141871.pdf
"1997 Available from:  http://www.wto.org/english/tratop_e/tpr_e/tp67_e.htm [cited 2007 5th October];  8 Azmi IM, Alavi R. Trips, Patents, Technology Transfer, Fo reign Direct Investment and the Pharmaceutical Industry in  Malaysia.",Non-OADS,/arxiv_data1/oa_pdf/ee/c3/pharmpract-06-093.PMC4141871.pdf
Report version 1.1 S eptember 2003 available 20 January 2004 (in Danish)  at:http://e.gov.dk/uploads/media/Mediciner ing_bilag2_kommunal_hjemmesygepleje.pdf   43.,Non-OADS,/arxiv_data1/oa_pdf/c7/1e/pharmpract-06-103.PMC4141873.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/33/main.PMC4141889.pdf
http://dx.doi.org/10.1016/j.vaccine.2014.05.038 0264-410X/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/33/main.PMC4141889.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/33/main.PMC4141889.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/6e/main.PMC4141933.pdf
In the http://dx.doi.org/10.1016/j.fob.2014.07.007 2211-5463/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/dc/6e/main.PMC4141933.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: ER, endoplasmic reticulum; ERO1, ER oxidoreductin 1; GSH, glutathione; GSSG, glutathione disulﬁde; PDI, protein disulﬁde isomerase; TRX,thioredoxin ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/dc/6e/main.PMC4141933.pdf
Redox- active TRX domains a and a 0(gray boxes; Cys residues indicated by arrowheads) and redox-inactive TRX domains b and b0(white boxes) were predicted by NCBI conserved domain searches ( http://www.ncbi.nlm.nih.gov/Structure/cdd/ cdd.shtml ).,OADS,/arxiv_data1/oa_pdf/dc/6e/main.PMC4141933.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2014, 6: 24026 - http://dx.doi.org/10.3402/jom.v6.24026 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/42/f1/JOM-6-24026.PMC4141940.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24026 - http://dx.doi.org/10.3402/jom.v6.24026",Non-OADS,/arxiv_data1/oa_pdf/42/f1/JOM-6-24026.PMC4141940.pdf
"The median duration from the inclusion sample to dental sampling was 64 daysESBL-producing Enterobacteriaceae Citation: Journal of Oral Microbiology 2014, 6: 24026 - http://dx.doi.org/10.3402/jom.v6.24026 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/42/f1/JOM-6-24026.PMC4141940.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24026 - http://dx.doi.org/10.3402/jom.v6.24026",Non-OADS,/arxiv_data1/oa_pdf/42/f1/JOM-6-24026.PMC4141940.pdf
"At this point in time, at least 66% of patients infected with ESBL-E would be expected to be fecal carriers according to one earlierESBL-producing Enterobacteriaceae Citation: Journal of Oral Microbiology 2014, 6: 24026 - http://dx.doi.org/10.3402/jom.v6.24026 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/42/f1/JOM-6-24026.PMC4141940.pdf
Available from: http://www.unn.no/ getﬁle.php/UNN INTER/Fagfolk/www.antibiotikaresistens.no/NORM2010/norm_normvet_2010.pdf; 2011 [cited 5 March2007] 6.,Non-OADS,/arxiv_data1/oa_pdf/42/f1/JOM-6-24026.PMC4141940.pdf
J Oral Microbiol 2013; 5: 20736 - http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/f1/JOM-6-24026.PMC4141940.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24026 - http://dx.doi.org/10.3402/jom.v6.24026",Non-OADS,/arxiv_data1/oa_pdf/42/f1/JOM-6-24026.PMC4141940.pdf
"J Hosp Infect 1997; 36: 23 /C136.ESBL-producing Enterobacteriaceae Citation: Journal of Oral Microbiology 2014, 6: 24026 - http://dx.doi.org/10.3402/jom.v6.24026 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/42/f1/JOM-6-24026.PMC4141940.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
http://dx.doi.org/10.1016/j.nicl.2014.07.005 2213-1582/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
"After each stimulus, subjects used an MR-compatible trackball (Fellowes, http://www.fellowes.com)t o rate peak pain intensity on a computerized VAS, which consisted of a ver-tical scale labeled “no pain ”at the bottom and “most intense pain imagin- able ”at the top (DAPSYS, Brian Turnquist, Johns Hopkins University, http://www.dapsys.net ).",Non-OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
http://dx.doi.org/10.1001/archneurol.2011.9421555634 .,Non-OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
http://dx.doi.org/10.1111/j.1749-6632.2010.05446.x20392279 .,Non-OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
"Annals of Neurology 24, 41 –49.http://dx.doi.org/10.1002/ ana.4102401093415199 .",Non-OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
"Pain 140, 393 –394.http://dx.doi.org/10.1016/j.pain.2008.09.03018952372 .",Non-OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
"Brain and Language 102, 176– 185. http://dx.doi.org/10.1016/j.bandl.2006.",OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
"Neuroscience 10, 59 –70.http://dx.doi.org/10.1038/ nrn255519096369.",Non-OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
http://dx.doi.org/ 10.1002/hbm.2141622131304 .,Non-OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
"Psychiatry Research 174, 40 –46.http://dx.doi.org/10.1016/j.pscychresns.",Non-OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
"GigaScience 2, 6. http://dx.doi.org/10.1186/2047-217X-2-623628139 .",OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
http://dx.doi.org/10.1016/j.neuroimage.2009.07.02619631757 .,OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
http://dx.doi.org/10.1007/s00415-005-0028-416283098 .,Non-OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
http://dx.doi.org/10.1016/j.neubiorev.2005.06.00616183121 .,OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
http://dx.doi.org/10.1002/hbm.1007412454911 .,Non-OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.10.01917157035 .,OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
http://dx.doi.org/10.1002/mrm.1019112111932 .,Non-OADS,/arxiv_data1/oa_pdf/89/78/main.PMC4141974.pdf
